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Abstract 
Mesenchymal stem cells/multipotent stromal cells (MSCs) have a variety of 
unique properties that have made them a popular cell type in the study of tissue 
engineering. Their ability to undergo osteogenic, adipogenic and chondrogenic 
differentiation has long been appreciated. In addition to their capacity for 
skeletogenic differentiation, there are suggestions that MSCs have additional 
roles in organising tissue vasculature through interactions with endothelial cells 
(ECs). However, suitable experimental models to test these unique MSC 
activities are lacking and the mechanisms are unclear. Here, we have developed 
a novel 3D in vitro co-culture spheroid model of MSCs and ECs. 
Development and further investigations into this 3D co-culture spheroid model 
has resulted in many novel discoveries. Using calcium depletion from cell culture 
media to quantify osteogenic differentiation of MSCs in both 2D and 3D 
represents a complimentary assessment method that is non-destructive. Co-
culture of MSCs and ECs was also found to promote osteogenic differentiation 
whilst having no detrimental effects on cell viability during long-term culture. 
Further investigations into the 3D co-culture of MSCs and ECs demonstrated 
spontaneous endothelial organisation. Using this model it was possible to track 
endothelial restructuring and identify the signalling processes involved, ultimately 
focusing on platelet-derived growth factor and notch signalling. 
Using a combination of pre-differentiated MSCs and ECs within the 3D co-culture 
system, osteochondral spheroids were developed. These spheroids were 
analysed using a combination of novel and traditional imaging techniques; it was 
found that osteochondral spheroids self-organised into distinct bone and cartilage 
regions, similar to those observed at the osteochondral boundary and during 
early endochondral ossification. This in vitro multiple cell culture system 
represent a simplified tractable model of osteochondral tissue.  
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Chapter 1 : Introduction 
1.1 Stem Cells 
Stem cells have the capacity to produce an indefinite number of cells of the same 
type (self-renewal) and give rise to other cell types through differentiation 
(Mochizuki et al., 2014). The differentiation capacity or potency of stem cells 
makes them unique. Stem cells can be roughly divided into four groups 
depending upon their potency; totipotent, pluripotent, multipotent and unipotent 
(Surani et al., 2008). There are two totipotent cell sources: a fertilised egg and 
early embryonic cells; these cells are able to produce all other cell types within 
the body. Pluripotent cells are able to differentiate into most cell types; 
specifically they are able to differentiate into cells from all three germ layers but 
not extra-embryonic tissues (Kerr et al., 2006). The three germ layers are: 
endoderm, mesoderm and ectoderm, these are the three different groups of cells 
that arise during the gastrulation phase of embryonic development. Multipotent 
cells are able to differentiate into multiple cell types, however, these cell types are 
from one germ layer (Pittenger, 1999). Unipotent cells are only able to 
differentiate into one cell type (Guettier, 2005). 
Scientific publications on stem cells started in the 1960’s, however, in the 1990’s 
stem cell research became an area of intense scientific interest (Lajtha, 1967, 
Bradley, 1990). This interest arose due to the culture human embryonic stem 
cells within the laboratory. Stem cells generally have three sources; embryonic 
stem cells, adult stem cells and induced pluripotent stem cells (iPS cells)  
(Alvarez et al., 2012). Mammalian embryonic stem cells are isolated from the 
inner cell mass of a blastocyst and characterised as pluripotent. Adult stem cells 
are sourced from a wide variety of adult tissues; these are often considered to be 
multipotent or unipotent depending upon their source (Murphy et al., 2003). iPS 
cells are artificially derived from non-stem cells that have been genetically 
reprogrammed. The first iPS cell was created through the addition of four 
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transcription factors, Oct4, Sox2, KLF4 and c-Myc into mouse fibroblasts 
(Takahashi and Yamanaka, 2006). 
1.1.1 Embryonic Stem Cells 
Mammalian embryonic stem cells (ESCs) are derived from the inner cell mass of 
a blastocyst or developing embryo. The first ESCs were derived from mouse 
embryos; Evans and Kaufman were able to extract pluripotent stem cells from 
mice embryos. These cells were cultured and maintained in vitro and were shown 
to differentiate in vivo and in vitro (Evans and Kaufman, 1981). Mouse ESCs in 
vitro cell cultures were achieved through co-culture with feeder layers of 
mitotically inactive fibroblasts in combination with Leukaemia inhibitor factor (LIF). 
This co-culture promoted viability and proliferation of the cells (Martello and 
Smith, 2014, Onishi and Zandstra, 2015).  
Human ESCs are also derived from the inner cell mass of a blastocyst; in vitro 
cell culture is maintained by co-culture with a feeder layer of mitotically inactive 
fibroblasts. However, human ESCs do not require LIF (Schnerch et al., 2010). 
This small difference highlights the importance of different species at both the 
molecular and cellular level. The use of human ESCs for research has great 
potential due to their pluripotent differentiation potential. However, due to a 
blastocyst being destroyed to obtain these cells they are surrounded by ethical 
controversy. Because of these ethical concerns, human ESC research is highly 
regulated; in the UK all research using human ESCs is performed under license 
from the human fertilisation and embryology authority (Abdalla, 2009). This does 
not prevent human ESC research but makes it a more complex process. This has 
led to an increased demand for alternative cell sources, culminating in the 
generation of iPS cells and the increasing trend of adult stem cells. 
1.1.2 Adult Stem Cells 
Adult stem cells are a multipotent or unipotent cell type that is found throughout 
the body post embryonic development (Vaes et al., 2015). Compared to ESCs, 
: Introduction 
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adult stem cells are less potent; however, they are not ethically controversial due 
to being sourced from adults following informed consent (Alvarez et al., 2012). 
Within the body, adult stem cells are a small and unique population of cells found 
within tissues such as, bone, liver, teeth, cord blood and skin (Hong et al., 2014). 
The roles of adult stem cells are maintaining tissue homeostasis and tissue repair 
after injury. They are able to achieve this through their self renewal capacity and 
differentiation potential (Hass et al., 2011). These abilities are supported through 
a specialised microenvironment known as the stem cell niche (Kopp and Rafii, 
2007). Adult stem cells are considered multipotent; nevertheless, a few unipotent 
adult stem cells exist, depending upon cell type and tissue source (Mariano et al., 
2015). This multipotency is restrictive compared to the pluripotent potential of 
ESCs. However, controversial research has shown that under specific in vitro 
culture conditions adult stem cells are able to transdifferentiate into cell types of 
alternative germ layers, indicating adult stem cells may have a broader potential 
but further validation work is required (Fan et al., 2014). 
Overall adult stem cells are considered to have a variety of advantages 
compared to ESCs; adult stem cells are less tumourigenic compared to ESCs, 
reducing the risk of tumour formation following therapeutic application (Kang et 
al., 2012). Due to the wide variety of adult tissue sources, autologous cell 
therapies have viable potential, unlike ESCs (de Munter and Wolters, 2013). 
However, the main advantage is the lack of ethical issues that are commonly 
associated with ESCs. These advantages have led to adult stem cells being used 
in a variety of therapies, including bone marrow transplants and coronary artery 
disease (Mathe, 1964, Botham et al., 2013). One of the most popular adult stem 
cells for these regenerative medicine therapies is mesenchymal stromal 
cells/mesenchymal stem cells (MSCs) (Sensebe et al., 2010). 
1.2 Mesenchymal Stromal Cells 
Mesenchymal stromal cells, often also referred to as mesenchymal stem cells 
were first isolated from bone marrow in the 1970’s by Fridenstein, they were 
characterised as a clonogenic cell, with a fibroblast-like morphology and plastic 
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adherence (Friedenstein et al., 1976). In addition to this, MSCs also 
demonstrated the ability to differentiate into osteoblasts, adipocytes and 
chondrocytes (Cook and Genever, 2013). This combination of self renewal and 
skeletal differentiation identified MSCs as a stem cell. Unfortunately a specific cell 
surface marker for MSCs has not been identified. This has resulted in MSC 
characterisation being performed through tri-lineage differentiation potential, 
morphology and a panel of non-specific cell surface markers. MSCs are 
described as being positive for the cell surface markers CD29, CD44, CD73, 
CD90, CD105 and CD166. Negative for CD11a, CD13, CD19, CD34, CD45, 
CD79a, CD144 and CD235a (Dvorakova et al., 2008, Karp and Leng Teo, 2009). 
Additional markers such as Stro-1 CD146 and CD271 have also been described 
in the literature (Whyte et al., 2011).  
1.2.1 Mesenchymal stromal cell isolation 
Historically MSCs were initially sourced from adult bone marrow; subsequently 
this MSC source has received the most attention. Within bone marrow MSCs 
represent approximately 0.01-0.001% of the total cell population (Li et al., 2011). 
Despite the low frequency, bone marrow aspirations are able to produce enough 
viable cells for therapies or scientific research. In addition MSCs are easily 
expanded within ex vivo culture conditions, making this cell type popular for stem 
cell research and treatments. MSCs have been sourced from a wide variety of 
tissues such as; adipose tissue, liver, spleen, detal pulp and umbilical cord blood 
(Mohammadi et al., 2015, Krampera et al., 2007). Due to the wide variety of 
tissues from which MSCs have been sourced, it has been hypothesised that 
MSCs have the ability to enter the circulatory system and travel to sites of injury 
(Tondreau et al., 2005). This has led to MSCs being intravenously injected for 
therapeutic research, which has proven successful (Oh et al., 2012, Introna et al., 
2014). However, several studies have failed to detect MSCs within peripheral 
blood diminishing this theory (Kollar et al., 2011).  
MSCs sourced from different tissues all express the three main characteristics 
used to identify this cell type. The panel of non-specific cell surface markers 
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previously mentioned (Section 1.2), morphology and skeletal differentiation 
potential. However, the anatomical location of MSCs may affect specific 
characteristics; MSCs derived from synovium have demonstrated the ability to 
undergo chondrogenesis more readily compared to bone marrow derived MSCs 
(Sakaguchi et al., 2005). Adipose derived MSCs have been shown to more 
readily transdifferentiate into a Schwann cell-like phenotype compared to bone 
marrow derived MSCs (Krampera et al., 2007). This indicated that MSCs from a 
specific tissue might be partially programmed to enhance local tissue repair, 
emphasising the importance of selecting an appropriate tissue source for 
scientific experiments and cellular therapies. 
1.2.2 Mesenchymal stromal cell differentiation  
One of the main characteristics of MSCs is their ability to undergo skeletal 
differentiation; a schematic representation of this is shown in Figure 1.2.1. Under 
ex vivo conditions this differentiation by exposing MSCs to a cocktail of inductive 
stimuli has been well defined, more specifically osteogenic differentiation is 
induced through the addition of dexamethasone, β-glycerophosphate and 
ascorbic acid (Cook and Genever, 2013). Adipogenic differentiation is performed 
through the addition of insulin, isobutylmethylxathine, indomethacin and 
dexamethasone. Chondrogenic differentiation is induced through the use of 
dexamethasone, ascorbic acid, insulin transferring selenium, transforming growth 
factor-β3 (TGF-β) or TGF-β1 and proline (Vater et al., 2011, Mueller et al., 2010).  
The three clearly defined cell types MSCs are able to differentiate into are all 
from the mesoderm. Controversially MSCs have been described as undergoing 
endoderm-like and ectoderm-like tissue differentiation. This transdifferentiation is 
possible through the addition of inductive stimuli similar to standard 
differentiation. MSCs have been shown to differentiate into a neuron-like cell type 
through the addition of β-mercaptoethanol, retinoic acid, forskolin, platelet derived 
growth factor, basic fibroblast growth factor and glial growth factor (Mahay et al., 
2008). However, this process is limited as removal of these factors results in the 
loss of neuronal-like phenotype (Yi et al., 2012). 
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Figure 1.2.1 – Schematic representation of MSC differentiation 
MSCs are able to undergo tri-lineage mesoderm differentiation into osteoblasts, 
chondrocytes and adipocytes. MSCs are also able to undergo self renewal to 
produce more MSCs. Controversially MSCs have been described as 
transdifferentiating into neural-like and epithelial-like cells.  
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1.2.3 Therapeutic potential of mesenchymal stromal cells 
Since their discovery the potential of MSCs for stem cell therapies has been 
widely acknowledged. Indeed, MSCs were inadvertently one of the very first cell 
types to be used in stem cell therapy; bone marrow transplants to treat leukaemia 
were successfully pioneered in the 1960’s (Mathe, 1964). Since this initial 
ground-breaking success the strategies conceived to utilise MSCs have been 
extensive. MSCs have a wide variety of advantageous properties for a wide 
range of disease therapies.  
MSCs can be sourced from a wide variety of tissues, allowing autologous cell 
therapies, for example adipose tissue can be harvested to treat bone defects (Im 
et al., 2005). MSCs are a strong candidate for skeletal repair, within the native 
bone tissue, MSCs contributed towards the normal repair and remodelling 
process. MSCs differentiated into osteoblasts, the primary role of these cells is to 
produce the mineralised extra cellular matrix of the bone (Zanetta et al., 2009). 
Uniquely MSCs have been described as possessing both immunoprivileged and 
immunosuppressive properties, making them potentially an allogeneic cell 
source. MSCs do not express major histocompatible complex (MHC) class II, 
limiting their detection via the immune system (Liu et al., 2006, Romieu-Mourez 
et al., 2007). MSCs have also been shown to inhibit T-cell proliferation and 
natural killer cell lysis (Asari et al., 2009). 
MSCs are currently being used in clinical trials for the treatment of graft versus 
host disease. Graft versus host disease is a common complication that occurs 
following allogeneic tissue transplantation. The transplanted immune cells attack 
the hosts own cells damaging tissues within the whole body. Intravenous 
infusions of MSCs from allogeneic sources have been shown to successfully treat 
the disease and significantly increase survival rates (Ringden et al., 2006, Introna 
et al., 2014). MSCs have also been used in successful clinical studies for a range 
of bone tissue diseases, such as osteoporosis and osteogenesis imperfecta 
(Antebi et al., 2014, Chan and Gotherstrom, 2014). These successes are most 
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likely attributed towards MSCs playing an important role in their native bone 
tissue. Intriguingly MSCs have also been used to successfully treat circulatory 
diseases, such as ischemia. Using animal models, application of MSCs in cell 
aggregates has been shown to improve limb ischemia, this is due to MSCs 
inhibiting cellular apoptosis and releasing large numbers of growth factors, such 
as TGF-β (Bhang et al., 2012a, Chen et al., 2013b). 
Despite the success observed within clinical trials and studies, MSCs have not 
received FDA approval as a licensed cellular therapy; one of the major reasons 
for this is a lack of a specific cell surface marker (Mendicino et al., 2014). 
Therefore, the use of MSCs as an off the shelf allogeneic cell source within an 
industrial setting is not yet possible. Additionally, the efficacy of MSC engraftment 
and differentiation in vivo has also been questioned. Large quantities of MSCs 
have been implanted and have subsequently undergone apoptosis or virtually 
disappeared within the body (Noad et al., 2012). This causes safety concerns 
regarding tumour formation and other unwanted side effects (Volarevic et al., 
2011). Consequently, studies have begun to focus on the use of MSCs as a cell 
source for basic research and in vitro models. Initially these studies focused on 
drug screening and toxicity, however, MSCs are starting to be utilised in cancer 
studies, tissue models and developmental biology (Astashkina et al., 2012). 
Specifically MSCs have shown promise in understanding human bone repair. 
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1.3 Adult bone repair 
During adult bone repair, cartilage tissue initially forms at the site of injury. This 
cartilage tissue is then infiltrated by new blood vessels; triggering the cartilage 
tissue to be replaced with functional vascularised bone tissue (Tannous et al., 
2013, Sisask et al., 2013). The cells that initiate this bone repair process in adult 
tissue have been identified as hematoma-derived cells. These hematoma-derived 
cells express the same cell surface markers and skeletal differentiation potential 
as MSCs, but have not been specifically identified as MSCs (Oe et al., 2007, 
Koga et al., 2013). MSCs have significant therapeutic potential for adult bone 
repair; they are a native cell type that plays a key role in bone tissue 
homeostasis, moreover, during adult bone repair hematoma-derived cells that 
express the same phenotype as MSCs are identified as the initiation cell source. 
Therefore, MSCs have close links to bone tissue homeostasis and adult bone 
repair. 
1.3.1 Adult bone repair and mesenchymal stromal cells 
Within humans the skeleton undergoes a continuous remodelling process during 
adulthood. This remodelling process is performed by two cell types: osteoblasts 
and osteoclasts. Osteoblasts are derived from MSCs and deposit the calcified 
bone matrix; osteoclasts are derived from haematopoietic stem cells and resorb 
the calcified bone matrix (Kular et al., 2012). Ex vivo MSCs have been shown to 
successfully produce bone tissue and many studies have claimed to use 
undifferentiated MSCs or osteogenic differentiated MSCs to successfully treat 
bone defects (El-Gendy et al., 2013, Granchi et al., 2012). However, few human 
clinical trials using MSCs have been performed and the efficacy of these 
treatments is disputed (Meijer et al., 2007). These poor results are mainly 
attributed towards a lack of vascularisation. Therefore, the use of chondrogenic 
MSCs could prove successful; cartilage is an avascular tissue so a lack of 
vascularisation is not detrimental and normal bone repair starts with the formation 
of cartilage tissue at the site of injury. 
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Alternative treatments utilising the chondrogenic differentiation potential of MSCs 
in bone defects have proven successful. Chondrogenic MSCs were found to have 
superior bone formation in vivo compared to osteogenic differentiated MSCs and 
undifferentiated MSCs (Farrell et al., 2011, Janicki et al., 2010). Indeed, the 
utilisation of chondrogenic adult MSCs have proven successful for bone repair. 
Ex vivo human MSCs underwent both chondrogenic differentiation and 
hypertrophy treatment. These hypertrophic chondrocytes were then implanted 
into the bone defects of mice. The cells were found to have physiologically 
remodelled the bone, vasculature and hematopoietic compartment. These results 
showed that chondrogenic MSCs were able to successfully produce a functional 
bone repair. These results were attributed towards an endochondral ossification-
like process and this model could be used for fundamental and translational 
research (Scotti et al., 2013, Scotti et al., 2010). 
1.3.2 Endochondral ossification 
Endochondral ossification is the term used to describe the formation of long 
bones during embryonic development and provides a suitable environment for 
haematopoiesis (Chan et al., 2009). A simplified schematic version of this can be 
seen in Figure 1.3.1. In brief, the process of endochondral ossification starts with 
primitive mesenchymal cells condensing together with the centrally-located cells 
differentiating into chondrocytes though Sox9 expression. This a-vascular 
chondrocyte centre undergoes hypertrophy and begins to synthesise collagen 
type X and mineralise the surrounding matrix. This simultaneously triggers blood 
vessel recruitment through secretion of vascular endothelial growth factor (VEGF) 
and directs adjacent mesenchymal cells to become osteoblasts and subsequently 
bone matrix. The in-growth of blood vessels triggers the cartilage core to undergo 
resorption of the cartilage matrix and replacement with vascularised bone 
(Kronenberg, 2003, Maes et al., 2002). The endochondral ossification process 
highlights the importance of the cellular microenvironment for macro scale tissue 
development.  
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Figure 1.3.1 - Schematic representation of endochondral ossification 
Endochondral ossification is the process of embryonic long bone development. 
Primitive mesenchymal cells condense together to form a cartilage core. The 
cartilage core simultaneously signals the recruitment of blood vessels and 
differentiation of adjacent cells into bone tissue. The in-growth of blood vessels 
triggers resorption of the cartilage core and replacement with vascularised bone 
tissue. During adult bone healing a similar process occurs, were cartilage tissue 
is initially produced within the damaged region before being replaced with 
vascularised bone tissue. 
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1.4 The stem cell niche 
A stem cell niche is the term used to describe the microenvironment in which a 
stem cell resides. The concept of a stem cell niche was first conceived by 
Schofield in the 1970’s, he hypothesised that stem cells must associate with 
other cells which determine behaviour. This behaviour ensures that stem cells 
proliferate to maintain a population but also differentiate as required (Schofield, 
1978). This initial definition has since expanded and a stem cell niche refers to 
the specific anatomical compartment in which stem cells are located (Van Zant 
and Liang, 2012). This compartment is composed of different cell types alongside 
the microenvironment, including physical and chemical cues. More specifically 
biochemical signalling from neighbouring cells, soluble factors, extra-cellular 
matrix (ECM), sheer forces and oxygen tension all play an important role within 
the stem cell niche (Chen et al., 2013c). Understanding this environment is 
important for the in vitro culture of stem cells and future applications in medicine 
(Moore and Lemischka, 2006).  
One of the most well defined stem cell niches is that of haematopoietic stem cells 
(HSCs). HSCs are located within the bone marrow and differentiate into all 
haematopoietic lineages (Greenbaum et al., 2013). The HSC niche is well 
defined due to clear cell surface marker profile expressed. The HSC niche is not 
believed to be anatomically restricted, resulting in temporary and spatial 
regulation (Adamo et al., 2009, Adamo and García-Cardeña, 2012). Bio-
mechanical forces play a key role, fluid sheer stress on HSCs has been shown to 
increase expression of RUNX1 a regulator of haematopoietic development 
(Keung et al., 2010). Low oxygen concentration is also critical, HSC respond to 
hypoxic conditions to shift towards a glycolysis based metabolism that promotes 
survival, tracer studies have confirmed HSCs reside within poorly perfusing 
regions with low oxygen (Sakaguchi et al., 2005). 
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1.4.1 Mesenchymal stromal cell niche 
Due to the lack of a specific cell surface marker in combination with the wide 
range of tissues in which MSC-like cells have been identified, the MSC niche has 
not been clearly defined. In general it is known that the MSC niche is composed 
of multiple cell types, ECM and an oxygen gradient (Figure 1.4.1). Nevertheless, 
two main types of niches within the bone marrow have been proposed; endosteal 
and perivascular (Balduino et al., 2012). The endosteal niche is most commonly 
associated with HSCs; this niche is closely associated with the endosteum region 
of bone, which is the interface between bone and bone marrow (Cordeiro-Spinetti 
et al., 2015). Within this niche stem cell specifically associate with osteoblasts, 
osteocytes and the bone matrix (Pazzaglia et al., 2014). The most popular theory 
is that MSCs reside within a perivascular niche (Jørgensen et al., 2004, Crisan et 
al., 2008). The perivascular niche is closely associated with the vascular 
structures of the tissue. Therefore, a perivascular niche is not tissue restricted, 
unlike an endosteal niche (Ghajar et al., 2013). This further supports the theory 
that MSCs reside within a perivascular niche; MSCs have been derived from a 
wide variety of tissues associated with the vasculature. The exception to this is 
MSCs sourced from cartilage which is an avascular tissue (Barbero et al., 2003). 
This highlights the probably important relationship between MSCs and 
endothelial cells due to the close association with the vasculature. Indeed, 
endothelial cells and the vasculature are a frequently overlooked vital component 
of bone tissue, bone is one of the most vascularised tissues within the body 
(Brandi and Collin-Osdoby, 2006). 
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Figure 1.4.1 – Schematic representation of the perivascular MSC niche 
The perivascular MSC niche is a complex microenvironment composed of 
multiple cell types such as: osteoblasts and endothelial cells. There are also 
physical cues within the niche, such as bone matrix, blood vessels and oxygen 
gradients. 
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1.5 Endothelial Cells 
Endothelial cells (ECs) originate from the mesoderm and form the inner lining of 
blood vessels; subsequently ECs are present within the majority of the body’s 
tissues. ECs are able to form a selectively permeable membrane that provides 
multiple functions; a barrier between blood and tissue, homeostasis regulation, 
inflammatory and immune response, angiogenesis and vasculogenesis (Bazzoni 
and Dejana, 2004). Homeostasis is the regulation of body temperature within 
mammals through blood vessel dilation or restriction. Angiogenesis is the 
formation of new blood vessels from a pre-existing blood vessel; this process is 
also referred to as vascularisation. Vasculogenesis is the formation of new blood 
vessels within the developing embryo (Sumpio et al., 2002). In addition to these 
important roles ECs are also implicated within the stem cell niche, ECs regulate 
the diffusion of molecules such as oxygen, growth factors and other small 
molecules. Specifically within the perivascular niche of MSCs, ECs are an 
important cell type (Colmone and Sipkins, 2008). 
ECs have been sourced from a variety of tissues for in vitro scientific culture, 
sources include; human umbilical veins, aorta, coronary artery, pulmonary artery, 
iliac artery and dermal microvasculature (Park et al., 2006, Lloyd et al., 2013). 
Like MSCs, ECs vary depending upon their source. Human umbilical vein 
endothelial cells (HUVECs) are considered one of the most commonly used and 
well defined ECs. HUVECs are generally used in the study of the adult 
endothelium and are used to recreate normal adult blood vessels within in vitro 
conditions (Manna and Jain, 2014). Aorta, pulmonary artery and coronary artery 
derived ECs are sourced from large vessels and are more commonly used to 
study coronary artery diseases (Chang et al., 2013b). Dermal microvasculature 
ECs are a neonatal source that is most commonly used within tumour studies 
(Dong et al., 2013). 
The vascularisation process is highly important for normal embryonic 
development, adult homeostasis and repair (Street et al., 2002). The loss of 
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vascularisation to any tissue results in cellular apoptosis and subsequently critical 
failure. One of the most common uses of ECs has been in the study of the 
vasculature within cancer tumours. From these cancer studies the importance of 
vascular endothelial growth factor (VEGF) in promoting angiogenesis within ECs 
has been revealed (Coultas et al., 2005, Xiong et al., 2014). Additionally 
transmembrane proteins such as vascular endothelial (VE)-cadherin have also 
been demonstrated to play an important role in the cellular arrangement of ECs 
(Bentley et al., 2014). Recent developments within the field of tissue engineering 
for regenerative medicine have found vascularisation critical for the successful 
implantation of the next generation of supportive devices (Novosel et al., 2011). 
Specifically, 3D scaffolds sympathetically designed to incorporate native vascular 
had improved clinical performance compared to those which did not (Xiao et al., 
2015). 
1.6 Three-dimensional cell culture models 
The first ex vivo cell culture was performed in 2D on tissue culture plastic; this 
has subsequently developed into a variety of 3D strategies to more closely 
recreate the native in vivo environment (Haycock, 2011). Traditional 2D culture 
does have advantages; convenient, in-expensive, reproducible and robust for 
statistical analysis. However, differences in cell morphology, differentiation 
potential, therapeutic capacity and maintenance of phenotype have all been 
reported (Ivers et al., 2014, Brennan et al., 2015, Cha et al., 2015, Zeng et al., 
2015). To combat this, different 3D-based cell culture strategies have been 
developed including; scaffolds, bioreactors and cell aggregates or spheroids 
(Ravi et al., 2015). 
1.6.1 Scaffolds 
Scaffold is the termed used to describe any material specifically developed for 
cells to be cultured on. Scaffolds were initially conceived as an ECM replacement 
on which cells would colonise and subsequently functionalise.  They are 
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predominantly 3D in nature, however, 2D scaffolds are frequently utilised. The 
choice of material is fundamental in scaffold design; materials are able to adjust 
the physical and functional properties considerably. For example hard and soft 
materials can be used in various combinations to generate virtually every tissue 
within the body. Because of this the material and design used have significant 
impact on the success of the scaffold and subsequently scaffolds are designed 
for specific tissues. Indeed, biphasic and triphasic scaffolds are being utilised 
successfully to recreate both the physical and biological properties of tissues 
such as bone and cartilage (Marquass et al., 2010). However, the use of 
scaffolds has a range of advantages and disadvantages. The use of natural 
materials such as collagen and keratin are biocompatible, biologically functional 
with similar mechanical properties to the in vivo tissue. However, they are 
relatively expensive, ethically controversial due to them being sourced from 
healthy animals, have concerns regarding pathogen transmission and complex 
structural architecture is lost through synthetic production or tissue extraction 
(Long et al., 2014). By contrast the use of synthetic materials such as 
polycaprolactone and polyethylene glycol are relatively inexpensive, ethical 
controversy free and cannot cause pathogen transmission. However, they have 
poor biological compatibility, have little biological functionality and their physical 
properties are greatly different from those of natural tissue.  
 A recent development within the field of natural scaffolds, to avoid many of the 
disadvantages described previously is the decellularisation process. A tissue 
from a donor organism is harvested; the cells within the tissue are removed along 
with DNA and RNA, leaving a complex hierarchal organised structure. Within in 
vitro culture these decellularised scaffolds have been highly successful; however, 
translation into clinical use has been poor. Unfortunately, the clinical application 
of these decellularised tissues as heart valve replacements resulted in one study 
as having a 100% failure rate. Four out of four human patients who received 
decellularised heart valve replacements failed within a month of application. This 
failure was attributed to the decellularised tissue eliciting a strong inflammatory 
response causing rapid structural failure and degeneration of the graft (Simon, 
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2003). Subsequently the use of decellularised tissues for clinical applications has 
been conducted more conservatively with improved success rates. Overall 
decellularised scaffolds have a range of advantages and disadvantages. They 
have a complex architecture that can be easily colonised via in vivo or in vitro cell 
sources; they are biologically functional and have similar physical properties to 
the chosen material. However, they cannot be ethically produced, could cause 
possible pathogen transmission, have had poor success clinically and are 
relatively expensive (Minardi et al., 2015).  
1.6.2 Bioreactors 
Bioreactor is the term used to generally describe any device or system that can 
support biological material. Bioreactors have a wide range of sizes, from a few 
millilitres to thousands of litres, that are most commonly used within industry 
(Luh, 1995). During the 1990s one of the most numerous bioreactor systems 
used for cell biology research was the rotating walled vessel (NASA) bioreactor, 
this bioreactor was able to culture 3D cell clusters within a simulated microgravity 
environment (Duray et al., 1997). Since this initial development a wide range of 
bioreactors are now available that can exert a wide range of mechanical forces 
such as, stress, strain, compression and fluid forces (Rauh et al., 2011, Ji et al., 
2014). The use of bioreactors is currently the only method available to exert such 
a wide range of forces on biological material. Additionally, they can be combined 
with imaging and measuring devices for combined in situ analysis. However, 
bioreactors have a variety of disadvantages such as; requiring a large number of 
cells, expensive, complex assembly and being prone to infections (Bilodeau and 
Mantovani, 2006). 
1.6.3 Cell aggregates  
Cell aggregates or cell spheroids are 3D structures composed entirely of cells 
that have aggregated together. They do not contain any scaffold material and can 
be frequently created without the use of specialised equipment such as a 
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bioreactor. There are four main methods to producing cell aggregates, rotating 
plate culture, hanging droplets, non-adhesive U-bottom well plates and semi-solid 
gel culture (Figure 1.6.1) (Hildebrandt et al., 2011). The generation of cell 
aggregates is relatively simple; most cell types are able to spontaneously form a 
3D spheroid structure when appropriate culture methods are used. Moreover 3D 
spheroid aggregates have been shown to produce ECM components such as 
collagen in greater quantities compared to traditional 2D culture (Murphy et al., 
2015). Overall cell aggregates have several advantages; they require a relatively 
low cell number, no materials are required due to cell-cell interactions and they 
are inexpensive compared to bioreactors and scaffolds. There can be variation in 
cell aggregate size depending upon the method used to generate them; however, 
using either the hanging droplet or non-adhesive U-bottom well plate method 
prevents this. The main disadvantage with all cell aggregates is that they require 
dexterous handling to prevent damage. 
Within specific biological research fields the use of cell aggregates has been 
essential. Specifically, within cancer biology cell aggregates have been found to 
more closely represent the native tumour environment. In particular they have 
been highly important when mimicking avascular tumours due to being 
structurally, biologically and physically similar. Furthermore, cell aggregates have 
been successfully used for toxicology testing and high-throughput drug 
screenings with great efficacy compared to other cell culture methods (Thoma et 
al., 2014). From these original and highly successful single-cell aggregates the 
concept of more complex cell aggregates arose. The use of multiple cell types 
within a single cell aggregate has been used to create retinospheres. 
Retinospheres are composed of three different cell types from embryonic avian 
retina being arranged in the same layers as those of the in vivo retinal layers 
(Berchtold et al., 2011). These more advanced multi-cellular aggregates are 
commonly referred to as organotypic models or organoids. 
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Figure 1.6.1 – Schematic representation of the different methods to produce 
cell aggregates 
A - Rotating plate culture. B – Hanging droplet culture, a small volume of liquid is 
placed on the lid of a petri dish which is then inverted. C – Specialised plastic 
ware such as U-bottomed non-adherent plates. D – Semi-solid gel culture, this 
can also be combined with the technique depicted in C.  
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1.6.4 Ex vivo organotypic cell culture 
The term organotypic was originally used to describe the 3D structure cells from 
siliceous sponges made when cultured ex vivo. This original organotypic model 
was primarily a single cell-type aggregate that formed a 3D spheroid-like 
structure (Wilson, 1907). Since this initial observation over 100 years ago the 
uses of organotypic cell culture and models have developed significantly, human 
tissues such as kidney and retina have been recreated. Organotypic cell culture 
models are unique in their ability to mimic aspects of organ function through the 
use of multiple cell types (Lancaster and Knoblich, 2014). Indeed, organotypic 
models used in combination with high-throughput imaging systems, chemical 
probes, biological probes and gene analysis; have made automated analysis both 
robust and practical (Li et al., 2015).  
One of the most recent developments in organotypic models is the use of tissue 
slices in combination with ex vivo cell culture to more closely replicate the native 
environment. This type of model has been particularly successful in recreating 
dental tissue within the laboratory. Specifically, this model has been used to 
observe the effects of bacterial infection within dental tissue. Increased bacteria 
within the oral cavity are known to cause infection and subsequently abscesses. 
However, indentifying the specific bacteria involved has been difficult due to the 
lack of appropriate models. Using an organotypic model of mandible slices it was 
possible to identify that Streptococcus anginosus group of bacteria are an 
opportunistic pathogen which can causes disease within the oral cavity (Roberts 
et al., 2013). This model has also been further developed to include the use of 
MSCs for regenerative medicine purposes. Fluorescently labelled MSCs were 
placed into the mandible model and found to produce cells with an appropriate 
phenotype in the relevant regions (Colombo et al., 2015). The success of these 
3D cell culture models has been attributed towards the increase in cell-adhesion 
molecules, such as integrin-linked kinase, compared to 2D systems (Sakai et al., 
2003). 
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1.6.5 Integrin-linked kinase 
Integrins and Integrin-linked kinase (ILK) provides a physical link between the 
cellular cytoskeleton and the ECM. Generation of these connections activates 
intracellular signals, such as Mitogen activated protein kinase  (MAPK) and 
Phosphoinositide 3-kinase  (PI3K) that contribute towards cell proliferation, 
differentiation, survival and migration (Figure 1.6.2) (Hsu et al., 2015, Zheng et 
al., 2015, Yoon et al., 2015, Wang et al., 2014). The loss of ILK leads to a range 
of global cellular effects, such as a decrease in the number of cell-cell 
connections and decreased cadherin expression (Novak et al., 1998). However, 
there is limited understanding of how ILK is able to interact and be influenced by 
a variety of cell signalling pathways, such as Wnt (Miller and Moon, 1996). 
Little is known about how ILK expression affects MSCs, however, ILK expression 
is down regulated during chondrogenic differentiation (Goessler et al., 2006, 
Goessler et al., 2009). ILK over expression was induced through adenoviral 
transduction in vitro and was found to increase MSC proliferation and reduce 
apoptosis. These ILK over expressing MSCs were then transplanted into a 
myocardial infarction porcine model and found to improve ventricular remodelling 
and cardiac function (Mao et al., 2014). 
ILK plays an important role in the maintenance of ECs and endothelial tissues, 
diseases such as uraemia (urea in the blood) cause damage to the vasculature 
and ECs. Within a mouse model ILK knock out was induced in ECs, the cells 
expressed enhanced apoptosis, increased reactive oxygen species production 
and decreased cell proliferation when exposed to a urea toxin. Therefore, ILK 
plays an important role in EC protection against urea toxins through an unknown 
molecular mechanism (Garcia-Jerez et al., 2015). Additionally the importance of 
ILK in angiogenesis has been reported. Through the use of a novel inhibitor 
molecule, ILK transcription was suppressed. This inhibitor molecule was applied 
to in vitro and in vivo melanoma assays and found to suppress angiogenesis 
within both models. These results were attributed towards reduced EC migration 
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through cytoskeleton rearrangement (Lu et al., 2013, Chen et al., 2007). ILK is an 
important molecule that allows cells to interact with their external environment, 
either directly through binding with ECM or indirectly through cell-cell adhesion. 
Indeed, these cell-ECM and cell-cell adhesions are the force bearing structures 
that respond to forces from the surrounding environment of multi-cellular tissues 
(Collins and Nelson, 2015).   
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Figure 1.6.2 – Schematic representation of integrin-linked kinase 
Integrins provide a link between the cytoskeleton of a cell and the extra cellular 
matrix (ECM), this can trigger PI3K and MAPK signalling leading to changes in 
cell survival, migration and proliferation. 
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1.6.1 Multiple cell culture 
Traditional cell culture has consisted of using a single cell type; the culture of 
cells from an individual cell source is often used to generate a specific cell line. 
The continuation of these cell lines is fundamental for reproducible biological 
research. Therefore, culturing multiple cell types together has been shunned for 
fear of cross-contamination. Indeed, cross-contamination within cell lines has 
frequently been reported, the HeLa cell line has been reported as one of the most 
common contaminants (Jager et al., 2013, Kniss and Summerfield, 2014). 
However, the culture of a single cell type does not accurately recreate the in vivo 
environment.  
Within the physiological environment, native tissues are multi-cellular systems. 
The interactions of these various cells is imperative for proliferation, viability, 
differentiation, growth factors and extra cellular matrix production (Hui and 
Bhatia, 2007, Nam et al., 2011, Sorrell et al., 2007, Traphagen et al., 2013). 
Subsequently in vitro co-culture of multiple cell types has been used to enhance 
research in a wide range of fields. Within breast cancer studies, aromatase 
inhibition is the main treatment method in oestrogen receptor positive breast 
cancer (Sasano and Harada, 1998). However, monoculture of breast cancer cell 
lines have below detection levels of aromatase at both mRNA and enzymatic 
activity level (Sanderson et al., 2001). Therefore, cell lines were developed with 
aromatase transfection to reduce this discrepancy (Sun et al., 1997). However, 
co-culture of primary breast cancer cell lines with adipose stromal cells 
significantly increased aromatase mRNA (Miki et al., 2007). 
1.6.2 Co-culture of MSCs and ECs 
MSCs are traditionally derived from bone marrow, a highly vascularised tissue. 
Additionally the MSC stem cell niche is most likely perivascular; therefore, within 
the native environment MSCs are closely associated with ECs. Indeed, a variety 
of studies have shown that MSCs affect ECs and vice versa (Ramasamy et al., 
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2014, Kusumbe et al., 2014). MSCs are able to enhance angiogenesis through 
expression of VEGF (Beckermann et al., 2008, Timmers et al., 2011). ECs affect 
MSCs through paracrine factors; EC conditioned medium applied to MSCs was 
found to enhance proliferation, osteogenic differentiation and viability (Saleh et 
al., 2011a). 
One of the first direct co-cultures of MSCs and ECs was used in the treatment of 
critical sized calvarial defects in immunodeficient mice. The co-culture of the two 
cell types resulted in a greater number of functional blood vessels compared to 
individual application of either ECs or MSCs (Koob et al., 2011). Ex vivo direct 
co-culture of MSCs and ECs in 3D spheroid culture had enhanced osteogenic 
potential and inhibited adipogenic potential. Additionally observations of cellular 
organisation within the spheroids revealed ECs formed a segregated network 
(Saleh et al., 2011b). This enhancement of osteogenic potential of MSCs in co-
culture with ECs has been reported in several studies, however, the effect is 
attributed towards unknown paracrine cross talk (cell signalling) between MSCs 
and ECs that is currently undefined (Gershovich et al., 2013, Sasaki et al., 2015). 
1.7 Cell Signalling 
Cell signalling is a highly complex process of communication between cells. Cell 
signalling is important as it orchestrates development during embryogenesis, 
homeostasis within adult tissues and repair following injury (Jones, 2000). Cell 
signalling has been substantially linked with cellular organisation, both during 
embryonic development and tissue repair (O'Dea and King, 2013). Three 
signalling pathways that play an important role in these key cellular processes 
are: fibroblast growth factor signalling, platelet derived growth factor signalling 
and notch signalling, and are described in future detail below.  
1.7.1 Fibroblast growth factor signalling  
Fibroblast growth factor (FGF) signalling is an evolutionarily conserved signalling 
cascade responsible for a wide range of cellular functions such as; wound 
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healing, embryonic development, angiogenesis and metabolism (Katoh, 2002, 
Belov and Mohammadi, 2013, Dorey and Amaya, 2010, Sun et al., 1999). FGFs 
can have both a paracrine and autocrine effect; FGF is able to exert its cellular 
affects through FGF receptors (FGFR) in a complex with heparan sulphate (HS) 
(Yayon et al., 1991). In humans there are 22 members of  the FGF family, these 
all share a conserved 120 amino acid sequence, however, only 18 of these 
members signal via interactions with FGFR (Ornitz and Itoh, 2001). There are a 
total of seven FGFRs that are encoded through four FGFR genes, the additional 
FGFRs occur due to isoforms (Johnson and Williams, 1993).  Binding of FGF to 
FGFR results in activation of signalling cascade, four key pathways can be 
activated; MAPK, PI3K, Phosphoinositide phospholipase C-γ (PLC- γ) and Janus 
Kinase (JAK or JAK-STAT), a schematic representation of this can be seen in 
Figure 1.7.1 (Furdui et al., 2006). These signalling pathways are known to initiate 
anti-apoptotic signalling, cell growth, proliferation and enhance c-Myc expression 
(Gotoh, 2008). FGF signalling regulation is critical to ensure appropriate 
stimulation, this occurs through a negative feedback loop and receptor 
autoinhibition (Wang et al., 2002, Plotnikov et al., 1999). 
1.7.2 Platelet derived growth factor signalling 
Platelet derived growth factor (PDGF) signalling is considered to be both an 
autocrine and paracrine form of signalling. A wide range of cellular behaviours 
are known to be affected by PDGF signalling, such as: proliferation, migration, 
morphology and angiogenesis (Heldin and Westmark, 1999). It is able to exert its 
cellular effects by binding to platelet derived growth factor receptor (PDGFR). 
Activation of PDGFR triggers PI3K, JAK and PLC-γ signalling, this causes a 
range of cellular changes; some of these changes are caused by reorganisation 
of actin filaments within the cytoskeleton (Figure 1.7.2) (Takagi et al., 2014, 
Shioda et al., 2009, van Wieringen et al., 2009). Activation of PDGFR-β in 
fibroblasts has been known to stimulate chemotaxis on a collagen substrate 
(Popova et al., 2004).  
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Figure 1.7.1 – Schematic representation of FGF signalling pathway 
FGF binds to FGFR in a complex with heparan sulphate (HS). Binding of FGF to 
FGFR results in a signalling cascade of four different pathways: PI3K, JAK-STAT, 
MAPK and PLC-γ. This leads to changes in cell survival, metabolism, 
angiogenesis, proliferation and cell potency. 
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Figure 1.7.2 – Schematic representation of the PDGF signalling pathway 
PDGF binds to PDGFR, this binding triggers a signalling cascade of three 
different pathways, PI3K, JAK-STAT and PLC-γ. This leads to changes in 
proliferation, angiogenesis, migration and morphology 
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1.7.3 Notch signalling 
Nearly 100 years ago the Notch gene was initially observed in Drosophila, the 
phenotype of “notches” within the wings were described, resulting in the name 
(Morgan, 1917). Notch signalling is an evolutionary conserved juxtacrine 
signalling pathway (Wearing et al., 2000, Nakano et al., 2015) . Within humans 
there are four Notch receptors and five ligands. Activation of Notch signalling 
occurs through direct interaction of a receptor with the ligand of a neighbouring 
cell, resulting in activation of the Notch gene (Hill-Felberg et al., 2015, Wang et 
al., 2015). A schematic of this can be seen in Figure 1.7.3, in brief the signal-
sending cell expresses Delta-like or Jagged ligand on the cell surface, Fringe is 
able to regulate the binding of these ligands with Notch (Moloney et al., 2000). 
Upon binding of Delta-like or Jagged with the signal-receiving cell, the notch 
intracellular domain (ICD) is released triggering changes to angiogenesis, 
migration, apoptosis, cell survival and proliferation (Simon et al., 2014). Abnormal 
Notch signalling is observed within many cancers such as; leukaemia and breast 
cancer. Inhibition of Notch could therefore be used as a possible cancer 
therapeutic (Egloff and Grandis, 2012). 
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Figure 1.7.3 – Schematic representation of the Notch signalling pathway 
The signal-sending cell expressed Delta-like or Jagged ligand at the cell surface, 
through Fringe regulation this is able to bind to Notch on the signal-receiving cell. 
Binding triggers release of the Notch intracellular domain (ICD) resulting in 
changes to angiogenesis, migration, apoptosis, cell survival and proliferation.  
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1.8 Project Aims 
Increasing evidence has begun to highlight the importance of both three-
dimensional culture and multiple cell culture systems. Traditional 2D single cell 
culture has frequently demonstrated poor translation compared to the native cell 
environment (Haycock, 2011, Miki et al., 2007). Therefore, the next generation of 
stem cell research requires using unconventional cell culture methods combining 
multiple cell types. Co-culture of MSCs with ECs has strong potential; MSCs 
most likely reside within a perivascular niche and subsequently interact with the 
ECs of the blood vessel (Crisan et al., 2008). Therefore, the aim of the project is 
to investigate the co-culture of MSCs and ECs in 3D spheroid culture. Initial 
investigations will optimise the ratio of MSCs and ECs within the spheroid model. 
The optimised co-culture spheroids will then be assessed during spheroid 
formation and long-term culture. Specifically the osteogenic differentiation 
potential of MSCs co-cultured with ECs will be quantified through the 
development of a novel assay. EC self-organisation previously described will be 
further characterised and investigated to establish the cell signalling pathways 
involved (Saleh et al., 2011b). Additionally the skeletal potential of MSCs will be 
investigated through partial differentiation to create osteogenic MSCs and 
chondrogenic MSCs, these cells will be used in combination with ECs to create 
ex vivo osteochondral models. 
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Chapter 2 : Materials and Methods 
2.1 Cell Culture Methods 
Human MSCs were used with the approval of the York Local Research Ethical 
Committee. All experimental protocols were conducted in accordance with The 
University of York Department of Biology Ethics Committee guidelines and were 
approved by the South Humber Local Research Ethics Committee. All tissue 
culture flasks and plates were purchased from Corning Life Sciences (Corning, 
NY, USA) unless otherwise stated. Foetal bovine serum (FBS) was purchased 
from BioSera (Labtech International Ltd, East Sussex, UK) after batch testing. 
Phosphate buffer saline (PBS), trypsin-EDTA and Dulbecco’s Modified Eagle 
Medium (DMEM) containing L-glutamine (2mM) and high glucose (Cat no. 
S41966-052) were all purchased from Invitrogen (Life technologies, Paisley, UK). 
All media contained 100 units/ml and 100 µg/ml penicillin-streptomycin (P/S) 
unless otherwise stated (Cat no. S15140-122, Invitrogen). Cells were incubated 
at 37oC, 5% CO2, 95% air in a humidified atmosphere. 
2.1.1 Extraction of Human MSCs from Femoral heads 
Following informed patient consent and approval by the South Humber Local 
Research Ethics Committee femoral heads extracted following hip replacement 
surgery at Clifton NHS treatment centre were transported in honey jars (Cat no. 
1LQA01, SLS, East Yorkshire, UK) containing 500 units/ml and 100 µg/ml P/S 
and 2.5 µg/ml Amphotericin B (Cat no. 1LXA01 Fisher Scientific, Loughborourgh, 
UK). The trabecular bone was removed from the femoral head and placed into a 
tube containing 10 ml DMEM and P/S. The trabecular bone was then minced 
using scissors; the supernatant was then collected and transferred to a separate 
tube. This process was repeated twice more, for the final stage, fresh medium 
was added before being vortexed for 1 minute. The supernatant was centrifuged 
at 450 xg for 5 minutes. The pellet was then resuspended in DMEM containing 
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P/S before being passed through a 70 µm cell strainer (Cat no. 11597522, Fisher 
Scientific). The strained supernatant was gently layered onto 12 ml Ficoll-Plaque 
Plus (Cat no. 1LHA02, VWR, Leicestershire, UK) and centrifuged at 350 xg for 30 
minutes with low braking. The supernatant was gently removed and the white 
layer of mononuclear cell layer was extracted using a plastic Pasteur pipette. The 
mononuclear cells were then added to 10 ml of wash buffer (5mM EDTA, 0.2% 
Bovine Serum Albumin (BSA) in PBS) (Sigma-Aldrich, MO, USA) before being 
centrifuged at 450 xg for 5 minutes. The supernatant was removed and the cell 
pellet was resuspended in DMEM containing 15% FBS and P/S, before being 
seeded into a T75 cell culture flask. The cells were left for 3-4 days to allow them 
to settle before the media was replaced – the cells were then expanded as 
described below (Section 2.1.3). 
2.1.2 Extraction of Human MSCs from the Tibial Plateau 
Following informed patient consent and approval by the South Humber Local 
Research Ethics Committee, tibial plateaus were taken during knee replacement 
surgery at Clifton NHS treatment centre. The bone samples were dissected into 
small pieces approximately 1 cm2 and placed bone marrow side down onto cell 
culture treated petri dishes. The petri dishes were then flooded with DMEM media 
containing 15% FBS and P/S. The petri dishes were incubated with the bone 
fragments to allow cell migration from the bone. After the one week the bone 
fragments were removed and the media replaced, the cells were then expanded 
as described below (Section 2.1.3). 
2.1.3 Human MSC Culture and Expansion 
Human bone marrow derived MSCs extracted via the methods described above 
were cultured in DMEM containing 15% FBS and P/S hereafter referred to as 
MSC basal medium. Upon reaching 90% confluency, the cells were passaged by 
incubation with 0.05% trypsin-EDTA for 5 minutes at 37oC; cell detachment was 
confirmed using a light microscope. The cells were then re-seeded at a 1 in 3 
ratio in MSC basal medium, containing FBS to neutralise the trypsin-EDTA. 
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MSCs were not used in any experiments beyond passage 5. MSC basal culture 
medium was changed twice a week. 
2.1.4 Human Umbilical Vein Endothelial Cell Culture and Expansion 
Human Umbilical Vein Endothelial Cells (HUVECs) were purchased from 
PromoCell (PromoCell, Heidelberg, Germany) and cultured in Endothelial Cell 
Culture Medium (Cat no. C-22010, PromoCell) containing the accompanying 
supplement mix; 10% FBS and P/S. HUVECs were cultured up to 90% 
confluency before being passaged using trypsin-EDTA as described above and 
re-seeded at a 1 in 3 ratio. Endothelial culture medium was replaced twice a 
week and HUVECs were used for experiments between passage 4 and 6. 
HUVECs were used due to them being a type of endothelial cell (EC); all 
experiments were performed with these cells and are commonly referred to as 
ECs rather than HUVECs.  
2.1.5 Human Dermal Fibroblast Culture and Expansion 
Human dermal fibroblasts (HDF) were purchased from Cascade Biologics (Life 
Technologies, UK). HDFs were cultured in DMEM containing 15% FBS and P/S, 
medium was changed twice a week and cells were passaged at approximately 
90% confluency using trypsin-EDTA and re-seeded at a 1 in 5 ratio. HDFs in all 
experiments were used between passage 7 and 10. 
2.1.6 Mycoplasma Testing 
All cells were regularly checked for mycoplasma. Mycoplasma testing was 
performed before every experiment on all cell types in culture. Mycoplasma 
testing was performed by taking a small aliquot of trypsinised cells and seeding 
them onto a 24-well plate. The cells were then left to adhere for at least 4 hours. 
Once the cells had attached, culture medium was aspirated and cells were 
washed with PBS twice before being fixed in 70% methanol for 5 minutes. Once 
the cells were fixed, methanol was removed and the cells were washed with PBS 
: Materials and Methods 
Page | 53  
 
twice, the PBS was fully removed before the cells were stained with 100 µl of 4’, 
6- diamidino-2-phenylindole (DAPI) at a concentration of 1 µg/ml in PBS. Once 
the stain was applied the cells were incubated in the dark at room temperature for 
5 minutes. After the incubation the DAPI was removed and the cells were washed 
three times with PBS. Observations of extra nuclear DNA indicative of a 
mycoplasma infection were made using a DMIRB, Leica fluorescence 
microscope and checked by a second independent observer. If positive, 
mycoplasma-contaminated cells were immediately destroyed.  
2.1.7 Live/Dead Cell Viability Staining 
Live/Dead viability staining was performed on 3D MSC and EC co-culture 
spheroids to ascertain the long term viability of 3D spheroid culture (Cat no. 
L3224, ThermoFisher, UK). The viability assay was used to stain living cells 
green, whilst dead cells would be stained red, from this the percentage of dead 
cells within a spheroid could be calculated. The stain was able to identify living 
cells through the enzymatic conversion of cell-permeable Calcein AM into 
fluorescent Calcein which is retained within living cells (green). Dead cells were 
identified through EthD-1 entering cells with a damaged membrane and 
undergoing a 40-fold enhancement of brightness upon binding with nucleic acid 
(red). Cell spheroids were prepared for the Live/Dead viability assay by firstly 
being washed twice with PBS; spheroids were then incubated at 37oC with 50 l 
of Live/Dead reagent for 45 minutes. The Live/Dead reagent contained 4 M 
EthD-1 and 2 M Calcein AM in sterile PBS. 
2.1.8 3D Cell Culture 
Cells were cultured in a 3D spheroid configuration; this was achieved using non-
adherent U-bottomed 96-well plates (Cat no. 1LQA01, Fisher Scientific). A cell 
suspension totalling 30,000 cells was added into the individual wells with 100 µl 
of appropriate medium containing 0.25% (w/v) methyl cellulose (Sigma-Aldrich), 
the cells then allowed to aggregated to form a spheroid (Figure 2.1.1). Various 
: Materials and Methods 
Page | 54  
 
combinations of cells were combined to create co-culture spheroids, such as 
MSCs and ECs or HDFs and ECs. MSC and EC combinations were cultured in 
media made up of 50% DMEM, 50% Endothelial cell media, 15% FBS, P/S and 
0.25% (w/v) methyl cellulose. HDF and EC were also cultured in the same media 
to act as a control. Media was changed twice a week via split feeding to prevent 
damage to the cell spheroid. 
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Figure 2.1.1– Formation of 3D co-culture spheroids using MSCs and ECs in 
non-adherent U-bottomed 96-well plates 
A cell suspension totalling 30,000 cells was added into each individual well of the 
non-adherent U-bottomed 96-well plates. Within 24 hours the cells aggregated 
together to form a spheroid, this 3D structure could then be maintained and 
culture within this environment. 
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2.2 Cell Tracker™ Labelling of Cells 
CellTracker™ was used to label MSCs, HUVECs and HDFs. Cells were labelled 
either green, red or blue using the relevant CellTracker™ described below. 
CellTracker™ green BIODIPY (8-chloromethyl-4,4-difluoro-1,3,5,7-tetramethyl-4-
bora-3a,4a-diaza-s-indacene, Cat no. C2102, Invitrogen, UK) absorption 522 nm 
and emission 529 nm. CellTracker™ red CMTPX (Cat no. C34552, Invitrogen) 
has an absorption at 577 nm and an emission at 602 nm. CellTracker™ blue 
CMHC (4-chloromethyl-7-hydroxycoumarin, Cat no. C2111, Invitrogen) 
absorbance 372 nm and emission 470 nm.  
2.2.1 Application of CellTracker™ Green, Red and Blue 
Approximately 1-2x106 cells were labelled using the quantity of CellTracker™ 
solution described below; optimisation of the CellTracker™ solution was also 
performed. Cells were trypsinised and counted using a haemocytometer before 
being centrifuged at 400 xg for 5 minutes, the supernatant was then removed and 
the cells washed with PBS before being centrifuged again at 400 xg for 5 
minutes. The supernatant was aspirated; this was done to remove any FBS from 
the solution. A CellTracker™ solution was then made using DMEM (0% FBS) 
with a final optimised concentration of either 0.5 µM red, 2µM green or 10 µM 
blue CellTracker™. The appropriate cells were then incubated in 4 ml of the 
CellTracker™ solution for 1 hour at 37oC, this allowed for the active uptake of the 
CellTracker™ into the cytoplasm of the cell were it remained for approximately 10 
days. After incubation the cells were centrifuged at 400 xg for 5 minutes, the 
supernatant was removed and DMEM containing FBS was applied. The cells 
were then incubated for 30 minutes at 37oC to ensure all extracellular 
CellTracker™ was neutralised, after this incubation period the cells were 
centrifuged at 400 xg for 5 minutes and the supernatant was removed. After this 
procedure the cells were fluorescently labelled in the desired colour and were 
seeded as required.  
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2.3 Histological Techniques 
2.3.1 Cryosectioning of 3D Spheroids 
Spheroids were carefully transferred from the U-bottomed 96-well plate into a cap 
of an Eppendorf tube using a cut 200 µl pipette tip. The medium was carefully 
removed before the cell spheroid was washed with PBS. The PBS was then 
gently aspirated and Tissue-Tek optimised cutting tissue (OCT) was added 
avoiding the incorporation of air bubbles, before being snap frozen in liquid 
nitrogen and stored at -80oC (Cat no. 4583, Sakura Finetek Europe, The 
Netherlands). The frozen spheroids were sectioned at 7 µm thickness using a 
Bright’s cryostat (OFT5000, Bright Instruments, UK) and placed onto Superfrost 
positive microscope slides (Cat no. SHE2505, Thermo Scientific). The slides 
were stored at -20oC until required. All images shown of spheroid sections are 
representative of the observations made within a minimum of three sections of 
three different spheroids, unless otherwise stated.  
2.3.2 Immuno staining 
Immuno staining was performed on both spheroid sections and 2D cultured cells; 
however, the fixation process different slightly between them. Spheroid sections 
on Superfrost slides were treated with 4% paraformaldeyde (PFA) for 5 minutes 
at room temperature, immediately after removal from -20oC storage. 2D cultured 
cells were washed twice with PBS at room temperature before being fixed using 
4% PFA for 5 minutes and washed twice more with PBS. After this process both 
samples were treated identically, non-specific binding was blocked via incubating 
the samples in 10% of appropriate animal serum for 30 minutes. Samples were 
incubated with primary antibodies (Table 2.3.1) in a PBS/0.1% BSA solution, 
within a humidity chamber for 1 hour at room temperature or 4oC overnight. The 
primary antibody was then carefully removed and the samples were washed 
three times with PBS before being incubated at room temperature in the dark with 
the appropriate conjugated secondary antibody (Table 2.3.2). Samples were then 
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washed a further three times with PBS to remove any excess non-specific 
secondary antibody. DNA staining to identify nuclei was also performed by 
incubating the samples for 10 minutes in 1 µg/ml DAPI. Samples were mounted 
using the appropriate sized coverslip and Vectashield (Vector Laboratories, 
Peterborough, UK) before being examined using either a Leica DMIRB 
fluorescent microscope or Zeiss LSM 780 multiphoton inverted microscope.  
Table 2.3.1 –Primary antibodies used for immuno fluorescent labelling of 
cells 
Primary 
Antibody Isotype 
Concentration 
Used Supplier Cat no. 
Collagen type 
I Rabbit IgG 1 in 20 AbCam Ab292 
Collagen type 
II Mouse IgG 1 in 100 AbCam Ab53047 
CD31 Rabbit IgG 1 in 20 AbCam Ab76533 
Sox9 Rabbit IgG 1 in 100 AbCam Ab36748 
Hes-1 Goat IgG 1 in 100 Santa Cruz I3002 
Runx2 Rabbit IgG 1 in 100 Santa Cruz Sc-10758 
Osteocalcin Mouse IgG 1 in 100 R&D Systems MAB1419 
Osteonectin Mouse IgG 1 in 100 DHSB AON-1 
pERK Rabbit IgG 1 in 100 R&D Systems AF1018 
Ki67 Rabbit IgG 1 in 100 AbCam Ab15580 
Mouse IgG 
Isotype 
control 1 in 100 
BD 
Pharmingen 555573 
Rabbit IgG 
Isotype 
control 1 in 100  Vector I-1000 
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Table 2.3.2 – Secondary antibodies used for immuno fluorescent labelling 
of cells 
Secondary 
Antibody 
Species 
Raised In 
Concentration 
Used Supplier 
Cat no. 
Alexa Fluor anti-
mouse 488 Goat 1 in 200 Invitrogen 
A-11001 
Alexa Fluor anti-
rabbit 488 Goat 1 in 200 Invitrogen 
A-11008 
Alexa Fluor anti-
mouse 647 Donkey 1 in 200 Bioss 
Bs-0310G 
Cy3 conjugated anti-
goat Rabbit 1 in 200 Millipore 
AP106C 
Cy3 conjugated anti-
rabbit Sheep 1 in 200 Sigma 
C2306 
 
2.4 Statistical Analysis 
Data presented within graphs shows mean ± standard deviation unless otherwise 
stated. Experiments were performed at least in triplicate using three different 
biological donors unless otherwise stated (N>9). All data were analysed using 
PRISM software (GraphPad Software, CA, USA) one-way and two-way ANOVA 
was performed on appropriate data sets with Tukey post test or Bonferroni post 
test. P values <0.05 were considered statistically significant. * P<0.05, ** P<0.01, 
*** P<0.001, **** P<0.0001.  
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Chapter 3 : Bone Formation of MSCs in 2D 
and 3D, With and Without ECs 
3.1 Introduction 
Within human bone marrow, the primary role of MSCs is to sustain tissue 
homeostasis (Nombela-Arrieta et al., 2011). The ability of MSCs to undergo 
osteogenic differentiation (bone formation) under specific in vitro culture 
conditions is often described as a method to characterise and identify this cell 
type (Lu et al., 2014, Siddappa et al., 2007). The majority of MSC osteogenic 
differentiation has been performed in 2D in vitro culture conditions. However, 
recent advances in 3D in vitro cell culture can be used to more accurately 
recreate the native environment (Laurent et al., 2013). The concept of multiple 
cells being cultured within the same environment has led to co-culturing MSCs 
and even tri-culturing MSCs with other cell types (Rinker et al., 2014, Gershovich 
et al., 2013, Saleh et al., 2011a). Within these studies it was found 2D and 3D co-
culture of human MSCs with ECs resulted in increased osteogenesis. More 
specifically MSCs co-cultured with HUVECs demonstrated an increased 
osteogenic potential through alizarin red (calcium deposition) and alkaline 
phosphatise (an osteoblast marker) staining. The increased osteogenic potential 
within MSCs has been attributed to a soluble factor(s) released by the HUVECs. 
This was demonstrated by culturing MSCs in HUVEC condition medium (Saleh et 
al., 2011a).  
These in vitro studies are further supported by in vivo evidence. Analysis of the 
link between angiogenesis and bone formation in vivo has started to suggest that 
MSCs play a vital role in vascular organisation and subsequent bone formation. 
This has been demonstrated in a variety of different ways, including implantation 
of MSCs to improve hind limb ischemia in mice (Bhang et al., 2012b). Again, 
these effects have been attributed to a soluble factor(s) which through in vivo 
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mice studies, the involvement of the Notch signalling pathway. Genetic disruption 
of Notch signalling within endothelial cells of mice resulted in impaired blood 
vessel morphology within bone marrow and reduced osteogenesis. Addition of 
recombinant Noggin as a Notch-controlled angiocrine regulator restored bone 
growth and mineralisation (Ramasamy et al., 2014).  
The process of bone formation and maintenance in vivo is a complex 3D process 
involving multiple cell types, various signalling pathways and mechanical stimuli. 
However, most in vitro bone analysis has been performed in 2D environments. 
The use of 3D systems to more accurately represent native characteristics and 
behaviours has become highly compelling. Within cancer cell studies the use of 
3D in vitro culture systems has been proven to more closely represent in vivo 
tumour behaviour. Various studies using 3D systems instead of 2D systems have 
shown 3D systems are more accurate when determining molecular tumour 
growth and facilitating drug discoveries (Laurent et al., 2013, Thoma et al., 2014). 
Therefore, the evolution of in vitro MSC bone formation from a conventional 2D to 
3D system has become essential. This will require the development of novel 
assay strategies to quantify and assess bone formation within 3D in vitro 
environments.   
Second harmonic generation (SHG) imaging can be used to visualise and 
quantify collagen within 2D and 3D culture. SHG is based upon a nonlinear 
optical effect by which photons of a specific frequency can interact with a material 
of the same frequency to generate new photons with twice the energy and half 
the wavelength. This phenomenon can be used within cell biology to visualise 
cells and tissue structure, without staining a material and subsequently damaging 
it. The use of SHG imaging for fibrillar collagen within a diverse range of tissues 
has been performed. Collagen type I and II are able to be SHG imaged due to 
their aligned fibre structure, unlike collagen type III and IV. Using this technique it 
is possible to assess collagen formation within diseases such as cancer and 
connective tissue disorders (Zipfel et al., 2003, Chen et al., 2012, Campagnola, 
2011). 
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3.2 Aims 
The general aims of the work presented within this chapter are to characterise 
the ability of human MSCs to undergo osteogenic differentiation within 2D and 3D 
environments, and to determine if the presence of human endothelial cells can 
affect this process.  
More specifically the objectives are to: 
 Determine comparative methods of quantifying osteogenic differentiation 
of MSCs within a 2D and 3D environment.  
 Develop new methods to quantify and assess bone formation using 
MSCs in a 3D environment. 
 Examine if co-culture of MSCs with ECs has an effect on osteogenic 
differentiation. 
 Use second harmonic generation imaging to qualitatively and 
quantitatively assess collagen within a 3D in vitro environment. 
 Determine if long term 3D culture of MSCs and ECs have detrimental 
effects on cell viability. 
: Bone Formation of MSCs in 2D and 3D, With and Without ECs 
Page | 64  
 
3.3 Methods 
3.3.1 Analysis of MSC Markers 
A panel of commonly used non-specific MSC cell surface markers were used to 
identify cells extracted from human hip and knee sources, using flow cytometry 
and approximately 50,000 MSCs were harvested per target antibody. MSCs were 
prepared by washing twice with PBS before being detached from the cell culture 
flask using wash buffer (5 mM EDTA, 0.2% BSA in PBS). Cells were centrifuged 
at 450 xg for 5 minutes before being resuspended in 1ml of wash buffer; this was 
then divided equally between 10 tubes. Primary antibodies were added to the cell 
suspension at the concentrations shown in Table 3.3.1 and incubated on ice for 
45 minutes. After incubation the samples were centrifuged at 400 xg for 5 
minutes and the supernatant was removed, fluorescently conjugated antibodies 
were resuspended in 500 µl wash buffer and stored on ice. Non-fluorescently 
conjugated antibody samples were resuspended in 100 µl of wash buffer and 
AlexaFlour 647 donkey anti-mouse antibody applied at a 1:200 dilution and then 
incubated on ice for 45 minutes. Samples were then washed with wash buffer 
before being centrifuged at 400 xg for 5 minutes and the supernatant removed. 
All samples were suspended in 1 ml of wash buffer before being analysed using 
CyAn™ ADP Analyzer (Beckman Coulter, CA, USA) at appropriate excitation and 
emission wavelengths and analysed using Summit and FlowJo software.  
: Bone Formation of MSCs in 2D and 3D, With and Without ECs 
Page | 65  
 
Table 3.3.1 MSC marker antibodies 
Target Conjugate Host Dilution Cat no. Supplier 
CD45 FITC Mouse 1:100  MRC04501 Caltag Labs 
CD166 PE Mouse 1:50  559263 
BD 
Pharmingen 
CD44 FITC Mouse  1:10 555478 
BD 
Pharmingen 
CD34 FITC Mouse  1:50 130-081-001 
Miltenyi 
biotech 
CD90 IgG Mouse  1:100 14-0909-81 ebioscience 
CD105 IgG Mouse  1:100  14-1057-81 ebioscience 
CD29 IgG Mouse   1:100 36741A 
BD 
Pharmingen 
CD73 IgG Mouse  1:100  550256 
BD 
Pharmingen 
Anti-mouse 
IgG 
Alexaflour 
647 Donkey   1:200 A-31571 Invitrogen 
 
3.3.2 Analysis of Endothelial Cell Markers 
HUVECs underwent flow cytometric analysis to determine expression of specific 
endothelial cell markers, specifically expression of the cell surface marker CD31 
(Cat no. sc-20071, Santa Cruz). A FITC conjugated CD31 was applied to the 
HUVECs using the same method as previously described (Section 3.3.1). 
3.3.3 Osteogenic Differentiation of 2D MSCs 
Osteogenic differentiation of MSCs was induced by culturing the cells in 
osteogenic induction medium. Osteogenic induction medium was created by the 
addition of 5 mM β-glycerophosphate, 50μg/ml ascorbic acid phosphate and 
10nM dexamethasone (all Sigma-Aldrich, UK) to standard 2D culture medium 
(DMEM, 15% FBS and P/S). The culture medium was replaced twice a week for 
up to 21 days. 
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3.3.4 3D co-culture of MSCs and endothelial cells 
MSCs and ECs were co-cultured together in the 3D system described previously 
(Section 2.1.7). U-bottomed 96 well plates contained individual cell spheroids 
within each well, these where then harvested at specific times and further 
analysed. Medium was replaced on the cell spheroids twice a week using a 
pipette and split feeding.  
3.3.5 Quantification of calcium within culture medium 
Standard techniques to quantify osteogenesis of MSCs in 2D translate 
ineffectively for 3D systems. Alizarin Red S staining for example cannot be used 
to quantify calcium deposits within spheroids sections. Sectioning a spheroid can 
result in sectioned material that varies greatly in size due to where they originated 
from; they can also easily tear and have missing material. Calcium depletion from 
culture medium could be used as a non-destructive, real-time method to quantify 
calcium incorporation and subsequent osteogenesis within 2D and 3D systems.  
To quantify the amount of calcium within culture medium, cells were first seeded 
for a period of 24 hours to allow them to be fully attached to tissue culture plastic 
(for 2D cultures) or to have formed a spheroid (for 3D). After this period the entire 
medium within the well was carefully removed using a pipette, and was replaced 
with 150 µl of appropriate medium for 96-well plate culture or 500 µl for 24-well 
plate culture. A schematic overview of the process within a U-bottomed 96 well 
plate can be seed in Figure 3.3.1.  A control sample of medium was placed into 
an adjacent well not containing cells, an example of this within a 24-well plate 
format can be observed in Figure 3.3.2. To reduce any potential discrepancies 
due to evaporation all un-used wells were filled with PBS and the well plates were 
wrapped with Parafilm (Cat no. SPU5601, Fisher, UK) leaving a small 1 cm gap 
to allow gas exchange during culture. The samples were then incubated for 
precisely 96 hours at 37oC, 5% CO2 and 95% air in a humidified environment 
before the medium samples were carefully removed and placed into separate 
Eppendorf tubes. The cell and control wells could be reused and fresh medium 
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was added and the process repeated for up to 24 days in culture. Individual 
medium samples were analysed using a QuantiChrom™ Calcium Assay Kit (Cat 
no. DICA-500, BioAssay Systems, CA, USA) as per the manufacturer’s 
instructions. Briefly, calcium ion (Ca2+) concentration was analysed by taking a 
5 µl sample of medium and adding it to 200 µl of the Calcium Assay Kit working 
reagent and incubated at room temperature for 3 minutes. The working reagent 
was prepared by combining equal volumes of Reagent A and Reagent B. The 
Calcium Assay Kit allowed the concentration of calcium ions within the medium 
samples to be calculated through optical density readings at 570 nm using a 
Dynex MRX II plate reader and a calcium ion standard. 
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Figure 3.3.1 – Schematic representation of medium removal and 
replacement for 3D calcium analysis 
A single well of a U-bottomed 96 well plate is filled with 150 µl of appropriate cell 
culture medium. After 96-hours at 37oC, 5% CO2 and 95% air in a humidified 
environment the medium is carefully removed using a pipette and replaced with 
fresh medium. The calcium concentration within the culture medium was then 
quantified and compared to a control medium sample. 
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Figure 3.3.2 – Schematic representation of a 24-well plate layout used to 
assess calcium depletion from culture medium 
Unused wells are flooded with PBS to reduce evaporation. Sample and control 
wells contain 500 µl of the same medium, however, only sample wells contain the 
relevant cells or cell spheroids. 
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3.3.6 Histological staining 
3.3.6.1 Alizarin red S 
Alizarin red S staining was performed to visualise calcification within osteogenic 
differentiated MSCs. Samples were washed with PBS twice followed by fixation 
using 4% Para formaldehyde (PFA) in PBS incubated at room temperature for 5 
minutes. The samples were then washed three times with PBS before being 
stained with a 40 mM Alizarin Red S solution pH 4.2 (Sigma-Aldrich, UK) for 20 
minutes at room temperature. After the incubation, the samples were washed 
three more times with PBS and once with tap water to remove any non-specific 
staining. The samples were then imaged using a light microscope (DRB, Leica). 
3.3.6.2 Alizarin red S elution and quantification 
Alizarin red S staining of samples within well plates could be quantified by elution 
of the stain. Once the stain had dried, the Alizarin red S staining was eluted by 
the addition of 400 µl of 10% (w/v) cetylpyridinium chloride (CPC) (Cat no. 
C0732, Sigma-Aldrich), which was added into the 24-well plate and incubated for 
1 hour at room temperature. After this incubation period, a 200 µl sample of the 
eluted stain was transferred into a 96-well plate and the absorbance of the eluted 
stain was measured using a Dynex MRX II plate reader at 630 nm.  
3.3.6.3 Alkaline Phosphatase and von Kossa staining 
To assess the osteogenic state of the MSCs, samples were stained to detect 
alkaline phosphatase (ALP) activity and von Kossa to identify mineralised 
deposits. Samples cultured in both basal and osteogenic medium conditions were 
examined. To stain for ALP samples were incubated in a solution of 0.2 mg/ml 
napthol AS-MX in 1% N,N-dimethylformamide diluted in 0.1M Tris (pH 9.2) with 
1 mg/ml Fast Red TR (all Sigma Aldrich) at room temperature for 2 minutes, any 
positive stained regions turned a pink colour. The samples were then washed 
twice with PBS before being fixed using 4% PFA at room temperature for 
: Bone Formation of MSCs in 2D and 3D, With and Without ECs 
Page | 71  
 
5 minutes. After fixation von Kossa staining was performed by incubation of the 
samples with a 1% silver nitrate (Sigma Aldrich) solution on a light box for 
60 minutes, any positive areas stained a grey/brown colour. Samples were then 
washed with dH2O, incubated in 2.5% sodium thiosulphate for 5 minutes and 
washed again in dH2O to remove any non-specific staining.  
3.3.7 Second Harmonic Generation Imaging 
Second harmonic generation imaging was used to detect collagen using a 
confocal multiphoton microscope. A 870 nm laser from the microscope was used 
to detect second harmonic generation between 400-500nm. 
3.3.8 Imaging and Quantification of staining 
Fluorescent and confocal microscopy was performed using a Zeiss LSM 780 
multiphoton inverted microscope. This microscope was used in combination with 
Zen 2009 imaging software (Zeiss, Germany), Volocity software (Perkin Elmer) 
and Image J (MBF – McMaster Biophotonics Facility, Canada) to process and 
analyse images. Light microscope images were taken using a DMIRB Leica Light 
microscope (Leica Germany). 
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3.4 Results 
3.4.1 MSC Characterisation 
To demonstrate that MSCs sourced from either femoral head or knee extracts 
expressed the same cell surface markers as those typically found three randomly 
selected donors were subjected to characterisation using flow cytometry. All 
MSCs tested positive for the known markers CD29, CD44, CD73, CD90 and 
CD105, and negative for the haematopoietic markers CD34 and CD45. Both 
knee and femoral head MSCs did not show a positive shift for CD166. Examples 
of the flow cytometry for femoral head MSCs are shown in Figure 3.4.1 whilst 
knee extracted MSCs are shown in Figure 3.4.2.  Due to the MSCs frequently 
being co-cultured with ECs, MSCs were immunofluorescently stained and 
analysed by flow cytometry for CD31, a common endothelial cell marker. All 
MSCs were negative for the CD31 (Figure 3.4.3).  
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Figure 3.4.1 – Flow cytometry analysis of femoral head cell extracts 
MSCs from femoral head extract and subsequent culture were antibody probed 
for CD29, CD34 CD44, CD45, CD73, CD90, CD105 and CD166, and analysed 
by flow cytometry. The histograms show marker expression (blue) relative to 
control (red). A positive shift in expression demonstrates antibody staining in the 
known MSC markers, whilst no shift was detected in the haematopoietic markers. 
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Figure 3.4.2 – Flow cytometry analysis of human knee cell extracts 
MSCs from knee extract and subsequent culture were antibody probed for CD29, 
CD34 CD44, CD45, CD73, CD90, CD105 and CD166, and analysed by flow 
cytometry. The histograms show marker expression (blue) relative to control 
(red). A positive shift in expression demonstrates antibody staining in the known 
MSC markers, whilst no shift was detected in the haematopoietic markers. 
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Figure 3.4.3 – Immunofluorescent and flow cytometry analysis of 
Mesenchymal stem cells for endothelial cell marker CD31  
Representative MSC (K39) donor stained for endothelial cell marker CD31. 
Immunofluorescence was conducted along alongside DAPI and IgG labelling 
before being imaged using a fluorescence microscope. The histogram shows 
analysis by flow cytometry CD31 markers expression is blue relative to IgG 
control red. No positive CD31 expression was detected with any MSC sample. 
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3.4.2 Endothelial Cell Characterisation 
To demonstrate that the HUVEC cells purchased from PromoCell were ECs at 
various passages, flow cytometric analysis of the cell surface marker CD31 was 
performed. All HUVECs tested positive for CD31 (Figure 3.4.4). HUVECs were 
also immunofluorescently labelled for CD31 and found to positively express 
CD31, unlike MSCs (Figure 3.4.5). 
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Figure 3.4.4 – Flow cytometry analysis of HUVECs for the endothelial cell 
marker CD31 
HUVECs purchased from PromoCell were cultured and antibody probed for 
CD31 a common endothelial cell marker. The histogram shows CD31 expression 
(blue) relative to IgG control (red). A positive shift shows HUVECs are positive for 
the endothelial cell marker CD31. 
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Figure 3.4.5 – Immunofluorescently labelling of HUVECs for the endothelial 
cell marker CD31 
HUVECs were stained for endothelial cell marker CD31 and IgG control and 
imaged via fluorescence microscopy. Positive CD31 expression and staining is 
clearly observed.  
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3.4.3 2D Osteogenesis of MSCs  
Many techniques can be used to assess osteogenic differentiation of MSCs in 
2D. In this section, conventional and new methods were used to assess and 
quantify MSC osteogenesis in three different biological donors; Donors 1, 2 and 3 
(K93, K129 and K107; K=knee sample). MSCs were cultured in basal medium or 
osteogenic induction medium on tissue culture plastic for up to 21 days. At 
various key time-points osteogenesis was assessed through ALP activity, Alizarin 
Red S staining for calcium deposits and von Kossa staining for phosphate 
deposits.  
ALP and von Kossa staining was performed on the three biological Donors 1, 2 
and 3 cultured in basal or osteogenic conditions (Figure 3.4.6). Pink staining 
indicating positive ALP activity was detected in Donors 1 and 2 following culture 
in osteogenic conditions after 14 and 21 days. Observations between Donor 1 
and 2 were highly similar, therefore, only Donor 1 is shown in this figure. 
However, Donor 3 showed no positive ALP staining at any time. No positive 
brown/black von Kossa staining was observed in any sample. 
Alizarin Red S staining was conducted and quantified via CPC elution and 
absorbance at 630nm (Figure 3.4.7). These results showed that Donors 1 and 2 
had statistically significant Alizarin Red S staining in osteogenic conditions 
compared to basal at days 14 and 21. However, Donor 3 only showed statistically 
significant Alizarin Red S staining at day 21 compared to basal conditions.  
An alternative non-destructive method to assess bone formation through the 
quantification of calcium within the culture medium was trialled. Using the same 
biological donors as previously mentioned, medium samples were collected every 
96 hours for up to 20 days. The amount of calcium within the culture medium was 
calculated and the depletion compared to control medium was tabulated (Figure 
3.4.8). Using this method it can be seen that Donors 1 and 2 had statistically 
significant calcium depletion in osteogenic conditions compared to basal at days 
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16 and 20. Donor 3 showed no significant difference in calcium depletion 
between osteogenic and basal culture conditions for any time point. These data 
indicate that Donors 1 and 2 were able to undergo osteogenic differentiation in 
2D conditions whereas Donor 3 showed little evidence of osteogenic capacity. 
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Figure 3.4.6 – ALP and von Kossa staining of 2D MSCs cultured in basal 
and osteogenic conditions for up to 21 days 
MSC Donors 1, 2 and 3 (K93, K129, K107) were cultured in either basal or 
osteogenic conditions for up to 21 days. At the key time points 0, 7, 14 and 21 
days they were stained with ALP and von Kossa and imaged by a bright field 
microscope. Both Donors 1 and 2 stained positive for ALP and von Kossa by day 
21, this figure only shows Donor 1. However, Donor 3 did not have positive ALP 
or von Kossa staining.  
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Figure 3.4.7 – 2D MSC Alizarin red S elution in both basal and osteogenic 
conditions in three different biological donors 
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MSC donors 1, 2 and 3 (K93, K129 and K107) were cultured in either basal or 
osteogenic conditions for up to 21 days. At key time points 0, 7, 14 and 21 days 
samples were fixed and stained with Alizarin red S before the dye was eluted 
using CPC. Using optical cytometry at 630nm comparison between basal and 
osteogenic conditions can be made. All three donors showed significant 
increases in Alizarin Red S staining after 21 days. Similarities can be seen with 
Donor 1 and 2 compared to calcium depletion studies. Donor 3 showed no 
positive ALP or von Kossa staining and minimal calcium depletion, however, a 
significant increase in Alizarin Red S staining can be seen at day 21. For each 
time point and biological donor four individual samples were tested (n=4). 
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Figure 3.4.8 – 2D MSC cumulative calcium depletion from basal and 
osteogenic culture medium with three different biological donors 
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MSC donors 1, 2 and 3 (K93, K129 and K107) were cultured in either basal or 
osteogenic conditions for up to 20 days. Medium samples were collected every 
96 hours and analysed to calculate calcium concentration compared to control 
medium. From this cumulative calcium depletion from the culture medium over a 
period of 20 days was calculated. Donors 1 showed significant calcium depletion 
from the culture medium compared to basal medium at days 16 and 20, these 
time points also show significant differences compared to day 4 osteogenic 
conditions. Donor 2 showed significant calcium depletion from the culture 
medium compared to basal at days 12, 16 and 20. Donor 3 showed no significant 
differences in calcium depletion, complementing previous results showing a lack 
of ALP and von Kossa staining (Figure 3.4.6). For each time point and biological 
donor six individual medium samples were tested (n=6). 
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3.4.4 3D Osteogenesis of Mesenchymal Stem Cells Co-cultured with 
Endothelial Cells 
In order to quantify bone formation in 3D spheroid culture a variety of different 
assays were conducted. Alizarin Red S staining was performed on 3D MSC-only 
and MSC-EC spheroids, unlike traditional 2D culture positive staining was 
observed from day 1, making this stain impractical for 3D analysis (Figure 3.4.9). 
Para-Nitrophenylphosphate (pNPP) based ALP activity assay were also 
performed on 3D MSC-EC spheroids and was found to show irregular results with 
large error bars, rendering this analysis method inappropriate (Figure 3.4.10). 
ALP and von Kossa staining showed positive results for MSC-only and MSC-EC 
spheroid sections (Donors 1 and 2), particularly strong ALP staining was 
observed in MSC-EC spheroids after 21 days in osteogenic conditions. However, 
negligible von Kossa staining was detected (Figure 3.4.11).  
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Figure 3.4.9 – 3D MSC-only and MSC-EC spheroid sections stained with 
Alizarin Red S at days 1 and 7 
Positive Alizarin Red S staining was observed at Day 1 and at Day 7 for both 
MSC-only and MSC-EC spheroids, making this stain impractical for 3D spheroid 
sections to assess osteogenesis.  
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Figure 3.4.10 – pNPP analysis on MSC-EC spheroids over 21 days in 
osteogenic and basal conditions using two different biological donors 
pNPP analysis was performed on biological donors K41 and K46 at days 0, 7, 14 
and 21. For day 21 spheroids cultured in both basal and osteogenic conditions 
are shown. pNPP analysis was inconsistent between time points, donors and 
conditions. Therefore, this analysis method was not further used to quantify bone 
formation in 3D spheroids. For each time point and biological donor three 
individual samples were tested (n=3). 
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Figure 3.4.11 – ALP and von Kossa staining on MSC and MSC-EC spheroid 
sections 
Representative sections of ALP and von Kossa staining performed on Donors 1 
and 2 (K93 and K129) MSC-only and MSC-EC spheroids at various time points 
cultured in either basal or osteogenic conditions. Pink staining is positive ALP 
staining which is most strongly seen in MSC-EC sections day 21 osteogenic 
conditions. No positive brown/black von Kossa staining was observed. 
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Using the calcium quantification method, medium samples from 3D MSC-only 
and MSC-EC spheroids were collected every 96 hours for up to 20 days. Six 
individual medium samples were tested per time-point, per biological donor (n=6). 
The cumulative calcium depletion was then calculated for biological Donors 1 and 
2 cultured in either basal or osteogenic 3D co-culture medium (Figure 3.4.12). 
These results showed that both Donors 1 and 2 had statistically greater calcium 
depletion for both MSC-only and MSC-EC spheroids when cultured in osteogenic 
conditions compared to basal controls. It was also observed that for both donors 
significantly greater calcium depletion was observed in MSC-EC osteogenic 
spheroids compared to MSC-only osteogenic spheroids at days 12, 16 and 20, 
despite MSC-EC spheroid containing half the number of MSCs. 
Donor 3 (K107) was unique as during 2D analysis it appeared to be osteogenic 
insert, this donor was also cultured in 3D MSC-only and MSC-EC spheroids in 
either basal or osteogenic conditions. The spheroids were then sectioned and 
stained for ALP and von Kossa (Figure 3.4.13). Medium samples were also 
collected and cumulative calcium depletion was tabulated (Figure 3.4.14). Similar 
to 2D culture, Donor 3 showed no positive ALP, von Kossa staining or significant 
calcium depletion. 
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Figure 3.4.12 – 3D cumulative calcium depletion from basal and osteogenic 
culture medium in MSC-only and MSC-EC spheroids  
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MSC donors 1 and 2 (K93 and K129) were cultured in either basal or osteogenic 
3D co-culture medium conditions for up to 20 days. Medium samples were 
collected every 96 hours and analysed to calculate calcium concentration 
compared to control medium. From this cumulative calcium depletion from the 
culture medium over a period of 20 days was calculated. Donor 1 osteogenic 
conditions shows significantly greater calcium depletion from day 12 compared to 
basal. Significantly greater calcium depletion in MSC-EC spheroids can be seen 
at days 12, 16 and 20 compared to MSC-only. Donor 2 had a similar cumulative 
calcium depletion patter to Donor 1; however, overall calcium depletion at day 20 
was less. For each time point and biological donor six individual medium samples 
were tested (n=6). 
: Bone Formation of MSCs in 2D and 3D, With and Without ECs 
Page | 93  
 
 
Figure 3.4.13 – ALP and von Kossa staining of Donor 3 MSC-only and MSC-
EC spheroid sections 
Representative sections of ALP and von Kossa staining performed on Donor 3 
(K107) MSC-only and MSC-EC spheroids at various time points cultured in either 
basal or osteogenic conditions. No pink or brown/black staining was observed 
showing the samples were ALP and von Kossa negative. 
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Figure 3.4.14 – Cumulative calcium depletion from Donor 3 MSC-only and 
MSC-EC spheroids culture in basal and osteogenic condition 
MSC Donor 3 (K107) was cultured in either basal or osteogenic 3D co-culture 
medium conditions for up to 20 days. Medium samples were collected every 96 
hours and analysed to calculate calcium concentration compared to a control. 
From this cumulative calcium depletion from the culture medium was tabulated. 
No statistically significant calcium depletion was observed at any time point in 
any condition. This further demonstrates biological Donor 3 osteogenic inert 
behaviour. For each time point, culture condition and spheroid type six individual 
media samples were tested (n=6). 
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Second harmonic generation (SHG) imaging was used to visualise collagen 
within spheroid sections. To act as a control a section of OCT and human bone 
tissue were analysed (Figure 3.4.15). OCT was used due to being a collagen-free 
material that was used in the process of sectioning both human bone and cell 
spheroids. In the SHG figures, a range indicator was applied to the images; blue 
represents background/negative whilst black and grey represents positive 
collagen imaging. The lightly porous structure of cancellous bone can be easily 
observed. SHG imaging was also performed on MSC-only and MSC-EC spheroid 
sections culture in either basal or osteogenic 3D co-culture conditions and 
representative images can be seen in Figure 3.4.16. Low collagen levels could be 
detected at the edges of the spheroid sections from day 1, however, by day 21 
higher collagen levels were observed, particularly in spheroids cultured in 
osteogenic conditions. However, a collagen structure similar to human bone was 
not detected.  
Image analysis was performed on the SHG images to quantify the intensity and 
subsequent collagen presence. Collagen type I is a marker of osteogenic 
differentiation of MSCs, therefore, this could be used as a novel quantitative 
technique to measure osteogenesis in 3D. Figure 3.4.17 shows the quantification 
of MSC-only and MSC-EC spheroids culture in either basal or osteogenic 
condition up to 21 days using human bone and OCT as a control. Human bone 
had significantly more SHG imaging pixel intensity compared to all other tested 
materials. 
SHG imaging is a non-destructive technique to quantify collagen within materials; 
however, it is unable to identify the type of collagen present. Immunofluorescent 
labelling of MSC-only and MSC-EC spheroid sections for collagen type I and II 
were performed (Figure 3.4.18). Positive Collagen type I staining was observed in 
both MSC-only and MSC-EC spheroid sections cultured in osteogenic conditions 
after 21 days. 
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Figure 3.4.15 – Second harmonic generation imaging of an OCT section and 
a human bone marrow section 
SHG imaging at 870nm was performed and expressed using a range indicator. 
Blue represents background or collagen-free material, whilst black/grey 
represents collagen containing material. A- Section of OCT, OCT was used as it 
is collagen free and was used to mount bone samples and cell spheroids for 
sectioning. B – 7µm section of human bone from the tibial plateau of the knee. 
The typical cancellous bone structure can be observed, which is slightly porous. 
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Figure 3.4.16 – Second harmonic generation imaging of MSC-only and 
MSC-EC spheroid sections at various time points 
SHG imaging at 870nm was performed and expressed using a range indicator. 
Blue represents background or collagen-free material; grey/black represents 
collagen containing material. MSC-only and MSC-EC spheroids were cultured in 
either basal or osteogenic conditions for up to 21 days and representative images 
are shown. Spheroids were then snap frozen, sectioned at 7 µm before being 
SHG imaged. At Day 21 spheroid sections were clearly visible against the 
background; however, an organised structure was not detected. 
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Figure 3.4.17 – Quantification of SHG imaging of MSC-only, MSC-EC 
spheroids, human bone and OCT 
Using Image J analysis software the average pixel intensity for the various SHG 
imaged sections was calculated. Human bone was used as a positive collagen 
control, whilst OCT was used as a negative collagen control. MSC-only and 
MSC-EC spheroids cultured in either basal or osteogenic conditions at various 
time points were then analysed. Human bone was found to have a significantly 
greater pixel intensity compared to all other materials analysed. No significant 
differences were detected between MSC-only and MSC-EC spheroids. For each 
time point and culture condition three individual spheroids or samples were tested 
(n=3). 
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Figure 3.4.18 – Collagen type I and II immunostaining of MSC-only and 
MSC-EC spheroid sections 
Spheroid sections from MSC only and MSC-EC spheroids cultured in osteogenic 
conditions for either 1 or 21 days were stained for collagen type I and II before 
being imaged via fluorescence microscopy. Positive collagen type I staining can 
be clearly observed at day 21. This confirmed that the collagen detected using 
SHG imaging is collagen type I. 
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3.4.5 Viability of Long-term 3D Culture of Mesenchymal Stromal Cells and 
Endothelial Cells 
Live/dead staining was performed on MSC-only and MSC-EC spheroids cultured 
for up to 21 days to assess the long term viability of 3D culture (Figure 3.4.19). 
Cell spheroids were cultured in basal 3D co-culture medium and split fed twice a 
week. At days 1, 7, 14 and 21 post seeding spheroids were imaged using a 
confocal microscope. A dead control was produced by 10 minute incubation in 
70% industrial methylated spirit (IMS)/dH2O before application of live/dead stain. 
Spheroids cultured up to 21 days of both MSC-only and MSC-EC composition 
showed strong living (green) staining. A few nuclei within each sample have 
stained dead (red), however, the extent of red is not as severe as the dead 
control. 
The percentage of dead cells within the MSC-only and MSC-EC spheroids was 
calculated using the images generated with live/dead staining and Image J 
analysis software (Figure 3.4.20). The dead control was found to have a 
significantly greater percentage of dead cells compared to all other MSC-only and 
MSC-EC spheroids. However, no differences were detected between MSC-only 
and MSC-EC spheroids. 
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Figure 3.4.19 – Live/dead staining of MSC-only and MSC-EC spheroids over 
21 days in culture 
3D multi-photon confocal microscopy was used to image live/dead staining 
performed on MSC-only and MSC-EC spheroids after 1, 7, 14 and 21 days in 
culture. Active cells were able to uptake the dye into the cytoplasm and stain 
living cells green. Dead cells have damage nuclei and exposed DNA resulting in 
the nuclei being stained red. Within the dead control limited green was detected 
whilst many red nuclei were. 
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Figure 3.4.20 – Percentage of dead cells within MSC-only and MSC-EC 
spheroids using Live/Dead assay 
Using the live-dead staining and Image J analysis software, the percentage of 
dead cells within MSC-only and MSC-EC spheroids cultured for 1, 7, 14 and 21 
days was calculated. MSC-only or MSC-EC spheroids incubated in IMS for 10 
minutes was used as a dead control. There were significantly more dead cells 
within the dead control compared to all other samples, no significant difference 
was observed between MSC-only and MSC-EC spheroids at any time point. For 
each time point and culture condition three individual spheroids were tested 
(n=3). 
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3.5 Discussion 
Due to the lack of a specific cell surface marker, characterising MSCs is 
performed using a broad panel of cell surface markers. MSCs have been 
described as positive for many markers such as CD29, CD44, CD73, CD90, 
CD105 and CD166. They have also been described as negative for the markers 
CD11a, CD14, CD19, CD34, CD45, CD79a, CD144 and CD235a (Dvorakova et 
al., 2008, Karp and Leng Teo, 2009). MSCs extracted from both femoral heads 
and knees tested positive for MSC markers CD29, CD44, CD73, CD90 and 
CD105. However for all donors, MSCs sourced from both femoral heads and 
knees did not test positive for the frequently used MSC marker CD166. Overall, 
the MSCs expressed the majority of known markers whilst negatively expressing 
the haematopoietic markers CD34 and CD45, this negative expression is 
regarded as a strong indicator of bone marrow MSCs (Busser et al., 2015). 
Collectively, the data indicate that the MSC samples used in this study had a 
commonly recognised MSC immunophenotype. 
Platelet endothelial cell adhesion molecule (PECAM-1) or CD31 is a cell surface 
marker used to identify endothelial cells (Ma et al., 2014). Within these 
experiments, ECs were frequently co-cultured with the MSCs. To prove the 
MSCs extracted from either femoral heads or knees were not contaminated with 
endothelial cells they were immunofluorescently labelled and analysed for the 
presence of CD31 and found to be negative. HUVECs were used as these are 
one of the most characterised and commonly used human primary endothelial 
cells. HUVECs were purchased from Promocell and were checked for CD31, they 
were found to positive expressed CD31 via immunofluorescence and flow 
cytometry. There are alternative endothelial cell sources such as; human cord 
blood and endothelial progenitor cells. However, these alternative cell sources 
were inferior to HUVECs for these experiments. Human cord blood endothelial 
cells are rare, therefore obtaining the numbers required for these experiments 
would be impractical (Kim et al., 2015, Henning et al., 2012). Endothelial 
progenitor cells have been directly compared to HUVECs when co-cultured with 
: Bone Formation of MSCs in 2D and 3D, With and Without ECs 
Page | 104  
 
adipose derived MSCs. Endothelial progenitor cells unable to produce a 
neovasculature, making these cells inferior of HUVECs when co-cultured in vitro 
(Haug et al., 2015). 
Osteogenic differentiation of MSCs cultured in standard 2D cell culture conditions 
has been well documented. Assessment has been frequently examined using 
stains such as ALP, Alizarin Red S and von Kossa (Jones et al., 2002, Im et al., 
2005). Quantification has also been performed through elution of Alizarin Red S 
staining and ALP activity by pNPP assessment (Shui and Scutt, 2001, Moreau 
and Xu, 2009). Using ALP and von Kossa staining osteogenesis within three 
biological MSC donors was assessed. Donors 1 and 2 both showed positive ALP 
staining but were negative for von Kossa staining. Von Kossa staining is used to 
identify mineralisation through phosphate deposits, due to these donors being 
cultured for up to 21 days it is possible that mineralisation would have occurred 
later. Uniquely Donor 3 (K107) was negative for both ALP and von Kossa staining 
after 21 days.  
These three biological donors were also stained with Alizarin Red S and 
quantification performed using CPC elution. Donor 2 showed significance a little 
earlier than Donor 1 at day 7, both Donor 1 and 2 showed significant staining for 
days 14 and 21. Overall Donor 1 had higher Alizarin Red S levels compared to 
Donor 2 at day 21, indicating that this donor was slightly more osteogenic. Donor 
3 showed limited osteogenesis through Alizarin Red S staining; a significant 
difference between basal and osteogenic conditions was detected at day 21. 
However, this is most likely a false positive; the highest elution with this donor 
was 0.5 ± 0.03. In contrast at the same time point Donors 1 and 2 had elution 
values of 2.7 ± 0.138 and 1.4 ± 0.137 respectively. Observations made using 
ALP and von Kossa staining indicate that Donor 3 was an osteogenic-inert MSC 
donor. 
Despite the variety of techniques available to assess osteogenesis in 2D, these 
techniques have not always translated for 3D studies. The generation of a 
method that can be performed in both 2D and 3D could be used as a 
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complimentary assessment method. The importance of calcium within bone 
formation has long been known. Many cellular products associated with 
osteogenesis are calcium based (Wen et al., 2012). Previous research has also 
indicated a link between ALP and calcium, decreases in ALP activity were seen 
in conjunction with decreased intra and extra cellular calcium (Abnoshi et al., 
2012). Therefore, quantifying calcium depletion within culture medium could be 
used to non-destructively assess osteogenic differentiation in both 2D and 3D cell 
culture conditions. Calcium depletion analysis from culture medium was 
performed on Donors 1, 2 and 3 cultured in 2D conditions for up to 20 days. 
Donor 2 showed significantly greater calcium depletion in osteogenic conditions 
compared to basal after 12 days, conversely Donor 1 significance was detected 
after 16 days. Overall, Donor 1 had higher calcium depletion after 20 days 
compared to Donor 2, these results are similar to those obtained through Alizarin 
Red S staining and elution. Donor 3 showed no significant difference in calcium 
depletion at any time, supporting evidence that Donor 3 is an osteogenic-inert 
biological donor.  
Overall similar results were detected using both Alizarin Red S and calcium 
depletion on Donors 1, 2 and 3. Calcium depletion is a slightly advantageous 
technique as it is non-destructive making it easier to collect more data points. 
This technique also appeared to be more accurate. Alizarin Red S staining on 
Donor 3 showed a significant difference at day 21 between basal and osteogenic 
conditions. Indicating that Donor 3 underwent osteogenic differentiation, however, 
no positive ALP or von Kossa staining was detected at any time point making this 
highly unlikely. The false positive Alizarin Red S staining might have been caused 
by increased cell proliferation caused by the osteogenic induction medium. 
Dexamethasone a component within osteogenic induction medium has been 
shown to promote proliferation in MSCs (Wang et al., 2012). 
Human bone is a complex 3D structure, to more closely represent this MSCs and 
ECs were cultured in cell spheroids using U-bottomed 96-well plates. Spheroids 
were sectioned and stained with Alizarin Red S, unlike 2D this method could not 
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be used quantitatively through CPC elution. Therefore, a quantitative technique 
for 3D osteogenic cell spheroid culture would be required. Alizarin Red S staining 
of spheroids sections was found to positively stain at both days 1 and 7 when 
cultured in basal conditions, making this stain inappropriate for both quantitative 
and qualitative assessment. pNPP is a procedure frequently used to assess 
osteogenic differentiation of MSCs. Translating this from traditional 2D to 3D 
resulted in large error bars and inconsistent results. These were most likely 
caused during the homogenisation process which generated heat and required 
extra stages compared to 2D. Generating heat during pNPP assessment can be 
detrimental due to this technique being used to quantify ALP, ALP is an enzyme 
making it sensitive to high temperature degradation. 
ALP and von Kossa staining were performed on 3D MSC-only and MSC-EC 
spheroid sections. Donor 1 and 2 both showed positive ALP staining, however, 
both these donors were negative for von Kossa. Negative von Kossa staining 
was also observed using these donors in 2D and is most likely due to these 
donors having poor mineralisation properties. Observation of the ALP staining 
performed on Donors 1 and 2 showed stronger positive staining on MSC-EC 
spheroids compared to MSC-only. The positive ALP staining was also more 
prominent at the spheroid edges compared to the centre for all positive samples. 
This could be caused by a nutrient gradient caused by the 3D spheroid structure; 
peripheral cells will have more nutrients compared to central cells. An oxygen 
gradient will also occur, it has been previously demonstrated that a low oxygen 
concentration can inhibit osteogenesis (Malladi et al., 2005). 
Cumulative calcium depletion from culture medium was calculated for Donor 1 
and 2, MSC-only and MSC-EC spheroids. It was found that significantly greater 
calcium depletion was detected after 12 days in spheroids cultured in osteogenic 
conditions compared to basal conditions. MSC-EC spheroids showed significantly 
larger calcium depletion compared to MSC-only spheroids, indicating that the 
presence of ECs improved osteogenesis. These results are supported by 
previous research showing co-culture of MSCs and ECs in 2D, 2D scaffold and 
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3D scaffold conditions increasing osteogenic differentiation of MSCs. This 
increase is most likely due to a soluble factor produced by ECs (Saleh et al., 
2011b, Gershovich et al., 2013, Pandula et al., 2014).  
Despite MSC-EC spheroids containing half the number of MSCs compared to 
MSC-only spheroids, ALP staining, calcium depletion and SHG imaging all 
indicated greater osteogenesis. This is most likely attributed to the strength of a 
soluble factor released by the ECs. Known growth factors that enhance 
osteogenesis are VEGF, bone morphogenetic protein (BMP), FGF and TGF-β 
(Budiraharjo et al., 2013, Kim et al., 2012, Park et al., 2014, Geiger et al., 2005). 
VEGF, FGF-16 and FGF-18 are all known to be produced by ECs (Imaizumi et 
al., 2000, Antoine et al., 2006). 
Donor 3 MSC-only and MSC-EC spheroids were also cultured in basal or 
osteogenic conditions for up to 21 days. ALP and von Kossa staining was 
negative for all conditions. Calcium depletion from the culture medium was also 
negative for all conditions. Biological Donor 3 appears to have limited osteogenic 
potential in 2D and 3D culturing systems. Variation between different biological 
donors is a common phenomenon with no correlation between age, gender or 
isolation source, previous studies have also found osteogenic-inert human MSCs 
(Siddappa et al., 2007, Phinney et al., 1999). These results also indicate that co-
culturing MSCs with ECs does not give false positive results regarding ALP 
staining or calcium depletion. 
SHG imaging has been used to non-destructively observe and quantify collagen 
within various tissues (Chen et al., 2012). Using a section of human bone marrow 
and OCT, SHG imaging was performed and optimised. SHG of human bone 
marrow was used to clearly image the complex slightly porous structure of 
cancellous bone. SHG imaging of MSC-only and MSC-EC spheroid sections was 
able to detect the collagen present at various time points and conditions. This 
was then quantified using Image J image analysis. Image analysis showed that 
human bone contained significantly more collagen compared to all other 
samples. No other significant differences were detected. Therefore, this 
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technique could not be used to demonstrate significant differences between 
MSC-only and MSC-EC spheroids cultured in either basal or osteogenic 
conditions, unlike cumulative calcium depletion. 
SHG imaging has been used frequently to observed and quantify collagen, 
however, this technique is unable to distinguish between collagen type I and II 
(Chen et al., 2012). Immunofluorescence was performed on MSC-only and MSC-
EC spheroids at days 1 and 21 for collagen type I and II. At day 21 both MSC-
only and MSC-EC sections stain positive for collagen type I and a basic subtle 
lattice structure was observed. Therefore, the collagen imaged through SHG was 
most likely collagen type I. 
Using U-bottomed 96-well plates as a 3D cell culture method has various 
advantages. Spheroid size, cell number, cell type and environment can all be 
controlled without the presence of scaffolds or other material. The long-term 
viability of MSCs and ECs within cell spheroids containing approximately 30,000 
cells is unknown. Live/dead staining was performed on MSC-only and MSC-EC 
spheroids cultured after 1, 7, 14 and 21 days. Live/dead staining was used as this 
has been frequently reported as a method to assess cell viability (Lewus and 
Nauman, 2005, Zullo et al., 2015). The spheroids expressed strong living (green) 
staining at all time points, for day 1 the dye penetration was quite poor resulting 
in a dark centre. In contrast the dead control no positive living (green) stain was 
detected but many dead (red) nuclei were. The percentage of dead cells within 
the various spheroids was calculated. The dead control was found to have a 
significantly greater percentage of dead cells compared to all other spheroids. No 
significant difference in the percentage of dead cells was detected between MSC-
only and MSC-EC spheroids for any time point. This demonstrates that culturing 
MSCs and ECs within 3D 30,000 cell spheroids in U-bottomed 96-well plates for 
up to 21 days has no detrimental effect of cell viability.  
The ability for this novel 3D co-culture model to sustain cell viability is most likely 
due to the spheroid diameter being less than 1,000 µm. Early angiogenesis 
studies on cancer tumours observed that angiogenesis did not occur when 
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tumours were less than 1 mm3 and during avascular phase of a tumour the 
diameter did not exceed 1 mm (Gimbrone et al., 1972, Knighton et al., 1977). 
Having a relatively low diameter is important as it allows sufficient diffusion of 
important molecules, such as nutrients, oxygen and waste products. Later studies 
expanded upon this analysis further using in vitro spheroid studies. It was found 
that the distance from the spheroid periphery at which cell-necrosis occurs 
depends upon cell type, cell consumption rate and cell density. This distance 
most commonly ranged between 100-220 µm when using human tumour cells 
(Sutherland, 1988). Bone marrow specifically is a highly vascularised tissue; most 
tissue regions of mouse bone marrow are within 15 µm from the nearest blood 
vessel. However, the oxygen tension within bone marrow is relatively low <32 
mmHg, compared to arterial blood >600 mmHg (Spencer et al., 2014, Tanoue et 
al., 2002). 
In summary the cells extracted from femoral heads and knees positively and 
negatively expressed the panel of cell surface markers associated with MSCs, 
therefore, these cells were identified as MSCs. HUVECs purchased from 
PromoCell were found to express the known endothelial cell marker PECAM-1 or 
CD31; therefore, these were identified as ECs. Using U-bottomed 96-well plates 
to create 3D cell spheroids was established and found to have no detrimental 
effects of cell viability during 21 day culture. Osteogenic differentiation of MSCs 
was proven in both 2D and 3D conditions and found to be enhanced by ECs. 
Calcium depletion from culture medium was found to be a new, non-destructive, 
real-time technique to assess osteogenic differentiation in both 2D and 3D 
environments. The next chapter will further examine the MSC-EC co-culture 
spheroid model specifically to observe; the cellular organisation, cell-cell 
relationships and possible signalling mechanisms. 
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Chapter 4 : 3D Co-cultured MSCs and ECs – 
A Self-organising Spheroid Model 
4.1 Introduction 
A frequently observed organisation pattern within multi-cellular spheroids or 
aggregates is when one cell type migrates towards the periphery of the structure. 
For example this organisation pattern has been observed when co-culturing 
osteoblast cells with ECs in a collagen-based spheroid model (Stahl et al., 2004). 
This phenomenon is most likely the result of the differential adhesion hypothesis, 
where it is proposed that heterotypic cells within aggregates sort into isotypic 
groups (Steinberg, 1975). This theory has been tested by altering the number of 
cadherin cell-cell adhesion molecules on cells within aggregates. It was found 
that cells with lower cadherin expression enveloped those with higher cadherin 
expression. This resulted in the lower cadherin-expressing cells being located at 
the periphery of the spheroid, however when cadherin levels were equalised, the 
cells returned to an evenly intermixed organisation (Duguay et al., 2003, Foty and 
Steinberg, 2005, Thompson et al., 2012). Therefore, the differentiation adhesion 
hypothesis creates an organisation pattern due to the physical “stickiness” of the 
cells (Newman, 1996).  
Cell signalling is a highly complex process of communication between cells and 
has many important functions; tissue development during embryonic 
development, adult tissue homeostasis and adult tissue repair. These functions 
all require cell migration and organisation to create and maintain functional 
tissues (O'Dea and King, 2013). Within humans there are many major signalling 
pathways that are known to control cell migration. Specifically three different 
signalling pathways are known to affect MSC and/or EC migration; FGF, Notch 
and ILK signalling and described further in Sections 4.1.1, 4.1.3, and 1.6.4. FGF 
signalling has been shown to affect EC migration, specifically HUVECs have 
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shown chemotaxis towards FGF-16 and FGF-18 ex vivo and application of FGF-2 
has been shown to enhance HUVEC migration (Antoine et al., 2006, Dos Santos 
et al., 2014). Notch signalling has been shown to affect both EC and MSC 
migration. Using a combination of computational and experimental procedures it 
was demonstrated that Notch signalling was able to affect vascular-endothelial 
cadherin junctions on ECs, this subsequently limited their directional migratory 
ability (Bentley et al., 2014). Inhibition of Notch signalling in MSCs though γ-
secretase inhibition or transcription factor knockout resulted in improved MSC 
migration (Xie et al., 2013). ILK is known to affect EC migration, novel ILK 
inhibitor treatment resulted in decreased EC migration and led to decreased 
capillary formation and angiogenesis in vivo and ex vivo (Tan et al., 2004). Cell 
signalling based migration and subsequent organisation is mainly attributed to 
biological rearrangement of the cytoskeleton and focal adhesions (Welf and 
Haugh, 2011). 
Uniquely, work in our laboratory showed that when MSCs and ECs were co-
cultured in 3D spheroids, the ECs self-organised into distinct segregated regions 
within the spheroid (Saleh et al., 2011b). Related research demonstrated that this 
self-organisation pattern was particularly prominent when MSCs, ECs and iPS 
cells were tri-cultured in matrigel, within this model it was found that ECs formed 
a primitive vascular like network throughout the spheroid structure (Takebe et al., 
2013). Currently the mechanisms responsible for this distinct pattern are 
unknown. The unique pattern of ECs when co-cultured within MSCs has been 
described as a primitive vascular-like network. Therefore, research into 
angiogenesis (the formation of new blood vessels) could be used to understand 
the signalling mechanisms responsible (Moens et al., 2014). The study of 
angiogenesis has been highly popular within cancer studies, inhibition of this 
process could be used for therapeutic treatments. Recent studies have described 
that both VEGF and PDGF signalling play an important role in angiogenesis 
(Zhao and Adjei, 2015). PDGF suppression has been successfully used to limit 
angiogenesis within cancer and destabilise the vascular endothelium (Dong et al., 
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2014, Roskoski, 2007). Additionally FGF, Notch and ILK signalling have all been 
described as affecting angiogenesis (Sections 4.1.1, 4.1.3 and 1.6.4). 
Angiogenesis and bone formation have been linked, specifically deferoxamine 
mesylate (DFM) treatment was shown to enhance blood vessel formation and 
bone tissue in mice (Kusumbe et al., 2014). Additionally a wide range of growth 
factors are known to affect osteogenic differentiation of MSCs and/or bone 
formation these include; FGF, insulin like growth factor (IGF), PDGF, TGF-β, 
bone morphogenic protein (BMP) and VEGF (Stegen et al., 2015, Hengartner et 
al., 2013, Colciago et al., 2009, Rahman et al., 2015, Wu et al., 2013). 
Therapeutic application of FGF-1 and FGF-2 has been shown to enhance bone 
regeneration, specifically immobilisation of FGF-2 and BMP-2 on scaffolds was 
found to enhance the osteogenic differentiation of MSCs (Budiraharjo et al., 
2013). PDGF is known to affect the differentiation potential of MSCs and has 
been reported as more effective than FGF; this is most likely attributed towards 
PDGF affecting the cellular morphology (Ng et al., 2008). Indeed, a large MSC 
morphology has been observed to result in enhanced osteogenic differentiation 
(Zhao et al., 2012). However, the use of growth factors therapeutically requires 
appropriate delivery system development; global application of growth factors can 
result in ectopic bone formation, overgrowth and severe inflammatory/immune 
response (Luginbuehl et al., 2004). 
Conversely the use of a pharmacological agent does not require the development 
of an appropriate delivery system, for example DFM has been shown to enhance 
bone formation. DFM is a chelating agent frequently used within human medicine 
to remove excess iron from the blood; it is also a prolyl hydoxylase inhibitor 
leading to enhanced hypoxia inducible factor one alpha (HIF-1α) (Kusumbe et al., 
2014). This study was conducted in conjunction with another that showed Notch 
signalling promoted EC proliferation and vessel growth. EC specific loss of Notch 
resulted in mice with impaired bone vessel morphology, growth, shortening of the 
long bones and decreased bone mass (Ramasamy et al., 2014). This result is 
supported by another study showing that Notch impaired osteogenesis, despite 
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Notch being activated during the differentiation process (Viale-Bouroncle et al., 
2014). 
4.1.1 FGF signalling in MSCs and ECs 
FGF is such a diverse signalling pathway it has been shown to have numerous 
effects on MSCs. FGF is known to effect the proliferation, osteogenic 
differentiation, chondrogenic differentiation, potency, bone repair, skeletal 
development and maintenance of MSCs (Stegen et al., 2015). Specifically 
stimulation of FGFR1 is known to induce proliferation and positively regulate 
maintenance of MSCs, through c-Myc stimulation and cyclin-dependant kinase 
inhibition (Dombrowski et al., 2013). FGFR-2 acts as a regulator molecule that 
promotes osteogenic differentiation in MSCs through mediation of the MAPK 
signalling pathway (Miraoui et al., 2009). FGFR-2 also promotes chondrogenic 
differentiation of MSCs through inhibition of TGF-β and insulin-like growth factor 
(IGF) signalling (Ito et al., 2008). Multiple skeletal congenital disorders such as 
chondrodysplasia are associated with deregulation of the FGF pathway. FGFR-3 
mutations are known to affect long bone development (endochondral 
ossification), leading to diseases such as hypochondroplasia and achondroplasia 
(Chen et al., 2013a, Di Rocco et al., 2014). Therefore, FGFR-3 is important in 
skeletal development. Therapeutic application of both FGF-1 and FGF-2 has 
been used in a variety of studies to improve bone regeneration (Iwaniec et al., 
2002, Kuhn et al., 2013). 
FGF is essential for the culture of ECs ex vivo; FGF-2 induces both proliferation 
and migration (Dos Santos et al., 2014). One of the most important cellular 
processes FGF is involved with is angiogenesis. Application of FGF-2 has been 
shown to enhance vascular sprouting, tube formation and decreased EC 
apoptosis through induced activation of Jagged-1 a ligand of Notch (Matsumoto 
et al., 2002). Due to the broad range of the FGF family understanding the specific 
role during vascular development is difficult. Indeed, FGF-1 and FGF-2 single 
and double knockout mice show no gross vascular defects (Javerzat et al., 2002). 
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However, it is known that both FGF-1 and FGF-2 can regulate the angiogenesis 
process. FGF-2 is able to induce angiogenesis indirectly through VEGF signalling 
(Auguste et al., 2001). FGF is able to enhance EC proliferation, migration, 
cadherin receptor expression and gap-junction communication (Hatanaka et al., 
2012, Haddad et al., 2008). 
4.1.2 PDGF signalling in MSCs and ECs 
MSCs are known to abundantly express PDGFR and are subsequently 
influenced by PDGF signalling (Ball et al., 2007). PDGF signalling plays a crucial 
role in MSC commitment to osteogenesis, chondrogenesis and adipogenesis. 
PDGF signalling has been described as being more potent in MSC differentiation 
than fibroblast growth factor (FGF) signalling and TGF-β signalling. Specifically 
PDGF treatment enhanced MSC osteogenic differentiation further than FGF and 
TGF-β (Ng et al., 2008). This effect on MSC differentiation could be controlled by 
cell shape, cytoskeleton actin is known to be reorganised following PDGF 
stimulation and the differentiation potential of MSCs is known to be affected by 
MSC cell morphology (Woodring et al., 2003, McBeath et al., 2004). Specific 
inhibition of PDGFR has shown to result in MSCs with a more rounded 
morphology. Additionally PDGFR inhibition has resulted in increased MSC 
potency (Ball et al., 2012).  
Little is known about the effects of PDGF signalling on ECs specifically; however, 
PDGF and PDGFR stimulation has been shown to produce a pro-angiogenesis 
phenotype (Wyler von Ballmoos et al., 2010). Global effects of PDGF signalling 
on angiogenesis are more well documented, PDGF signalling has recently been 
described as an alternative angiogenesis signalling pathway (Zhao and Adjei, 
2015). Traditionally angiogenesis signalling has been related to VEGF 
specifically, however, combinational therapies of PDGF and VEGF inhibition have 
been shown to reduce blood vessel formation within cancer tumours (Dong et al., 
2014). This result is complimented by the knowledge that a combination of PDGF 
and VEGF has been shown to enhance postnatal angiogenesis and used as a 
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successful therapy post myocardial infarction in animal models (Rehman et al., 
2003).   
4.1.3 Notch signalling in MSCs and ECs 
Notch has been shown to have a range of effects on MSCs. Inhibition of Notch 
signalling within MSCs has been linked to decreased proliferation and survival, 
increased CXCR4, migration and stem cell potency (Liao et al., 2014, Xie et al., 
2013). Using both small molecular inhibitors and transcription factors, Notch 
signalling was reduced within MSCs, surface protein and mRNA levels of CXCR4 
were significantly increased. CXCR4 is believed to be one of the most important 
molecules responsible for MSC migration towards the site of injury. Within MSCs 
decreased Notch, leads to increased CXCR4 and subsequently increased 
migration. Co-culture of MSCs with other stem cells has shown MSCs are able to 
enhance the potency of other cells through Notch-1 and Hes-1 stimulation 
(Haragopal et al., 2015). Within bone tissue Notch signalling is linked to bone 
remodelling, rheumatoid arthritis, bone-loss and osteoblast inhibition. Within a 
mouse rheumatoid arthritis model, genes encoding Notch were markedly 
elevated within MSCs, subsequent treatment with Notch inhibitors resulted in 
improved bone formation and osteoblast activity. Therefore, Notch is associated 
with inflammatory mediated bone loss in diseases such as rheumatoid arthritis 
(Zhang et al., 2014). 
Notch-1 and Notch-4 receptors and three Notch ligands are known to be 
expressed in ECs (Kume, 2009). Notch signalling has been reported as important 
in EC proliferation, migration, angiogenesis and survival (Liu et al., 2013, Kerr et 
al., 2015, Chang et al., 2013a). Increased Notch-3 expression in ECs leads to 
enhanced cell migration (Howard et al., 2013). Global expression of Notch within 
ECs is important, deletion of Notch-1 receptor within ECs results in severs 
vascular defects resulting in embryonic lethality (Gale et al., 2004). The specific 
roles of Notch within EC angiogenesis are highly complex, in brief Notch activity 
switches between the tip and stalk of the developing blood vessel stimulating 
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sprouting. During this process Notch signalling is closely linked with VEGF and 
both signalling mechanisms act as key regulators in angiogenesis (Thomas et al., 
2013). Again, the importance of Notch and VEGF in the angiogenesis of tumours 
has also been reported. However, a greater understanding of the role of Notch 
within angiogenesis is required before anti tumour therapies can be developed 
(Liu et al., 2014). 
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4.2 Aims 
The general aims of the work presented within this chapter are to characterise 
further the 3D co-culture model of MSCs and ECs, using a variety of different 
techniques to quantify self-organisation and to identify the possible mechanisms 
involved. 
More specifically the objectives are to: 
 Determine the optimal ratio of MSCs and ECs within 3D co-culture 
spheroids. 
 Develop non-invasive real-time imaging strategies to quantify co-culture 
spheroid organisation. 
 Characterise EC self-organisation patterns within co-culture spheroids and 
establish whether EC self-organisation is directed by MSCs. 
 Identify cell signalling pathways responsible for EC self-organisation.  
 Observe if known pharmacological agents affect EC self-organisation 
within the novel 3D co-culture model. 
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4.3 Methods 
4.3.1 Formation of co-culture spheroids at various ratios 
Various different ratios of MSCs:ECs were tested in the 3D co-culture method 
described in Section 2.1.7. All MSC-EC spheroids were cultured in 3D co-
cultured medium containing 50% DMEM, 50% endothelial cell medium, 15% 
FBS, P/S and 0.25% (w/v) methyl cellulose. The MSC:EC ratios examined were 
80:20, 65:35, 50:50, 35:65 and 20:80, all spheroids had a total of 30,000 cells. 
Therefore the 80:20 spheroid contained 24,000 MSCs and 6,000 ECs. 
4.3.2 Formation of co-cultured human dermal fibroblast and endothelial 
cell spheroids 
To test whether the self-organisation observed in MSC-EC spheroids was 
dependent on the presence of MSCs specifically, HDF-EC co-culture spheroids 
were created. The HDF-EC spheroids were cultured in 3D co-culture medium 
containing; 50% DMEM, 50% endothelial cell medium, 15% FBS, P/S and 0.25% 
(w/v) methyl cellulose, the same medium used in MSC-EC spheroid culture. The 
method used to create HDF-EC spheroids is the same as previously described in 
Section 2.1.7, however, MSCs were substituted with HDFs between passage 7-
10. 
4.3.3 Formation of co-cultured spheroids with various inhibitor and 
pharmacological treatments 
To help determine the signalling mechanisms responsible for the self-
organisation observed in the MSC:EC spheroids, various inhibitors were added to 
the cell suspension after the final stage of cell tracker labelling and prior to the 
suspension being placed into the U-bottomed well plate. The spheroids were then 
cultured for up to 7 days in the presence and absence of platelet-derived growth 
factor receptor inhibitor (PDGFRi), integrin-linked kinase inhibitor (ILKi), fibroblast 
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growth factor receptor inhibitor (FGFRi), Dibenzazepine (DBZ) and epidermal 
growth factor receptor inhibitor (EGFRi). Table 4.3.1 shows the various inhibitor 
treatments used on MSC-EC spheroids, the signalling pathways affected and the 
concentrations used. In Table 4.3.2 more specific information on the inhibitors 
such as chemical name and specificity are given. The pharmacological agent 
deferoxamine mesylate (DFM) (Cat no. D9533, Sigma-Aldrich, UK) was also 
added to various MSC-EC spheroids. DFM was added into appropriate culture 
medium to give a final concentration of 100 µM. For comparative purposes an 
MSC only spheroid with 50% of the population labelled red and 50% of the 
population labelled green was also produced. 
Table 4.3.1 – Inhibitor treatments used on MSC-EC spheroids 
Inhibitor 
name 
Signalling 
Pathway 
Concentration 
Used Supplier Cat No. 
ILKi 
 ILK 2 µM Millipore 407331 
PDGFRi 
 PDGF 3 µM Santa Cruz sc 205794 
EGFRi 
 EGF 100 nM Tocris 1037 
FGFRi 
 FGF 4 nM Tocris 3044 
DBZ 
 Notch 3 µM Tocris 4489 
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Table 4.3.2 – Specific inhibitor information used on MSC-EC spheroids 
Inhibitor 
name Full name Specificity 
ILKi 
N-methyl-3-(1-(4-(piperazin-1-
yl)phenyl)-5-(4'-
(trifluoromethyl)biphenyl-4-yl)-1H-
pyrazol-3-yl)propanamide 
Suppresses ILK-mediated 
phosphorylation of Akt at 
Ser473 site 
PDGFRi 
3-Fluoro-N-(6,7-dimethoxy-
2,4-dihydroindeno[1,2-
c]pyrazol-3-yl)phenylamine 
Reversible ATP-
competitive inhibitor of 
PDGFR-α and β 
EGFRi 
4-[(3-Bromophenyl)amino]-6,7-
dimethoxyquinazoline 
hydrochloride 
Potent inhibitor of EGF 
receptor tyrosine kinase  
FGFRi 
N-[2-[[4-
(Diethylamino)butyl]amino]-6-(3,5-
dimethoxyphenyl)pyrido[2,3-
d]pyrimidin-7-yl]-N'-(1,1-
dimethylethyl)urea 
Selective FGFR-1 and 
FGFR-3 inhibitor, 
DBZ 
N-[(1S)-2-[[(7S)-6,7-Dihydro-5-
methyl-6-oxo-5H-
dibenz[b,d]azepin-7-yl]amino]-1-
methyl-2-oxoethyl]-3,5-
difluorobenzeneacetamide 
Inhibitor of Notch γ-
secretas, preventing 
cleavage of the Notch ICD  
 
4.3.4 Pre-treatment with integrin-linked kinase inhibitor 
Due to inhibitor treatments being applied to both MSCs and ECs when in 3D co-
culture, the effect of pre-treatment of MSCs-only with ILKi was tested. MSCs 
were treated with ILKi at the same concentration shown in Table 4.3.1 for 96 
hours in 2D before being used in labelled 3D co-culture MSC-EC spheroids. The 
spheroids were then analysed for up to 5 days to observe if MSC-only ILKi pre-
treatment had any effect.  
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4.3.5 Imaging techniques and quantification 
4.3.5.1 2D time-lapse imaging of co-culture spheroids 
A 50-50 mixture of MSCs and ECs were placed as a random suspension into a 
U-bottomed 96-well plate. This cell culture plate was then placed into an 
incubator attached to a DMIRB Leica Light microscope. A needle was then 
inserted through the plate and attached to a 5% CO2, 95% air gas cylinder. The 
light microscope was then automatically set-up to capture images every 15 
minutes for up to 24 hours. This was done to preliminarily assess the time taken 
for the cell suspension to aggregate and form a spheroid. 
4.3.5.2 4D imaging of co-culture spheroids 
Using a Zeiss LSM 780 multiphoton inverted microscope with a 37oC incubator 
attachment and 5% CO2 95% air cylinder it was possible to simultaneously 
culture cells whilst imaging them in 3D. Spheroids were produced using the 
method described in Section 2.1.7 and labelled as described in Section 2.2.1. 
MSC-EC spheroids were analysed and to act as a control MSC-only spheroids 
with 50% of the MSCs were fluorescently labelled green and the other 50% 
fluorescently labelled red. The appropriate cell suspension was added into the U-
bottomed 96-well plate and surrounding wells were flooded with PBS to minimise 
evaporation. The cells were then incubated for 4 hours in a normal incubator at 
37oC to allow early cellular aggregation. Immediate transfer and imaging of a cell 
suspension resulted in cell death due to damage caused by the laser light 
intensity. 3D imaging was then performed every 20 minutes for a total of 16 
hours, during which time the cell suspension aggregated for form a spheroid. 
4.3.5.3 Quantification of spheroid volume and spheroid surface 
Spheroid volume was calculated using Volocity software (Perkin Elmer) using the 
quantification package. Specifically, the fluorescent volume was calculated as 
either µm3 or mm3 using pre-determined pixel to µm scale bars. It was possible to 
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calculate the percentage of either red or green cells at the spheroid surface. 
Using the Volocity quantification package surface analysis was performed and 
the area of green or red could be calculated, this was then converted into a 
percentage. 
4.3.5.4 Internal organisation of spheroids 
Using the plot profiler extension on Image J software (MBF – McMaster 
Biophotonics Facility, Canada) analysis of various cross-sections of spheroids 
was performed. Each spheroid section had a minimum of three different z-axes 
drawn across them; plot profile was then able to calculate the amount of either 
red or green at a specific point on the z-axis. At least three different sections of 
the same spheroid type were then analysed this way, before the data was 
averaged together to give an estimate of the internal organisation within the 
spheroid sections. 
4.3.5.5 Quantification of endothelial cell networks 
Using the freehand extension on Image J software the length and width of 
endothelial cell networks within spheroid section images were calculated. The 
number of branches was calculated manually. 
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4.4 Results 
4.4.1 Characterisation of CellTracker™ green and red profiles  
CellTracker™ green and red labels were applied to different cell types as 
described in Section 2.2.1 to enable tracking by fluorescence microscopy. Figure 
4.4.1 shows individual spheroids labelled with CellTracker™ green (A) and red 
(B), these were used to optimise the excitation laser wavelength. Spectral 
analysis of the emission profiles were performed using this optimised laser 
wavelength (780 nm). 
Figure 4.4.2 shows 2D MSCs and ECs labelled using CellTracker™ green and 
red respectively. Emission profiles were captured using a non-descan detector in 
three different regions. Region 1: 400-500nm, Region 2: 500-550nm and Region 
3: 560-650nm, these correspond to the blue, green and red regions of the visible 
light spectrum.  Individual cells can be easily identified within the relevant colour 
region; any bleeding between the two different CellTracker™ colours is 
undetectable by the human eye. These analyses validate the use of 
CellTracker™ green and red labels to distinguish different cell types in mixed 
cultures. 
: 3D Co-cultured MSCs and ECs – A Self-organising Spheroid Model 
Page | 125  
 
 
Figure 4.4.1 – Laser optimisation and spectral analysis using CellTracker™ 
Green and Red 
A – Optimisation of laser excitation wavelength using a CellTracker™ green 
labelled spheroid. B – Optimisation of laser excitation wavelength using a 
CellTracker™ red labelled spheroid, optimised wavelength was found to be 
780 nm. C – Spectral analysis of CellTracker™ green and red when excited with 
a laser at 780 nm. Emission profiles were detected by a non-descan detector 
ranging between 400-800 nm. 
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Figure 4.4.2 – 2D co-culture of fluorescently labelled MSCs and ECs 
MSCs and ECs were labelled with fluorescent CellTracker™ green and red 
respectively before being co-cultured in 2D. Image was captured using a 
multiphoton confocal microscope using an excitation wavelength of 780 nm. The 
non-descan detector was split into three different regions. Region 1: 400-500 nm, 
Region 2: 500-550 nm and Region 3: 560-650 nm, these correspond with blue, 
green and red on the visible light spectrum. Clear separation can be seen 
between green MSCs and red ECs, highlighted with green and red arrows. 
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4.4.2 Characterisation of co-cultured spheroids 
Five different ratios of MSC:EC were co-cultured to form spheroids, these were 
20:80, 35:65, 50:50, 65:35 and 80:20. Within these experiments MSCs were 
always fluorescently labelled green and ECs red, the various MSC:EC spheroids 
were then cultured for up to 7 days. Fluorescent whole spheroid images can be 
seen in Figure 4.4.3. All combinations were able to form spheroids within 1 day; 
however, 20:80 spheroids had poor structural integrity after 7 days in culture. 
Using the fluorescent whole spheroid images the diameter was measured for the 
various MSC:EC spheroids for up to 7 days in culture (Figure 4.4.4). Spheroid 
diameter decreased most dramatically between days 1 and 5 in culture as 
previously observed  (Saleh et al., 2012). No significant differences in spheroid 
diameter at different ratios were detected, however, 20:80 spheroids appeared 
consistently smaller compared to 80:20. The various MSC:EC spheroids were 
sectioned after day 1, 3 and 5, self-organisation was only clearly detected in 
50:50 MSC:EC spheroids, representative spheroid section images can be seen in 
Figure 4.4.5. Between approximately day 3 and 5, ECs self-organised to form a 
primitive vascular-like network evenly distributed throughout the spheroid. All 
other ratios resulted in ECs predominantly at the periphery of the spheroid at all 
time-points.  
 
: 3D Co-cultured MSCs and ECs – A Self-organising Spheroid Model 
Page | 128  
 
 
Figure 4.4.3 – Various fluorescently labelled whole MSC:EC spheroids 
cultured for up to 7 days 
Whole fluorescently labelled MSC:EC spheroids were imaged using a fluorescent 
microscope. The various ratio co-culture spheroids were cultured for up to 7 
days. MSCs were labelled green and ECs labelled red, all combinations were 
able to form spheroids within 1 day, however, the structural integrity of 20:80 
spheroids after 7 days was poor.  
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Figure 4.4.4 – Spheroid diameter of various MSC:EC spheroids cultured for 
up to 7 days 
Spheroid diameter of various ratio MSC:EC spheroids was measured from 
fluorescent images using Image J software over a period of 7 days.  Spheroid 
diameter decreased during culture, this is most striking between day 1 and 5. No 
significant differences between the various ratios were detected; however, 20:80 
spheroids were consistently smaller compared to 80:20. For each time point and 
spheroid type, 12 individual spheroids from three different biological donors were 
measured (n=12) 
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Figure 4.4.5 – Fluorescent spheroid sections of various MSC:EC ratios 
The various fluorescently labelled MSC:EC spheroids were collected and snap 
frozen at days 1, 3 and 5. MSCs were labelled green and ECs red. Spheroids 
were sectioned and imaged using a fluorescence microscope to observe internal 
organisation patterns. 50:50 MSC:EC spheroids showed a unique primitive 
vascular-like network of ECs. 
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4.4.3 Three dimensional spheroid formation of co-cultured MSCs and ECs 
Following these observations, from here on all MSC-EC spheroids used a 50:50 
mixture of the two different cell types unless otherwise stated. To understand the 
self-organisation pattern observed, the spheroid formation process was analysed 
in more detail. Initial studies were performed using time-lapse imaging on a light 
microscope; this was done to assess the formation time between cell suspension 
to cell spheroid. Using this technique it was possible to observe the spheroid 
formation process, Figure 4.4.6 shows selected time coded images from this 
analysis. It was observed that from cell suspension to spheroid formation took 
approximately 15 hours. 
This initial spheroid formation analysis was then developed into fluorescently 
labelled 4D imaging using a confocal microscope. A fluorescently labelled MSC-
EC spheroid was analysed and 3D images were captured every 20 minutes. To 
reduce cell death caused by the laser light, the cell suspension was left for 4 
hours before imaging was conducted. A selection of key time-points can be 
observed in Figure 4.4.7; MSCs were labelled green whilst ECs were labelled 
red. After 17 hours and 20 minutes after initial cell seeding a 3D cell spheroid 
was clearly observed. To act as a control for MSC-EC spheroid formation an 
MSC-only spheroid with half the population of MSCs labelled green and the other 
half red was created. This was then analysed using the same 4D imaging 
technique (Figure 4.4.8).  
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Figure 4.4.6 – Time-lapse of MSC-EC spheroid formation using a light 
microscope 
Time-lapse analysis of MSC-EC spheroid formation was performed for up to 24 
hours capturing images every 15 minutes. Here selected key time-points show 
the spheroid formation process. At 0:00 the cells are in a random suspension, at 
6:00 the cells have begun to aggregate. By 15:00 a cell spheroid is clearly visible 
and by 18:00 the cell spheroid structure is still maintained. Therefore, the 
spheroid formation process took approximately 15 hours. 
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Figure 4.4.7 – Three-dimensional time-lapse analysis of a fluorescently 
labelled MSC-EC spheroid during formation 
Three-dimensional time-lapse analysis or 4D imaging was performed on a 
fluorescently labelled MSC-EC spheroid, using a multi-photon confocal 
microscope. MSCs were labelled green and ECs red. 3D images were captured 
every 20 minutes for up to 16 hours. To reduce cell death caused by the laser 
light the cell suspension was incubated for 4 hours before being imaged. At this 
time point a random cell suspension can be observed, the cells begin to 
aggregate and a cell spheroid can be seen at 17:20. 
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Figure 4.4.8 – Three dimensional time-lapse analysis of a fluorescently 
labelled MSC-only spheroid during formation 
To act as a control three-dimensional time-lapse analysis or 4D imaging was 
performed on a fluorescently labelled MSC-only spheroid. Half of the MSCs were 
fluorescently labelled green whilst the other half were labelled red. A random cell 
suspension can be observed at time-point 4:00, the cells begin to aggregate and 
a spheroid can be seen at 17:20. 
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Using Volocity software the surface of the spheroid was analysed during the 
formation process. The percentage of either green or red cells at the spheroid 
surface was calculated every 20 minutes for a total of 16 hours (Figure 4.4.9). It 
can be seen that for the MSC-EC spheroid the percentage of red ECs increases 
during the spheroid formation, by contrast the MSC-only spheroid no increasing 
trend was observed. This spheroid surface analysis technique was then repeated 
using two additional biological donors. Both MSC-EC and MSC-only spheroids 
were analysed (Figure 4.4.10, Figure 4.4.11). For all MSC-EC spheroids, the 
percentage of red ECs increased at the surface by approximately 4% over the 
15-hour analysis period. In contrast all MSC-only spheroids the percentage 
change was no greater than 2%. 
Spheroid volume was also calculated using Volocity software during spheroid 
formation analysis (Figure 4.4.12). Both MSC-EC (50:50) and MSC-only 
spheroids had similar volumes that decreased at approximately the same rate 
over the same time period. 
: 3D Co-cultured MSCs and ECs – A Self-organising Spheroid Model 
Page | 136  
 
 
Figure 4.4.9 – Spheroid surface analysis during formation of MSC-EC and 
MSC-only spheroids 
From the 4D imaging performed on the MSC-EC and MSC-only spheroid, surface 
analysis was performed. This was used to quantify the percentage of green or 
red cells at the spheroid surface. For the MSC-EC spheroid it was determined 
that the percentage of red (EC) cells at the surface increased with time. For the 
MSC-only spheroid no change in spheroid surface was observed. 
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Figure 4.4.10 – Spheroid surface analysis during the formation of MSC-EC 
spheroids from Donors 1, 2 and 3 
Surface analysis was performed using the 4D imaging of three MSC-EC 
spheroids from three different biological donors. This analysis quantified the 
percentage of green MSCs or red ECs at the spheroid surface. For all donors the 
percentage of ECs at the spheroid surface increases by approximately 4% over 
the 15-hour analysis.  
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Figure 4.4.11 – Spheroid surface analysis during the formation of MSC-only 
spheroids from Donors 1, 2 and 3 
Surface analysis was performed using the 4D imaging of three MSC-only 
spheroids from three different biological donors. This analysis quantified the 
percentage of either green MSCs or red MSCs at the spheroid surface. For all 
donors the percentage change of either red or green MSCs did not exceed 2% 
over the 15-hour analysis.  
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Figure 4.4.12 – Spheroid volume analysis of MSC-EC and MSC-only 
spheroids during formation 
Spheroid volume was calculated using Volocity software for MSC-EC and MSC-
only spheroid s during formation. Both MSC-EC and MSC-only spheroids had 
similar volumes that decreased at approximately the same rate over the same 
time period (n=1). 
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4.4.4 Three dimensional spheroid co-culture of HDFs and ECs 
To determine whether the self-organisation relationship between MSCs and ECs 
was unique, HDFs were cultured with ECs in U-bottomed 96-well plates (Section 
4.3.2).  These HDF-EC spheroids were compared to MSC-EC spheroids, 3D 
confocal microscopy images can be seen in Figure 4.4.13. HDFs and MSCs were 
labelled green, whilst ECs were labelled red. These images show the whole 
spheroids over a period of 7 days, little difference can be observed by visual 
comparison. The spheroid diameter and spheroid surface of these two different 
spheroid types were calculated (Figure 4.4.14). It was found that HDF-EC 
spheroids were significantly smaller than MSC-EC spheroids at days 5 and 7 of 
culture.  There were also significantly more green labelled cells (HDFs) at the 
spheroid surface of HDF-EC spheroids compared to the percentage of green 
labelled cells (MSCs) in MSC-EC spheroids at days 3 and 7 of culture. 
The fluorescently labelled spheroids were snap frozen and sections to observed 
internal organisation, representative images from three different spheroids and 
three spheroid sections (N=9) can be seen in Figure 4.4.15. HDF-EC and MSC-
EC spheroids were compared at various time-points in culture, HDFs and MSCs 
were labelled green whilst ECs were consistently labelled red. Little to no 
organisation was detected in HDF-EC spheroids, at day 1 and 3 ECs appear 
more prominently at the spheroid periphery. In contrast MSC-EC spheroids 
demonstrated a different organisation pattern; ECs did not appear more 
prominent at the spheroid edge. The ECs appeared to be associated forming a 
network that was evenly distributed throughout the spheroid by day 3. The EC-
network length, width and branching was then calculated from these spheroid 
section images (Figure 4.4.16). A total of 24 spheroids sections from six 
spheroids were analysed (n=24). MSC-EC sections had a significantly greater 
EC-network length compared to HDF-EC sections at days 3 and 5. MSC-EC 
sections also had significantly more branching compared to HDF-EC spheroids at 
day 5. 
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Figure 4.4.13 – 3D confocal images of whole fluorescently labelled HDF-EC 
and MSC-EC spheroids 
Whole spheroid images of HDF-EC and MSC-EC spheroids were taken over a 7-
day culture period using a multi-photon confocal microscope. HDFs and MSCs 
were labelled green whilst ECs were labelled red. These whole spheroid images 
show little difference via visual comparison. 
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Figure 4.4.14 – Diameter and surface analysis of HDF-EC and MSC-EC 
spheroids 
The spheroid diameter of HDF-EC and MSC-EC spheroids was calculated, it was 
found that HDF-EC spheroids were significantly smaller than MSC-EC spheroids 
at days 5 and 7 of culture. Surface analysis of green labelled cells (HDFs or 
MSCs) found that significantly more green cells were at the spheroid surface of 
HDF-EC spheroids compared to MSC-EC spheroids at days 3 and 7 of culture. 
Spheroid diameter was calculated from four individual spheroids per time point 
(n=4) and spheroid surface analysis was conducted on three individual spheroids 
per time-point (n=3). 
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Figure 4.4.15 – Fluorescently labelled spheroid sections of HDF-EC and 
MSC-EC co-cultured spheroids 
Spheroids were fluorescently labelled to identify the two different cell types and 
representative images are shown from n=24 independent observations. HDF-EC 
and MSC-EC spheroids were compared to observe if MSCs directed EC self-
organisation. HDF or MSCs were labelled green and ECs were labelled red. Little 
self-organisation within HDF-EC spheroid sections was visibly detected, unlike 
MSC-EC spheroid sections where an EC network was observed from day 3. 
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Figure 4.4.16 – Endothelial cell network length width and branching 
analysis of HDF-EC and MSC-EC spheroids 
From the various HDF-EC and MSC-EC spheroid section images the EC 
networks within these sections were manually analysed using Image J software 
to quantify length (A), width (B) and branching (C). A significant increase in 
network length was detected in MSC-EC spheroids at days 3 and 5 compared to 
HDF-EC. A significant increase in the number of branches was detected in MSC-
EC day 5 sections compared to HDF-EC sections at day 5. A total of 24 different 
spheroid sections from six spheroids were analysed (n=24).  
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4.4.5 Effects of various inhibitor treatments on co-culture spheroid 
formation and organisation 
All experiments performed in this section were conducted using three different 
biological MSC donors; all images are representative of a minimum of three 
different spheroids from three different biological donors. All results are averages 
calculated from three biological donors. MSC-EC spheroids were treated with a 
variety of different inhibitor treatments to block key signalling pathways. Some of 
the signalling pathways, such as FGF and ILK are known to affect or be affected 
by EC migration. Whole spheroid images on these different inhibitor treatments 
and an MSC-only control (made of an equal mixture of green and red MSCs) can 
be seen in Figure 4.4.17. MSC-EC spheroids were treated with ILKi, PDGFRi, 
EGFRi, DBZ (Notch inhibitor) and FGFRi. Visual differences can be seen 
depending upon the inhibitor treatment; MSC-EC spheroids treated with ILKi 
clearly have more green MSCs at the spheroid surface compared to MSC-EC 
alone. Spheroids treated with PDGFRi also appear larger at Day 1. Using 
Volocity visualisation and rendering software an alternative whole spheroid 
images were generated, these images showed that both FGFRi and DBZ treated 
spheroids had more red labelled ECs at the spheroid surface (Figure 4.4.18). 
These whole spheroid images were then analysed to quantify diameter and 
percentage of green labelled MSCs at the spheroid surface (Figure 4.4.19).  
From this analysis it was found that PDGFRi treated spheroids were significantly 
larger at days 1 and 2 of culture and FGFRi treated spheroids were larger at day 
3. Spheroid surface analysis confirmed observations in Figure 4.4.17 and Figure 
4.4.18, ILKi treatment resulted in significantly more green MSCs being at the 
spheroid surface at days 1, 2 and 3 compared to MSC-EC untreated spheroids. 
PDGFRi treatment resulted in significantly fewer MSCs at the spheroid surface at 
days 1, 2 and 5. DBZ treatment resulted in significantly fewer MSCs at the 
spheroid surface at days 1, 2 and 3. FGFRi treatment resulted in significantly 
fewer MSCs at the spheroid surface at days 1 and 2. 
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Figure 4.4.17 – Whole 3D MSC-EC spheroids treated with various inhibitors 
Using 3D multi-photon confocal microscopy whole images of living MSC-EC 
spheroids were imaged. MSCs were labelled green and ECs red, except for the 
MSC-only control, 50% of the cells were labelled green and the other 50% red. 
Spheroids were treated with ILKi, PDGFRi, EGFRi, DBZ (Notch inhibitor) and 
FGFRi for up to 7 days in culture. PDGFRi treated spheroids appear larger, ILKi 
spheroids appear to have greater green and DBZ treated spheroids appear more 
red. 
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Figure 4.4.18 – Whole 3D MSC-EC spheroid images rendered using Volocity 
software 
Whole MSC-EC spheroids treated with various inhibitors were imaged as shown 
in Figure 4.4.17. However, using Volocity image rendering these alternative 
images were created, highlighting that FGFRi and DBZ treatment resulted in 
more red labelled ECs at the spheroid surface compared to untreated control 
MSC-EC spheroids. 
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Figure 4.4.19 – Spheroid diameter and surface analysis of MSC-EC 
spheroids treated with various inhibitors 
From the whole spheroid images analysis was performed to analyse spheroids 
diameter and the percentage of green cells (MSCs) at the spheroid surface. From 
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this analysis it was found that PDGFRi treated spheroids were significantly larger 
at days 1 and 2 of culture and FGFRi treated spheroids were larger at day 3, 
compared to MSC-EC untreated spheroids. Spheroid surface analysis confirmed 
observations in Figure 4.4.17, ILKi treatment resulted in significantly more green 
MSCs being at the spheroid surface at days 1, 2 and 3 compared to MSC-EC 
untreated spheroids. PDGFRi treatment resulted in significantly fewer MSCs at 
the spheroid surface at days 1, 2 and 5. DBZ treatment resulted in significantly 
fewer MSCs at the spheroid surface at days 1, 2 and 3. FGFRi treatment resulted 
in significantly fewer MSCs at the spheroid surface at days 1 and 2. Spheroid 
diameter was calculated from four individual spheroids, from three different 
biological donors per time point (n=16) and spheroid surface analysis was 
conducted on four individual spheroids, from three biological donors per time-
point (n=12). 
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The spheroids were sectioned at various time-points to identify internal 
organisation patterns, a minimum of three sections were images per individual 
spheroid. In addition each treatment type was performed using three different 
biological donors. Untreated control MSC-EC spheroids had previously 
demonstrated a vascular-like network of ECs evenly distributed throughout the 
spheroid (Section 4.4.2). Figure 4.4.20 shows this pattern was observed again in 
untreated MSC-EC spheroids, MSCs were labelled green and ECs red. However, 
the various inhibitor treatments had clear effects of cellular organisation within the 
spheroids. ILKi treatment resulted in a layer of green MSCs at the periphery of 
the spheroid. PDGFRi treatment resulted in a much thicker vascular-like network 
of ECs, however, this was more concentrated towards the centre of the spheroid. 
EGFRi treatment appeared to have no effect and a similar organisation pattern 
was observed compared to MSC-EC untreated spheroids. DBZ treatment 
resulted in a layer of ECs at the periphery of the spheroid. FGFRi treatment 
resulted in a tight group of ECs within the centre of the spheroid. MSC-only 
spheroids were composed of an equal number of MSCs labelled either green or 
red to act as a control, a random distribution of the two different coloured cells 
was observed. 
From these spheroid section images the EC network length, width and branching 
was calculated (Figure 4.4.21). A significant increase in network length was 
detected in PDGFRi treated spheroids at days 1 and 2. A significant increase in 
network width was detected in ILKi treated spheroids day 2 and PDGFRi treated 
spheroids days 1 and 2. For all time-points a significantly greater number of 
branches were detected with PDGFRi treatment. Overall EGFRi treatment 
appeared to have no effect of MSC-EC 3D spheroids, through the various 
qualitative and quantitative assessments no visual or significant differences were 
detected. Therefore, EGFRi was excluded from any further study. 
Despite EC network length, width and branching showing some significant 
differences between various inhibitor treatments, manual Image J software 
analysis was unable to analyse the overall distribution of MSCs or ECs within the 
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spheroid. Therefore, plot profiling was performed on the spheroid section images 
(Figure 4.4.22). The graphs show the distribution of either positive value (green 
MSCs) or negative value (red cells ECs or MSCs) through the z-axis of the 
section. Neutral values relate to no fluorescence, this was caused by the z-axis 
being outside the spheroid section or damage to the spheroid section. This 
analysis showed that ILKi and FGFRi treatment resulted in ECs being 
predominantly at the centre of the spheroid. PDGFRi treatment resulted in ECs 
being more centrally located compared to MSC-EC untreated sections. DBZ 
treatment resulted in a distribution similar to untreated sections. MSC-only 
sections showed a random and even distribution of green and red labelled MSCs 
throughout the sections. 
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Figure 4.4.20 - Spheroid sections of fluorescently labelled MSC-EC 
spheroids treated with various inhibitors 
: 3D Co-cultured MSCs and ECs – A Self-organising Spheroid Model 
Page | 153  
 
Representative spheroid sections from n=24 independent observations of MSC-
EC spheroids with various inhibitor treatments, MSCs were labelled green and 
ECs red. For the MSC-only control an equal ratio of MSCs were labelled green 
and red. Clear differences in the organisational patterns within the spheroid 
sections can be observed. PDGFRi treatment is most striking, with very large 
irregular EC-network arrangements when compared to MSC-EC untreated. ILKi 
treatment resulted in a thick peripheral layer of green MSCs at the spheroid 
surface. DBZ treatment resulted in the opposite and a thick peripheral layer of red 
ECs at the spheroid surface can be seen. FGFRi treatment resulted in a tight 
group of ECs at the centre of the spheroid. No organisation was detected in the 
MSC-only control spheroids. 
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Figure 4.4.21 – Endothelial cell network length, width and branching from 
MSC-EC spheroid sections treated with various inhibitors 
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Using the various MSC-EC spheroid section images the EC networks were 
manually analysed using Image J software to quantify (A) length, (B) width and 
(C) branching. A significant increase in network length was detected in PDGFRi 
treated spheroids at days 1 and 2. A significant increase in network width was 
detected in ILKi treated spheroids day 2 and PDGFRi treated spheroids days 1 
and 2. For all time-points a significantly greater number of branches were 
detected with PDGFRi treatment. EC network length, width and number of 
branches were calculated from observing a total of 8 spheroid sections from three 
different biological donors (n=24). 
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Figure 4.4.22 – Plot profiler analysis of MSC-EC spheroid sections treated 
with various inhibitors 
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Plot profiler analysis was performed to analyse the distribution of MSCs and ECs 
throughout the spheroid sections. The graphs show the distribution of either 
positive value (green cells) or negative value (red cells) throughout the z-axis of 
the section. Neutral values relate to no fluorescence caused by either areas 
outside the spheroid section or tears in the spheroid section. This analysis 
showed that ILKi and FGFRi treatment resulted in ECs being mainly in the centre 
of the spheroid. PDGFRi treatment resulted in ECs being more centrally located 
compared to MSC-EC untreated sections. DBZ treatment resulted in a 
distribution similar to untreated sections. MSC-only sections showed a random 
and even distribution of green and red labelled MSCs throughout the sections. 
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4.4.6 Deferoxamine mesylate treatment on co-culture inhibited spheroids 
MSC-EC spheroids with the various inhibitors were also treated with DFM, a 
known pharmaceutical agent that enhanced blood vessel formation and 
subsequently bone formation in mice (Ramasamy et al., 2014). The inhibitors 
ILKi, PDGFRi, DBZ and FGFRi were used as these were found to effect 
organisation of MSCs and ECs within 3D spheroid culture, unlike EGFRi. Figure 
4.4.23 shows whole 3D fluorescent MSC-EC spheroids treated with various 
inhibitors and DFM. From these whole spheroid images no visual differences due 
to DFM treatment were detected. These images were then analysed and the 
spheroid diameter and percentage of green labelled MSCs at the spheroid 
surface was quantified (Figure 4.4.24). This analysis revealed that PDGFRi+DFM 
spheroids were significantly smaller compared to PDGFRi only spheroids at day 
1. Surface analysis showed that MSC-EC+DFM spheroids had significantly fewer 
green labelled MSCs at the spheroid surface compared to MSC-EC only at day 3. 
The spheroids were then sectioned to observe if internal organisation was 
affected by the application of DFM. In Figure 4.4.25 these fluorescently labelled 
spheroid sections can be observed. The EC network, length, width and branching 
was then calculated from these spheroid sections (Figure 4.4.26). No significant 
differences in EC network length, width and branching were detected with DFM 
treatment. However, these results did show that inhibitor treatments resulted in 
similar organisation patterns previously observed (Section 4.4.5). 
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Figure 4.4.23 – 3D fluorescent images of whole MSC-EC spheroids treated 
with various inhibitors and DFM 
MSC-EC spheroids were treated with various inhibitors in combination with DFM. 
3D whole spheroid images were taken using a multi-photon confocal microscope. 
From the 3D whole spheroid images no visual differences occurred due to DFM 
treatment.
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Figure 4.4.24 – Spheroid diameter and surface analysis of MSC-EC 
spheroids treated with various inhibitors and DFM 
The diameter and surface of the spheroids was analysed, MSC-EC spheroids 
were cultured with various different inhibitors in combination with DFM. MSC-EC 
PDGFRi spheroids were significantly larger at day 1 compared to MSC-EC 
PDGFRi+DFM spheroids. DFM treatment also resulted in significantly fewer 
green labelled MSCs at the spheroid surface compared to MSC-EC untreated 
spheroids.
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Figure 4.4.25 – Spheroid sections of various fluorescently labelled MSC-EC 
spheroids treated with inhibitors and DFM 
Spheroid sections were taken to look at the internal organisation of green MSCs 
and red ECs within the co-culture spheroids treated with various inhibitors and 
DFM. The inhibitor treatments used were ILKi, PDGFRi, DBZ and FGFRi. Internal 
self-organisation of ECs within these spheroids was detected and differed 
depending upon inhibitor treatment but did not appear affect by DFM treatment.
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Figure 4.4.26 – EC network length, width and branching in MSC-EC 
spheroids treated with various inhibitors and DFM 
Through manual Image J software analysis, quantification of the EC network 
length, width and branching was calculated in the various MSC-EC spheroid 
sections with and without DFM treatment. No significant differences due to the 
treatment of DFM were detected; however, similar organisation patterns 
previously observed due to inhibitor treatments were detected. 
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4.4.7 Pre-treatment of Mesenchymal Stromal cells with ILK inhibitor 
To determine whether the organisation pattern observed in MSC-EC spheroids 
treated with ILKi was affecting primarily MSCs or ECs. MSCs were pre-treated 
with ILKi before generating pre-treated MSC-EC spheroids, within these 
spheroids ECs would not have been exposed to ILKi. ILKi was chosen due to 
effects on the spheroid surface being observed within 24 hours (Section 4.4.5).  
Fluorescently labelled whole spheroid images can be seen in Figure 4.4.27. Pre-
treatment of MSCs with ILKi had a clear effect of spheroid organisation, at day 1 
more green labelled MSCs can be seen at the spheroid surface compared to 
untreated control MSC-EC spheroids. These whole spheroid images were then 
analysed to calculate spheroid diameter and percentage of green MSCs at the 
surface (Figure 4.4.28). Spheroid diameter was unaffected by ILKi pre-treatment. 
However, the percentage of green labelled MSCs at the surface was significantly 
greater in ILKi pre-treated spheroids compared to untreated control MSC-EC 
spheroids for all time-points. ILKi treatment of MSCs resulted in significantly more 
MSCs at the spheroid surface at day 1 compared to untreated control MSC-EC 
spheroids. However, significantly fewer green labelled MSCs were at the 
spheroid surface in pre-treated spheroids compared to MSC-EC spheroids 
treated with ILKi for all time-points. 
These various spheroids were then sectioned to determine internal organisation 
patterns. Figure 4.4.29, ILKi treatment resulted in a thick peripheral layer of green 
MSCs for all time-points. Untreated control MSC-EC spheroids showed a lattice-
like network of ECs by day 3. ILKi pre-treatment resulted in a peripheral layer of 
green MSCs at day 1; this was not so obvious at days 2 and 3. No lattice-like 
network was detected in ILKi pre-treated spheroids, unlike untreated control 
MSC-EC spheroids. This demonstrated that ILKi pre-treatment had an effect on 
the organisation of ECs within the spheroid, to further examine this, EC networks 
were analysed to determine length, width and branching (Figure 4.4.30). This 
analysis showed no significant differences between untreated control MSC-EC 
spheroids, ILKi pre-treated MSC-EC spheroids and ILKi MSC-EC spheroids in 
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EC network length of branching. However, EC network width was significantly 
greater in ILKi treated spheroids compared to control untreated MSC-EC 
spheroids; this again confirms the results seen in Section 4.4.5. 
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Figure 4.4.27 – Fluorescently labelled 3D whole MSC-EC spheroids pre-
treated and treated with ILKi 
Fluorescently labelled MSC-EC spheroids were pre-treated and treated with ILKi, 
MSCs were labelled green and ECs were labelled red. These 3D whole spheroid 
images were captured using a multi-photon confocal microscope. ILKi pre-treated 
spheroid images show at day 1 pre-treatment has had a clear effect on spheroid 
formation, more green labelled MSCs are at the surface compared to MSC-EC 
untreated.  
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Figure 4.4.28 – Diameter and surface analysis of MSC-EC spheroids with 
and without ILKi pre-treatment 
From the fluorescent 3D whole spheroid images the spheroid diameter and 
surface was analysed. No significant differences in spheroid diameter were 
detected depending upon treatment; this result is consistent with those previously 
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obtained with ILKi treatment (Section 4.4.5). Surface analysis revealed that ILKi 
treatment of the whole spheroid resulted in significantly more MSCs at the 
spheroid surface for all time-points compared to untreated control MSC-EC 
spheroids. ILKi pre-treated spheroids had significantly more MSCs at the 
spheroid surface compared to untreated control MSC-EC spheroids at day 1. 
However, pre-treated spheroids had significantly fewer green MSCs at the 
spheroid surface compared to MSC-EC ILKi treated spheroids for all time-points.  
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Figure 4.4.29 – Sections of fluorescently labelled MSC-EC spheroids with 
and without ILKi pre-treatment  
Sectioning of the fluorescently labelled MSC-EC spheroids with and without ILKi 
pre-treatment were performed to observe internal organisation.  MSC-EC 
untreated spheroids showed EC self-organisation into a lattice-like network at day 
3. ILKi treated spheroids showed a thick peripheral layer of green MSCs at all 
time-points. ILKi pre-treatment resulted in a peripheral layer of green MSCs at 
day 1, however, this is then lost. However, no EC lattice-like organisation was 
detected. 
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Figure 4.4.30 – EC network length, width and branching analysis of MSC-EC 
spheroid sections with and without ILKi pre-treatment 
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EC network analysis was performed using manual Image J software on the MSC-
EC spheroid sections to with and without ILKi pre-treatment to quantify width, 
length and number of branches. No significant differences in EC network length 
were detected, however, at day 3 MSC-EC untreated and pre-treated spheroids 
showed greater network length compared to ILKi treated spheroids. A significant 
increase in EC-network width was detected in ILKi treated spheroids compared to 
MSC-EC untreated spheroids at day 2. No significant differences in network 
branching were detected at any time-point. 
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4.5 Discussion 
The multiphoton confocal microscope used had an adjustable laser wavelength, 
which needed optimisation to ensure accurate use of CellTracker™ green and 
red for cell tracking. A wide range of different excitation wavelengths were tested, 
from 700-850 nm and it was found that 780 nm had strong emission for both 
green and red CellTracker™. Once the optimised wavelength was established, it 
was important to make sure there was limited colour bleeding; therefore spectral 
analysis of the emission wavelengths for the two different CellTracker™ colours 
was performed. This spectral analysis showed there was a small overlap in the 
emission profile, however, the emission peaks were at approximately 520 nm and 
600 nm respectively so colour bleeding would be minimal. To confirm there was 
minimal bleeding and that region 2 and 3 of the non-descan detector were able to 
appropriate select between the two different CellTracker™ colours, MSCs and 
ECs were labelled green and red respectively before being analysed with the 
multiphoton confocal microscope. The analysis showed the individual labelled 
cells could easily be detected and separated into the appropriate spectral region 
with no visible bleeding between the two colours. The use of CellTracker™ 
labelling to identify two different cell types has been previously performed, 
however, variation between different equipment can occur (Burch et al., 2005). 
CellTracker™ labelling of cells has various advantages, for example mixed cell 
populations can be easily identified and tracked in real-time which would be 
difficult using end-point immunofluorescence staining. 
CellTracker™ labelling was then used to identify two different cell types MSCs 
and ECs within the 3D co-culturing model. Previous research in this laboratory 
into co-culture of MSCs and ECs in 3D U-bottomed 96-well plates showed that 
when the cells were equally mixed (50:50) the EC population formed segregated 
regions, however different ratios were not tested (Saleh et al., 2011b). Therefore, 
the effect of MSC:EC ratio on cell spheroid organisation was not determined. Five 
different ratios were found to all form spheroids within 24 hours; however, the 
20:80 spheroids by day 7 had poor structural integrity. This result could be due to 
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a reduced number of cell-cell adhesion molecules on ECs, co-culture of ECs with 
MSCs has been shown to reduce EC permeability through increased VE-
cadherin and β-catenin expression (Pati et al., 2011). These cell-cell adhesion 
molecules are essential for cell spheroid formation and subsequent maintenance 
(Shimazui et al., 2004). An alternative method to monitor spheroid formation and 
maintenance is through observations into the spheroid diameter during culture. 
These measurements showed that the spheroid diameter decreased, with the 
most notable shrinkage occurring between days 1 and 5, however, no significant 
differences between the various ratios were detected. Previous research has 
shown that within spheroids diameter was linked with cell viability; specifically for 
cancer modelling an increased spheroid diameter is seen in conjunction with a 
successful tumour model (Wen et al., 2013, Ivascu and Kubbies, 2006). 
However, MSCs are not a cancerous cell line and therefore do not exhibit the 
same cellular proliferation. Therefore, an increased spheroid diameter for non-
cancerous cell lines cannot be associated with cell viability. Indeed, a decrease in 
MSC-only spheroid diameter after 7 days in culture has been previously reported 
(Yamaguchi et al., 2014). 
Fluorescently labelled spheroids were then sectioned to examine internal 
organisation, it was found at day 1 for all ratios ECs were predominantly at the 
periphery of the spheroid. This result is most likely due to the differential 
adhesion hypothesis, by which a heterogeneous population of cells will form into 
isotypic groups (Foty and Steinberg, 2005). This result also demonstrates that 
ECs probably have lower homotypic cell-cell mechanism compared to MSCs, 
emphasised by the lack of structural integrity in 20:80 high EC content spheroids. 
By day 3, differences depending upon ratio were detected, 50:50 spheroids 
showed EC self-organisation into a lattice-like network evenly distributed 
throughout the spheroid. The mechanisms behind this self-organisation pattern 
are currently unclear. However, this could be used as a method to model 
angiogenesis within a stromal environment including bone marrow. From this 
point on 3D co-culture of MSC-EC spheroids was performed using the 50:50 ratio 
as this gave the greatest evidence of the unique self-organisation pattern. 
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Previous research into 3D tumour models has demonstrated that real-time 
quantitative analysis for pharmaceutical analysis and validation is essential (Vinci 
et al., 2012). Therefore, time-lapse analysis was performed on MSC-EC 
spheroids to further investigate the spheroid formation process which evolved 
into 4D image analysis using a multiphoton confocal microscope. This analysis 
technique combined with CellTracker™ labelled of MSCs and ECs allowed the 
individual cells, type and location to be identified in 3D during the spheroid 
formation process. To act as a control MSC-only spheroids were analysed, these 
contained a 50-50 mixture of MSCs labelled green or red. This was done to 
determine whether CellTracker™ labelling gave false positive results in spheroid 
organisation. These results showed that MSC-EC spheroid formation was a 
dynamic process. The percentage of red labelled ECs at the spheroid surface 
increased by approximately 4% during the analysis period in three different 
biological donors. This confirmed previous observed internal organisation results 
of a predominantly EC peripheral layer at day 1 in spheroid sections. This initial 
EC migration is most likely due to the differential adhesion hypothesis (Steinberg, 
1975). In contrast MSC-only formation analysis demonstrated that limited cell 
migration occurred within a homogenous cell type spheroid, for these spheroids 
the percentage change at the spheroid surface did not exceed 2% in three 
different biological donors. This small change at the spheroid surface might be 
due to the CellTracker™ green being more prone to photo bleaching than 
CellTracker™ red (De Los Santos et al., 2015). From the 4D imaging it was 
possible to calculate the spheroid volume throughout the formation process, both 
MSC-EC and MSC-only spheroids had a similar starting volume which decreased 
slightly towards the end of the formation process, this shows that the cell 
suspension was aggregating together. 
To determine if the EC network within MSC-EC spheroids was due to MSCs 
directing ECs or due to a capacity ECs naturally posses, MSCs were replaced 
with HDFs. ECs such as HUVECs have been described as spontaneously 
forming a network in 2D on Matrigel, this network has structural and 
organisational similarities to those observed within MSC-EC spheroid sections 
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(Mezentsev et al., 2005, Chiew et al., 2015). HDFs were chosen as they have 
been described as similar to adipose derived MSCs, they express the same cell 
surface markers as MSCs (CD29, CD44, CD90 and CD105) and have been 
claimed to demonstrate a tri-differentiation potential (Blasi et al., 2011). HDF-EC 
spheroids were compared directly to MSC-EC spheroids, whole spheroid images 
showed these cells were capable of forming spheroids within 24 hours and 
visually they look comparable. Further analysis into diameter and the spheroid 
surface revealed that HDF-EC spheroids were significantly smaller than MSC-EC 
spheroids at days 5 and 7. HDF-EC spheroids also had significantly more green 
HDFs at the spheroid surface compared to green labelled MSCs at the spheroid 
surface at days 3 and 7. Therefore, subtle differences between the two spheroid 
types were detected early on using non-destructive techniques. Whole spheroids 
were then sectioned to examine the internal organisation patterns, MSC-EC 
sections showed an EC network throughout the spheroid at days 3 and 5. In 
HDF-EC spheroid sections no EC network was detected, ECs appeared to form a 
layer predominantly around the periphery of the spheroid at day 1 and 3. Further 
analysis of the EC network showed at days 3 and 5, EC network length and 
branching were significantly greater in MSC-EC sections compared to HDF-EC 
sections. These results establish that there is a unique relationship between 
MSCs and ECs in 3D cell spheroid culture. Specifically a 50-50 mixture of MSCs 
and ECs in direct co-culture spheroids results in an EC network described as a 
capillary like structure (Saleh et al., 2011b). A similar structural observation was 
made when a small percentage (8%) of ECs were co-cultured with MSCs in 3D 
spheroids. However, these experiments were performed using much larger 
spheroids (150,000 cells per spheroid) ultimately resulting in a similar total 
number of ECs per spheroid as those described by Saleh in 2011 (Rivron et al., 
2012). Primitive vascular networks were also observed within a liver model 
containing MSCs, iPS cells and HUVECs tri-cultured spheroids on matrigel 
(Takebe et al., 2013). Unlike 2D culture, ECs do not possess an innate ability to 
spontaneously form a network within a 3D structure. Therefore, the next stage 
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was to evaluate possible MSC induced mechanisms responsible for this unique 
self-organisation pattern. 
To determine possible signalling pathways responsible for the EC self-
organisation pattern a variety of different inhibitor treatments were added to 
MSC-EC spheroids. Most of the signalling pathways had been linked as 
important for angiogenesis, MSC or EC migration. Unfortunately using these 
techniques, both MSCs and ECs were exposed to these inhibitor treatments; 
therefore, it is impossible to determine if they are acting in MSCs, ECs or both. 
Combinations of inhibitor treatments would also have enhanced the study, for 
example combining all inhibitor treatments could have demonstrated if a 
particular signalling pathway was more potent. Whole fluorescent spheroid 
images showed that inhibitor treatments had clear effects of MSC-EC spheroid 
formation and organisation. ILKi treated spheroids appeared greener compared 
to untreated control spheroids and DBZ treatment appeared to have the opposite 
effect, spheroids appeared redder. PDGFRi treatment appeared to make 
spheroids larger compared to control untreated MSC-EC spheroids. Spheroid 
diameter calculations showed that PDGFRi and FGFRi treated spheroids were 
significantly larger than untreated control MSC-EC spheroids. Strikingly a wide 
variety of differences were detected in the percentage of green MSCs at the 
spheroid surface. ILKi treatment resulted in significantly more MSCs at the 
spheroid surface; this result could be attributed to ILKi treatment having a greater 
effect on MSC cell-cell adhesion molecules, resulting in MSCs becoming less 
adhesive compared to ECs. Indeed, ILK transfected MSCs were shown to have a 
higher adhesion rate within a cardiac matrix compared to untreated control MSCs 
(Song et al., 2009). The differential adhesion hypothesis would then cause MSCs 
to envelope ECs causing an increase in MSCs at the spheroid surface (Lee et al., 
2011, Gess et al., 2008).  PDGFRi treatment resulted in significantly fewer MSCs 
at the spheroid surface. PDGF is known to play an important role in cell 
migration, specifically decreased PDGF expression has been seen in conjunction 
with reduced angiogenesis within tumours (Heldin and Westmark, 1999, Ho et al., 
2013). Therefore, PDGFRi treatment might have prevented ECs from migrating 
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into the spheroid, resulting in them becoming located predominantly at the 
spheroid surface. DBZ treatment resulting in Notch inhibition resulted in 
significantly fewer MSCs at the spheroid surface. Notch signalling has been 
identified as important in both MSC and EC migration. Inhibition of Notch 
signalling in vivo has been shown to result in the loss of directional migration of 
ECs, conversely Notch inhibition in MSCs has been shown to result in enhanced 
migration (Bentley et al., 2014, Xie et al., 2013). These studies are further 
supported as increased Notch expression within ECs has been shown to 
enhance cell migration (Howard et al., 2013). Therefore, DBZ treated and 
subsequent Notch inhibition will have affected EC migration, most likely 
preventing them migrating from the spheroid periphery. FGFRi treatment resulted 
in significantly fewer MSCs at the spheroid surface. FGF is a diverse signalling 
pathway that has numerous effects on both MSCs and ECs. Specifically EC 
migration has been shown to be effected specifically by FGF, FGF is known to 
stimulate angiogenesis and FGF application has been shown to enhance EC 
migration (Kim et al., 2012, Hatanaka et al., 2012). Therefore, FGFRi treatment 
could hinder EC migration, resulting in ECs becoming immovable at the spheroid 
surface. 
Internal organisation of MSCs and ECs within the spheroids was visualised 
through spheroid sections. ILKi inhibition resulted in a dense layer of peripheral 
MSCs, this result compliments those observed using non-destructive spheroid 
surface analysis. Within the core of the spheroid ECs were evenly distributed, 
and an EC network was not observed, this result could be linked to previous 
observations of reduced EC migration through ILKi treatment in vivo and in vitro 
(Lu et al., 2013, Chen et al., 2007). PDGFRi treatment resulted in a lattice-like EC 
network; however, it was much thicker and does not appear evenly distributed 
throughout the spheroid. Specifically PDGFR has been shown to be activated in 
response to chemotaxis (Popova et al., 2004). Therefore, loss or reduced 
chemotaxis within ECs could result in uncoordinated cell migration, ultimately 
preventing ECs being evenly distributed throughout the spheroid. Additionally 
PDGF has been shown to play an important role in angiogenesis, specifically in 
: 3D Co-cultured MSCs and ECs – A Self-organising Spheroid Model 
Page | 177  
 
the morphology of blood vessels (Dong et al., 2014, Robinson et al., 2008). 
Therefore, loss of PDGF could have resulted in the thicker EC network observed. 
EGFRi treatment appeared to have no effect on MSC-EC internal organisation. 
This result was expected as EGF has been shown to have no effect on MSC 
migration and only affect EC migration in combination with VEGF and FGF 
(Ponte et al., 2007, Maretzky et al., 2011). DBZ and FGFRi treatment appeared 
to completely prevent an EC lattice-like network, both these treatments are 
known to hinder angiogenesis (Fons et al., 2015, Kerr et al., 2015). Therefore, 
EC migration and organisation were hindered preventing network development. 
MSC-only spheroid sections show a random distribution of both green and red 
labelled MSCs. Demonstrating random self-organisation did not occur and 
CellTracker™ labelled had no effect on cellular organisation. From these 
spheroid sections the EC network length, width and branching were calculated. 
These calculations mainly showed that PDGFRi treatment had significant effects 
on EC length, width and branching compared to untreated control MSC-EC 
sections. PDGF has been shown to play an important part in stabilising the 
vascular endothelium (Roskoski, 2007). In vivo studies have found PDGF 
inhibition resulted in significantly shorter neovessel lifespan, therefore, these 
thicker EC networks could be attributed to a loss of a vessel formation checkpoint 
(Yao et al., 2014). Plot profiling was used to try and visualise the distribution of 
either MSCs or ECs within the spheroid sections. This technique was able to 
demonstrate that inhibitor treatments did effect cellular distribution. ILKi and 
FGFRi showed few red labelled ECs at the section periphery and the majority of 
ECs were at the core of the spheroid. MSC-only spheroid sections confirmed 
random cell distribution in the homogenous cell type spheroid section. 
Unfortunately, this technique could not be used for statistical evaluation. 
DFM treatment was performed in addition to MSC-EC inhibitor treatments as this 
pharmacological agent had been shown to enhance angiogenesis in mouse 
bones exposed to Notch inhibition (Ramasamy et al., 2014). Therefore, it was 
hypothesised that DFM treatment might recover angiogenesis hindrance caused 
by inhibitor treatments. However, very few differences between untreated and 
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DFM treated spheroids were detected. DFM exposure did result in significantly 
smaller spheroids in conjunction with PDGFRi treatment and significantly fewer 
MSCs were at the spheroid surface in MSC-EC+DFM compared to untreated 
control MSC-EC spheroids at day 3. DFM treatment on human MSCs has been 
shown to enhance the expression of angiogenic factors such as VEGF and TGF-
β, stimulating known alternative PDGF pathways (Potier et al., 2008). Additional 
studies using rat trachea in conjunction with DFM exposure showed increased 
gene expression of PDGF and TGF-β (Dai and Churg, 2001). Therefore, DFM 
treatment might have negated the effects of PDGFRi treatment. In vitro studies 
using human aortic ECs in conjunction with DFM exposure showed enhanced 
tube formation, cell proliferation and migration (Ikeda et al., 2011). Thus DFM 
treatment could have stimulated EC proliferation; subsequently resulting in the 
spheroid surface appearing redder in MSC-EC+DFM compared to untreated 
control MSC-EC spheroids. Spheroid section analysis of internal organisation 
patterns showed no visual differences due to DFM treatment, this was confirmed 
through EC network length, width and branching calculations. DFM was used at a 
concentration of 100 µM as this was below the cytotoxicity concentration (Chung 
et al., 2013). However, in Ramasamy et al. study a much higher concentration 
was injected into mice, therefore, the concentration for 3D spheroids might have 
been too low (Ramasamy et al., 2014). In vitro work is also performed in a closed 
system; therefore, DFM might have enhanced an alternative signalling pathway 
found in vivo. 
To determine whether ILKi treatment primarily affected MSCs rather than ECs, 
MSCs were pre-treated with ILKi for 96-hours before being used in co-culture 
spheroids. To further confirm the results observed ILKi pre-treatment could be 
performed on ECs only. These ILKi pre-treated spheroids were then analysed 
compared to untreated control and ILKi control spheroids. Whole spheroid 
images and surface analysis showed that overall ILKi treatment does most likely 
principally affect MSCs. Significantly more fluorescent MSCs were at the 
spheroid surface of both ILKi pre-treated and ILKi control spheroids compared to 
untreated control spheroids.  However, significantly fewer fluorescent MSCs were 
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at the spheroid surface of ILKi pre-treated spheroids compared to ILKi control 
spheroids. Indicating that pre-treatment affected the initial spheroid formation; 
however, the potency of the pre-treatment was transient. This result was 
expected as ILKi exposure was not continued during ILKi pre-treated spheroid 
formation and culture. Indeed, alternative ILKi treatments have shown to have a 
transient effect on tumour physiology (Kalra et al., 2015).  
Overall the results within this chapter demonstrate the important relationship 
between MSCs and ECs within a 3D environment. Uniquely using CellTracker™ 
green and red labelling in combination with 3D and 4D imaging techniques 
resulted in a tractable in vitro 3D model being developed. Quantification of 
spheroid diameter and spheroid surface analysis were able to indirectly quantify 
tissue organisation within this complex 3D structure non-destructively. Additional 
spheroid sections were able to observe internal cellular organisation with greater 
specificity. These techniques showed that MSCs are able to direct EC self-
organisation, resulting in a 3D lattice-like EC network that was evenly distributed 
throughout the spheroid. This EC network has been previously observed within 
similar studies and has been described as a primitive vascular-like network with 
links to angiogenesis. However, the underlying mechanism of this 3D EC network 
and a direct link to angiogenesis are currently undefined. Within 2D in vitro 
culture a similar network of ECs has been frequently used as an angiogenesis 
assay (Mezentsev et al., 2005). However, the use of a 3D in vitro culture system 
is able to more closely represent the in vivo environment compared to 2D. 
Therefore, a wide variety of different pharmacological agents were added to 
MSC-EC spheroids to determine the novelty of 3D MSC-EC spheroids as an 
angiogenesis model. It was found that 3D EC network organisation was affected 
by the known angiogenesis signalling pathways FGF, PDGF and Notch, however, 
currently the evidence shown is not definitive. Equally treatment with EGFRi that 
has no direct links with angiogenesis was found to have no affect on the EC 
network, further confirming the durability of this model. However, to fully confirm 
these effects inhibition or significant reduction of specific downstream markers 
are required. The next chapter will further evaluate the concept of using MSCs 
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and ECs in 3D spheroid culture as an in vitro tractable model, specifically for 
human osteochondral tissue. 
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Chapter 5 : Pre-differentiation of MSCs and 
ECs - A 3D in vitro Osteochondral Model  
5.1 Introduction 
Many skeletal elements within the human body are primarily constructed of bone 
tissue with cartilage tissue on articulating surfaces. Consequently, combining 
these two tissues has often been the aim for the treatment of diseases such as 
osteoarthritis. Both natural and synthetic osteochondral plugs have been 
developed and used to successfully treat osteoarthritis. Autologous 
osteochondral plugs taken from non-load bearing regions of joints have been 
used to successfully treat patients suffering from severe arthritis (Berti et al., 
2013). The combination of MSCs and triphasic scaffolds have also been used to 
artificially create osteochondral plugs; these were then used to successfully treat 
chronic defects within an ovine model (Marquass et al., 2010). 
Another area of interest regarding bone formation is a process known as 
endochondral ossification. This is important for long bone development in the 
embryo (Chan et al., 2009). The process is not fully understood in humans due to 
the ethical controversy regarding the study of human foetal development 
(Klimanskaya, 2013). However, from the use of other mammalian models it is 
believed that primitive mesenchymal cells condense to form cartilage tissue; this 
tissue is then invaded by blood vessels triggering the cartilage tissue to 
differentiate into bone tissue (Kronenberg, 2003, Maes et al., 2002). During adult 
bone healing a highly similar process takes place; therefore, fully understanding 
endochondral ossification could also have significant impact in understanding 
bone healing (Sisask et al., 2013, Tannous et al., 2013).  
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The skeletal differentiation potential of MSCs has made them an attractive cell 
type in the field of tissue engineering and regenerative medicine of bone tissue. 
MSCs have been combined with growth factors and scaffolds to enhance their 
skeletal regenerative capacity (Tamama et al., 2010, Levorson et al., 2013). 
These combinations have been successful in vitro, however therapeutic 
translation has been poor, currently no MSC-based therapy has received FDA 
approval (Mendicino et al., 2014). This limitation is often associated with MSCs 
being a heterogeneous cell population that lacks a specific cell surface marker 
(Keating, 2012). However, the ability of MSCs to differentiate into both an 
osteogenic and chondrogenic lineage makes them a unique cell source for bone 
tissue modelling. Therefore, the use of MSCs as a model cell type to study 
skeletal diseases and therapies has strong potential 
Recent studies have begun to combine both the osteogenic and chondrogenic 
potential of MSCs to create biphasic osteochondral tissues. However, one of the 
main challenges is the effective differentiation of MSCs in both an osteogenic and 
chondrogenic lineage is culture medium. Traditionally two separate medium 
formulations are required. Therefore, the concept of pre-differentiation of MSCs 
has been previously used to prime MSCs towards a lineage of choice. MSCs 
have been pre-differentiated for chondrogenic and osteogenic applications 
(Babur et al., 2015, Grayson et al., 2010, Genovese et al., 2009). Therefore, 
using pre-differentiated osteogenic and chondrogenic MSCs in conjunction with a 
supportive osteochondral medium could enhance this developing area of 
research (Guo et al., 2009).  
Additionally osteochondral research has overlooked ECs. Within the native bone 
environment, ECs play an important role in tissue homeostasis and repair 
following injury. Specifically a lack of blood vessels or impair blood vessel 
formation within bone is seen in conjunction with degenerative diseases such as 
osteoporosis, osteoarthritis and non-union fracture healing (Prasad et al., 2014, 
Findlay, 2007, Dickson et al., 1994). ECs and blood vessels provide key 
regulatory cues that direct tissue function, indeed many factors have been found 
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that are angiogenesis stimulating and important in bone development and repair. 
These include PDGF, FGF, VEGF, TGF-β and BMPs (Stegen et al., 2015). Using 
cell spheroids provides a 3D novel approach to in vitro recreation of 
osteochondral tissue in a scaffold-free manner. This tractable system can be 
easily manipulated to look at a wide range of cell types in various combinations 
with the addition of pharmacological agents to influence key regulatory cues. 
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5.2 Aims 
The general aims of the work presented in this chapter are to investigate the use 
of the novel 3D co-culture system described previously in combination with pre-
differentiated MSCs and ECs as an osteochondral bone model. 
More specifically the objectives are to: 
 Determine the pre-differentiation time required for osteogenic and 
chondrogenic separation of MSCs. 
 Use pre-differentiation osteogenic and chondrogenic MSCs in 3D co-
culture and establish a 3D co-culture model. 
 Use fluorescent labelling techniques to track three different cell types 
within 3D spheroid culture. 
 Create various osteochondral spheroid combinations using osteogenic and 
chondrogenic MSCs with ECs. 
 Determine possible mechanisms involved in osteochondral organisation.  
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5.3 Methods 
5.3.1 Cell Culture Methods 
5.3.1.1 Chondrogenic Differentiation of human MSCs 
Chondrogenic differentiation of MSCs was induced by culturing the cells in 
chondrogenic induction medium. Chondrogenic induction medium was created by 
the addition of 50 µg/ml L-Ascorbic acid, 100 nM dexamethasone, 40 µg/ml L-
proline (Sigma-Aldrich, UK, Cat no. P5607), 1% ITS+ Universal culture 
supplement premix (VWR International, Cat no. 47743) and 10 ng/ml TGF-β1 
(PeproTech, Cat no. 100-21) to DMEM plus P/S. The culture medium was 
replaced twice a week for up to 21 days. 
5.3.1.2 Pre-differentiation of MSCs in either osteogenic or chondrogenic 
culture medium 
To determine the period of time required for MSCs to become differentiated 
enough for them to maintain either osteogenic or chondrogenic phenotype within 
osteochondral media. MSCs were pre-differentiated for either 7 or 14 days in 
osteogenic or chondrogenic differentiation medium before being placed into 
osteochondral differentiation medium (Section 5.3.1.3). 
5.3.1.3 Osteochondral Differentiation of human MSCs 
Osteochondral medium was used to support either an osteogenic or 
chondrogenic pre-differentiated MSCs. Osteochondral media contained DMEM, 
5% FBS, P/S with the addition of 50 µg/ml L-Ascorbic acid, 5mM β-
glycerophophate, 100 mM dexamethasone, 40 µg/ml L-proline and 1% ITS+  
Universal culture supplement premix. 
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5.3.2 Formation of 3D osteochondral spheroids 
5.3.2.1 3D osteochondral + endothelial cell medium 
3D osteochondral medium contained 50% DMEM, 50% endothelial cell medium, 
10% FBS, P/S, 0.25% (w/v) methyl cellulose with the addition of 50 µg/ml L-
Ascorbic acid, 5mM β-glycerophosphate, 100 mM dexamethasone, 40 µg/ml L-
proline and1% ITS+ Universal culture supplement premix. 
5.3.2.2 3D spheroid formation of various osteochondral spheroids 
MSCs were pre-differentiated with osteogenic or chondrogenic induction medium 
(Section 3.3.3 and 5.3.1.1) for 7 or 14 days before being used to create 3D 
spheroids. A schematic representation of this method can be seen in Figure 
5.3.1. Osteogenic MSCs were labelled with CellTracker™ red, chondrogenic 
MSCs were labelled with CellTracker™ green and ECs were labelled with 
CellTracker™ blue. These three different cell types were then pooled in various 
combinations to make osteochondral spheroids. The cell spheroids were created 
by the same method described in Section 2.1.7, all spheroids contained a total of 
30,000 cells. Cells were labelled using CellTracker™ using the method described 
in Section 2.2.1.  
5.3.2.3 3D Osteo + Chondro spheroids 
MSCs were pre-differentiated in osteogenic or chondrogenic induction medium 
for 7 or 14 days before being used to create individual 3D spheroids with a total 
of 15,000 cells per spheroid, using the method described in Section 2.1.7.  A 
schematic representation of this method can be seen in Figure 5.3.2. These 
individual osteogenic or chondrogenic cell suspensions were left for 24 hours 
from initial seeding to form spheroids. After this incubation period the spheroids 
were then transferred into the same well to allow for combination of the two 
separate spheroids. 3D osteo+chondro spheroids totalling 30,000 cells were 
culture in the 3D osteochondral medium described in Section 5.3.2.1. 
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Figure 5.3.1 - Schematic representation of the procedure to produce an 
osteochondral spheroid  
MSCs were pre-differentiated for 7 or 14 days before being consider either 
osteogenic or chondrogenic. Osteogenic MSCs were labelled with CellTracker™ 
red, chondrogenic MSCs were labelled with CellTracker™ green and ECs were 
labelled with CellTracker™ blue. These three different cell types were then 
pooled in various combinations to create osteochondral spheroids. 
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Figure 5.3.2 – Schematic representation of the procedure to produce an 
osteo+chondro spheroid 
MSCs were pre-differentiated for 7 or 14 days before being consider either 
osteogenic or chondrogenic. Osteogenic MSCs were labelled with CellTracker™ 
red, chondrogenic MSCs were labelled with CellTracker™ green. 15,000 labelled 
osteogenic or chondrogenic MSCs were then placed in a U-bottomed well plate 
for 24 hours to create a spheroid. These two separate spheroids were then 
combined together to create an osteo+chondro spheroid totalling 30,000 cells. 
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5.3.3 Histological staining techniques 
5.3.3.1 Alcian Blue staining 
Alcian blue staining was performed to visualise glycosaminoglycans within 
chondrogenic differentiated MSCs. Samples were washed with PBS twice 
followed by fixation using 4% PFA incubated at room temperature for 5 minutes. 
The samples were then washed three times with PBS before being stained with 
10 mg/ml Alcian blue solution pH<1 (Sigma-Aldrich, UK) for 30 minutes at room 
temperature. After the incubation, the samples were washed in dH2O to remove 
non-specific staining. The samples were then imaged using a light microscope 
(Section 3.3.8). 
5.3.4 Quantification of CellTracker™ within defined regions 
Spheroid sections were analysed using ImageJ software to quantify the amount 
of CellTracker™ green, red or blue within a specific region. Regions were 
manually defined before the average pixel intensity of the specific colour was 
quantified. A minimum of three separate spheroid sections were used for all 
quantification studies with background staining subtracted.  
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5.4 Results 
5.4.1 Characterisation of pre-differentiated MSCs in 2D towards an 
osteogenic or chondrogenic lineage 
MSCs were cultured in either osteogenic or chondrogenic culture medium for 7 or 
14 days before being cultured in osteochondral culture medium. Figure 5.4.1 
shows 2D MSCs stained with Alizarin red, ALP and von Kossa for osteogenic 
differentiation and Alcian blue for chondrogenic differentiation. Both 7 and 14 
days of pre-differentiation in either osteogenic or chondrogenic culture medium 
were able to cause separation between the two different lineages. This 
separation of the lineages was not lost when cultured in osteochondral medium. 
Alizarin red staining was positive for both osteogenic and chondrogenic lineages, 
however, ALP staining was only positive for osteogenic cells and Alcian blue was 
only positive for chondrogenic cells. 
MSCs were pre-differentiated in standard 2D culture conditions for either 7 or 14 
days. The MSCs were then transferred into U-bottomed well plates to assess 
whether pre-differentiation had effects on 3D osteochondral or osteo+chondro 
spheroid formation (Figure 5.4.2). 7 days of pre-differentiation had no detrimental 
effects on the ability of MSCs to form 3D spheroids in any combination. However, 
14 day pre-differentiated chondrogenic MSCs were unable to form structurally 
individual spheroids. Therefore, 7 days of pre-differentiation was used for all 
future osteochondral and osteo+chondro spheroid experiments.   
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Figure 5.4.1 – Pre-differentiation of MSCs in either osteogenic or 
chondrogenic condition for 7 or 14 days 
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MSCs were cultured in either osteogenic or chondrogenic culture medium for 7 or 
14 days before being cultured in osteochondral medium for a total of 21 days in 
culture. To act as controls, MSCs were also cultured in only osteogenic and 
chondrogenic culture medium for 21 days. All 2D MSC samples were stained with 
Alizarin Red and ALP/von Kossa for bone markers and Alcian blue for cartilage 
markers. Both 7 and 14 days of pre-differentiation were successfully able to 
produce either osteogenic or chondrogenic cells when transferred into 
osteochondral medium. Alizarin red staining was positive in all chondrogenic 
MSCs. However, Alizarin red stains calcium which is also present within cartilage. 
ALP and von Kossa staining was only positive for osteogenic samples and Alcian 
blue staining was only positive for chondrogenic samples. 
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Figure 5.4.2 – 3D spheroids made with 7 or 14 day pre-differentiated 
osteogenic and chondrogenic MSCs 
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MSCs were pre-differentiated in either osteogenic or chondrogenic induction 
medium for 7 or 14 days before the cells were used to create 3D spheroids. After 
24 hours from the initial cell suspension spheroids were imaged. 7 days of pre-
differentiation was able to produce individual osteogenic, chondrogenic, 
osteo+chondro and osteochondral spheroids. However, MSCs pre-differentiated 
for 14 days in chondrogenic induction medium were unable to form individual 
spheroids, resulting in failed chondrogenic spheroids and osteo+chondro 
spheroids. 
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5.4.2 Generation of 3D osteochondral spheroids using pre-differentiated 
MSCs and ECs  
ECs and blood vessels have been shown to play an important role in the 
maintenance of bone tissue and repair following injury (Findlay, 2007, Stegen et 
al., 2015).  Pre-differentiated MSCs were combined with ECs to further assess 
osteochondral spheroids. Various combinations of cells were trialled, resulting in 
a maximum of three different cell types within one spheroid. Therefore, the use of 
CellTracker™ blue was introduced to indentify this additional cell type. Figure 
5.4.3-A shows the use of CellTracker™ blue, green and red in 2D tri-culture to 
individually identify the  different cell types of either; ECs (blue), chondrogenic 
MSCs (green) and osteogenic MSCs (red). The three different regions of the non-
descan detector ranging between 400-800 nm were able to individually identify 
the three different cell types. Figure 5.4.3-B shows the spectral analysis of the 
three different CellTracker™ colours; all three have separate peak emission 
wavelengths with little emission spectrum overlap. 
CellTracker™ blue, green and red were used to identify ECs, chondrogenic 
MSCs and osteogenic MSCs respectively throughout further experiments. 
Various combinations of the three different cell types were combined to create a 
variety of different 3D osteochondral spheroids, these were osteogenic and 
chondrogenic MSCs (OC), osteogenic MSCs and ECs (OE), chondrogenic MSCs 
and ECs (CE) and all three (OCE) (Figure 5.4.4). All four combinations were 
found to successfully produce 3D spheroids that were cultured for up to 7 days. 
The spheroids were then sectioned for further analysis of the internal 
organisation (Figure 5.4.5). All whole spheroid and spheroid section images show 
representatives of the observations made across multiple donors and multiple 
spheroids. These spheroid sections showed that OC and OCE spheroids had 
clear self-organisation patterns. OC spheroids had lateral-like separation of the 
osteogenic and chondrogenic MSCs, OCE spheroids had a predominantly green 
core region (chondrogenic MSCs) and a predominantly red outer region 
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(osteogenic MSCs). These various regions were highlighted in separate images 
using white dotted lines. OE and CE spheroids showed no clear self-organisation 
patterns. 
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Figure 5.4.3 – 2D tri-culture of fluorescently labelled MSCs and ECs  
A – 2D tri-culture of fluorescently labelled ECs (blue), chondrogenic MSCs 
(green) and osteogenic MSCs (red). These three different cell types were 
individually detected in the relevant region using a non-descan detector ranging 
between 400-800nm. B – Spectral analysis of the three different CellTracker™ 
fluorophores revealed separate emission peaks with little emission spectrum 
overlap.
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Figure 5.4.4 – Various 3D spheroid combinations using ECs, osteogenic 
and chondrogenic MSCs 
MSCs were pre-differentiated in appropriate medium for 7 days before being 
used in combination with ECs to produce a variety of 3D osteochondral 
spheroids. Osteogenic MSCs (O) were labelled red, chondrogenic MSCs (C) 
were labelled green and ECs (E) were labelled blue. The various combinations 
created were OC, OE, CE and OCE. All four different combinations were able to 
successfully produce 3D spheroids that were cultured for up to 7 days. The 
images shown are representative of the observations made across various 
spheroids and biological donors. 
: Pre-differentiation of MSCs and ECs - A 3D in vitro Osteochondral Model 
Page | 200  
 
 
Figure 5.4.5 – Spheroid sections of various EC, osteogenic and 
chondrogenic MSC combinations 
The various 3D osteochondral spheroid combinations were then sections to look 
at internal organisation patterns and representative images are shown from n=24 
independent observations. No self-organisation was observed within OE and CE 
spheroids. However, OC spheroids showed a lateral-like separation of the 
osteogenic MSCs (O) and the chondrogenic MSCs (C). OCE spheroids also 
showed self-organisation of a core region that was predominantly green 
(chondrogenic MSCs) with an outer region that was predominantly red 
(osteogenic MSCs). The regions are highlighted using white dotted lines. 
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The self-organisation observed within the OC and OCE spheroid sections was 
further analysed. Figure 5.4.6-A shows a day 1 OC spheroid section that has 
been divided into an osteogenic region highlighted using the red dotted line and a 
chondrogenic region highlighted using a green dotted line. These regions were 
then analysed over 5 days to quantify the amount of CellTracker™ green or red 
present (Figure 5.4.6-B). Per time point and condition three spheroids from two 
different biological donors were analysed (n=6). This analysis confirmed that for 
all time points a significantly greater amount of CellTracker™ red was detected in 
the osteogenic regions and a significantly greater amount of CellTracker™ green 
was detected in the chondrogenic regions.  
OCE spheroid sections showed a self-organisation pattern of a core of 
predominantly green (chondrogenic MSCs) and outer region of predominantly red 
(osteogenic MSCs). Figure 5.4.7-A shows a day 1 OCE spheroid section that has 
been highlighted to show the core region (yellow) and the outer region (white). 
The colours yellow and white were chosen to differentiate these regions from the 
osteogenic and chondrogenic regions seen in OC sections. OCE spheroid 
sections contained ECs, therefore, the regions could not be defined as 
osteogenic or chondrogenic. The quantity of either CellTracker™ green, red or 
blue within these two different regions was calculated at days 1, 3 and 5 of 
culture (Figure 5.4.7-B). Per time point and condition three spheroids from two 
different biological donors were analysed (n=6). For all time points the centre 
region had a greater quantity of CellTracker™ green (labelling chondrogenic 
MSCs) whilst the outer region had a significantly greater quantity of CellTracker™ 
red (osteogenic MSCs). No difference in CellTracker™ blue (ECs) was detected 
between the two regions. 
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Figure 5.4.6 – OC spheroid section analysis of osteogenic and 
chondrogenic regions 
A – Day 1 OC section separated into either osteogenic or chondrogenic regions 
using red or green dotted line. B – Spheroid sections at Days 1, 3 and 5 were 
analysed, CellTracker™ green or red present within either the osteogenic or 
chondrogenic regions were calculated. It was found for all time points significantly 
greater CellTracker™ red intensity was detected in osteogenic regions and 
significantly greater CellTracker™ green intensity was detected in chondrogenic 
regions. Per time point and condition three individual spheroids from two 
biological donors were analysed (n=6). 
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Figure 5.4.7 – OCE spheroid section analysis of central and outer regions 
A – Day 1 OCE spheroid section separated into either a core region (yellow) or 
outer region (white) using dotted lines. B – Spheroid sections at days 1, 3 and 5 
were analysed to quantify the amount of CellTracker™ green, red or blue present 
within the two different regions. For all time points a significantly greater quantity 
of CellTracker™ red was detected within the outer regions and a greater quantity 
of CellTracker™ green was detected within the core regions. No difference in 
CellTracker™ blue was detected between the regions. Per time point and 
condition three individual spheroids from two biological donors were analysed 
(n=6). 
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5.4.3 Further analysis of 3D Osteo+Chondro spheroids using pre-
differentiated MSCs  
MSCs were pre-differentiated for 7 days in either osteogenic or chondrogenic 
induction medium before being made into individual spheroids and combined to 
form osteo+chondro spheroids using the method described in Section 5.3.2.3. 
Figure 5.4.8 shows osteo+chondro spheroids from the initial combination of the 
two spheroids through to 3 days of culture. The two individual spheroids became 
connected within 8 hours, the spheroids then merged together to form a single 
spheroid by day 3, whilst retaining distinct red/green separation. These spheroids 
were then sectioned to examine the internal organisation (Figure 5.4.9). A clear 
separation between the two different spheroids is still visible at day 1; however, 
the spheroids have begun to merge together. The osteogenic MSCs (red) and 
chondrogenic MSCs (green) remain segregated, however, an integrated 
osteochondral boundary forms between the two cell types. 
The osteo+chondro spheroids sections were then separated into osteogenic and 
chondrogenic regions, this is highlighted by the red and green dotted lines shown 
in Figure 5.4.10-A. The spheroid sections were the analysed after days 1, 2 and 3 
in culture, a significantly greater pixel intensity of CellTracker™ red was detected 
in osteogenic regions whilst a significantly greater pixel intensity of CellTracker™ 
green was detected in chondrogenic regions (Figure 5.4.10-B).  Per time point 
and condition three spheroids from two different biological donors were analysed 
(n=6) 
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Figure 5.4.8 – Osteo+Chondro 3D spheroids during culture 
Osteogenic MSC and chondrogenic MSC 3D spheroids containing a total of 
15,000 cells were generated separately. After 24 hours in culture, these two 
spheroids were then combined in the same well, within 8 hours the two separate 
spheroids connect, by day 3 they have merged together to form a single 
spheroid. 
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Figure 5.4.9 – Osteo + Chondro spheroid sections with magnification of 
osteochondral boundary 
Osteo + chondro spheroid were sections to observe internal organisation. Clear 
distinction between the two spheroids can be seen at day 1, however, by day 3 
the spheroids have merged together to form a single spheroid. 
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Figure 5.4.10 – Osteo + Chondro spheroid section analysis of osteogenic 
and chondrogenic regions 
A – Day 3 osteo + chondro spheroid section separated into osteogenic and 
chondrogenic regions using red and green dotted lines respectively. B – 
Quantification of the CellTracker™ red or green intensity within the osteogenic or 
chondrogenic regions at days 1, 2 and 3. A significantly greater quantity of 
CellTracker™ red was detected in osteogenic regions and a significantly greater 
quantity of CellTracker™ green was detected in chondrogenic regions. Per time 
point and condition three individual spheroids from two biological donors were 
analysed (n=6). 
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5.4.4 Expression of bone, cartilage and endothelial cell markers in 
various osteochondral spheroid during long term in vitro culture  
From these initial studies, three spheroid combinations were assessed for 
expression of bone, cartilage and endothelial markers through 
immunofluorescent labelling (Section 2.3.2). This was done to independently 
verify the distribution and function of osteogenic MSCs, chondrogenic MSCs and 
ECs with the spheroids. The spheroids studied were osteochondral (OC) 
spheroids composed of a 50-50 mixture osteogenic and chondrogenic MSCs; 
osteo+chondro (O+C) spheroids these were created through the combination of 
an osteogenic MSC spheroid and a chondrogenic MSC spheroid  
(Section5.3.2.3); and osteochondral and endothelial (OCE) spheroids containing 
an equal mixture of endothelial cells, osteogenic and chondrogenic MSCs. To act 
as a control MSC-only spheroids were cultured in basal conditions. All other 
spheroids were cultured in 3D osteochondral medium. 
The various osteochondral spheroid combinations were cultured for 21 days 
before being sectioned and immunofluorescently labelled for collagen type I, 
collagen type II, CD31, Sox 9 and osteonectin (Figure 5.4.11). Collagen type I 
and osteonectin are bone markers; collagen type II and Sox 9 are cartilage 
markers. Positive collagen type I staining and limited collagen type II staining 
were observed within OC, OCE and O+C spheroid sections. Within OC and O+C 
sections collagen type I and II staining appeared laterally separated. OCE 
sections collagen type II appeared more predominantly within the centre of the 
section whilst collagen type I was predominant at the spheroid surface. Positive 
CD31 staining was only observed within OCE spheroid sections; this staining 
appeared evenly distributed throughout the spheroid. No positive Sox 9 staining 
was observed within any spheroid section. Positive osteonectin staining was 
observed within OC, OCE and O+C spheroid sections; this staining appeared to 
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be evenly distributed through the spheroid. These observations confirm the 
cellular distribution observed within Section 5.4.2 and 5.4.3. 
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Figure 5.4.11 – Immunofluorescent labelled of various osteochondral 
spheroid combinations for bone, cartilage and endothelial markers 
Immunofluorescent labelling of various osteochondral spheroid combinations was 
performed after 21 days in culture. Collagen type I and osteonectin are bone 
markers; collagen type II and Sox9 are cartilage markers. Positive collagen type I 
staining was observed in OC, OCE and O+C spheroid sections. Minimal collagen 
type II staining was observed in OCE and O+C spheroid sections. CD31 staining 
was only observed in OCE spheroid sections. Sox 9 staining was not observed 
for any osteochondral spheroid combination. Osteonectin staining was observed 
in OC, OCE and O+C spheroid sections.  
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5.4.5 Effects of PDGFR, FGFR and Notch inhibition on osteochondral 
spheroids  
To determine the role of signalling mechanisms in osteochondral spheroids, 
specifically the mechanisms involved in the lateral self-organisation pattern 
previously observed (Section 5.4.2). Whole spheroids were cultured with the 
addition of various inhibitors of PDGF, FGF and Notch signalling pathways at the 
concentrations described in Section 4.3.3. Inhibitor treatment was added to the 
cell suspension prior spheroid formation. To act as a control MSC-only (M-only) 
spheroids were produced, these contained a 50-50 mixture of MSCs stained with 
CellTracker™ green and red. The inhibitors used were PDGFRi, FGFRi and DBZ 
(Notch inhibitor) more details of these can be found on Table 4.3.2; these three 
inhibitor treatments were used as PDGF, FGF and Notch signalling have been 
linked with osteochondral defects. PDGF and FGF have been shown to enhance 
healing of osteochondral defects (Younger et al., 2015, Maehara et al., 2010). In 
contrast, Notch signalling has been shown to inhibit osteochondral healing 
through hindering osteogenic differentiation of MSCs (Matthews et al., 2014). The 
spheroids were culture for up to 3 days with the various inhibitor treatments and 
representative images can be seen in Figure 5.4.12. PDGFRi treatment resulted 
in much larger spheroids; however, no visual differences were observed with the 
other inhibitor treatments.  
The whole spheroid images were analysed to calculate the spheroid diameter 
and the percentage of green labelled MSCs at the spheroid surface (Figure 
5.4.13). The whole spheroid image analysis provides a rapid high throughput 
technique to quantify spheroid organisation. PDGFRi treatment resulted in a 
significantly greater spheroid diameter compared to untreated control OC 
spheroids at days 1, 2 and 3. No significant differences were observed for any 
other inhibitor treatment. The percentage of green labelled MSCs at the spheroid 
surface was not affected by the various inhibitor treatments. 
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To observe internal organisation the spheroids were sectioned (Figure 5.4.14). 
Untreated control OC spheroids appeared to have a lateral separation, 
osteogenic MSCs (red) appeared to separate from chondrogenic MSCs (green). 
This separation of the two different cell types occurred within untreated control 
OC spheroids and with PDGFRi, FGFRi and DBZ inhibitor treatments. Therefore, 
inhibitor treatments appeared to not affect the organisation of osteogenic or 
chondrogenic MSCs in osteochondral spheroids. MSC-only sections showed a 
random distribution of green and red labelled MSCs. 
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Figure 5.4.12 – Whole 3D osteochondral spheroids treated with various 
inhibitors 
Whole 3D osteochondral spheroids were treated with the various inhibitors; 
PDGFRi, FGFRi and DBZ (Notch inhibitor) and representative images are shown 
from n=6 independent observations. The inhibitor was added to the cell 
suspension, prior to spheroid formation. PDGFRi treatment appeared to result in 
larger spheroids; however, no additional visual differences were observed. 
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Figure 5.4.13 – Spheroid diameter and surface analysis of osteochondral 
spheroids treated with various inhibitors 
Spheroid diameter of the osteochondral spheroids treated with various inhibitors, 
showed PDGFRi treatment resulted in significantly larger spheroids at days 1, 2 
and 3. No other significant differences in spheroid diameter or percentage of 
green labelled MSCs at the spheroid surface were detected. Per time point and 
condition three spheroids from two different biological donors were analysed 
(n=6). 
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Figure 5.4.14 – Osteochondral spheroid sections treated with various 
inhibitors 
: Pre-differentiation of MSCs and ECs - A 3D in vitro Osteochondral Model 
Page | 216  
 
Osteochondral spheroids treated with various inhibitors were sectioned to 
observed internal organisation and representative images are shown from n=6 
independent observations. Osteochondral (OC) spheroids appeared to have a 
lateral separation, osteogenic MSCs (red) appeared to separate from 
chondrogenic MSCs (green). This separation of the two different cell types 
occurred within untreated control OC spheroids and with various inhibitor 
treatments (PDGFRi, FGFRi and DBZ). MSC-only sections appeared to show a 
random distribution of green and red labelled MSCs. 
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5.5 Discussion 
MSCs were pre-differentiated for either 7 or 14 days to determine the period of 
time required to sustain either an osteogenic or chondrogenic lineage within an 
osteochondral medium developed to maintain both differentiated phenotypes. An 
osteochondral medium able to support both osteogenic and chondrogenic MSCs 
in culture has yet to be fully established (Rodrigues et al., 2012). However, 
attempts have been made by combining the components of both osteogenic and 
chondrogenic culture media (Li et al., 2009).  
MSCs were pre-differentiated in osteogenic or chondrogenic medium for 7 or 14 
days followed by a further 14 or 7 days in osteochondral medium respectively. All 
pre-differentiated samples and control samples were cultured for a total of 21 
days unless otherwise stated. Pre-differentiated osteogenic MSCs stained 
positively for the osteogenic stains Alizarin red, ALP and von Kossa. However, 
pre-differentiated osteogenic MSCs stained negatively for the chondrogenic stain 
Alcian blue. The same positive and negative staining was observed in control 
osteogenic MSCs. Pre-differentiated chondrogenic MSCs stained positively for 
the osteogenic stain Alizarin red, however, ALP and von Kossa staining were 
negative; the chondrogenic stain Alcian blue was positive. The same positive and 
negative staining patterns were also observed in control chondrogenic MSCs.  
Positive Alizarin red staining can be attributed to staining calcium, therefore, this 
is not an osteogenic specific stain (Paul et al., 1983). 
To identify if pre-differentiation had an effect on the spheroid formation capacity 
of MSCs, 7 and 14 day pre-differentiated MSCs were placed in U-bottomed well 
plates. 3D whole spheroid imaging was performed after 24 hours to allow 
structural observations. Four different combinations using osteogenic and 
chondrogenic pre-differentiated MSCs were performed, it was found that 14 days 
of pre-differentiation had a detrimental effect on spheroid formation for 
chondrogenic MSCs. This made 14 day pre-differentiation unsuitable for future 
studies, therefore, 7 days of pre-differentiation was used for all further 
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experiments. Pre-differentiation of MSCs has been previously described as 
having detrimental effects on their proliferation and cell attachment potential 
(Fensky et al., 2014). Therefore, pre-differentiation may have decreased the cell 
adhesion molecules on the cell membrane of MSCs, these are essential for 
spheroid formation. Indeed the loss of the cell adhesion molecule α5-integrin has 
been shown to result in complete spheroid failure in ovarian cancer models 
(Casey et al., 2001).  
Previous osteochondral models have specifically only used osteogenic and 
chondrogenic MSCs (Babur et al., 2015, Guo et al., 2009, Marquass et al., 2010). 
However, native bone is a highly vascularised tissue and ECs play a key role in 
bone tissue homeostasis and repair following injury (Findlay, 2007, Stegen et al., 
2015). Therefore, combining osteogenic and chondrogenic MSCs with ECs would 
more closely represent the native environment. This resulted in up to three 
different cell types being cultured in 3D spheroids. Using the CellTracker™ 
labelling techniques previously described CellTracker™ blue was used to identify 
the additional cell type. CellTracker™ blue in combination with CellTracker™ 
green and red were able to individual identify fluorescently labelled ECs, 
chondrogenic and osteogenic MSCs. Spectral analysis of the three different 
CellTracker™ colours, showed separated peak emission wavelengths with little 
emission overlap. Tri-culture of 3D cell aggregates has been previously 
performed, however, within this system only two cell types were fluorescently 
labelled (Takebe et al., 2013).  
The three different cell types; osteogenic MSCs, chondrogenic MSCs and ECs 
were used to produce various osteochondral spheroid combinations, these 
combinations were: OC, OE, CE and OCE. These combinations were able to 
successfully produce 3D spheroids; however, observations of internal 
organisation demonstrated that OC and OCE spheroids underwent spontaneous 
cellular self-organisation. OC spheroids demonstrated a lateral separation of the 
osteogenic and chondrogenic MSCs. In contrast OCE spheroids demonstrated a 
central region that was predominantly green (chondrogenic MSCs) and outer 
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region that was predominantly red (osteogenic MSCs). Similar organisation to 
OCE spheroids has been artificially created through the addition of cell 
suspensions to existing cell spheroids (Urich et al., 2013). Further analysis of this 
organisation patterns through quantification of CellTracker™ green, red or blue 
confirmed these organisation patterns. Specifically OC spheroid sections were 
confirmed to have significantly more red labelled osteogenic MSCs within the 
manually defined osteogenic regions and significantly more green labelled 
chondrogenic MSCs in the chondrogenic regions. This demonstrates that manual 
CellTracker™ quantification was able to identify the osteogenic and chondrogenic 
MSC distribution within the spheroids. This technique had even greater 
importance when analysing OCE spheroid sections. Within these spheroid 
sections a core and outer region was manually identified, however, through 
CellTracker™ quantification of these regions it was possible to identify that ECs 
were evenly distributed between these regions. Therefore, the core region was a 
combination of mainly chondrogenic MSCs and ECs, whilst the outer region was 
mainly osteogenic MSCs and ECs. The organisation pattern observed within 
OCE spheroid sections shows similarities to those within early endochondral 
ossification. Specifically a cartilage core surrounded by a bone outer layer; this 
cartilage core is then infiltrated by new blood vessels triggering resorption of the 
cartilage core matrix and replacement with functional vascularised bone 
tissue.(Rodrigues et al., 2012, Scotti et al., 2010, Scotti et al., 2013). 
The concept of creating osteochondral tissue has been performed using a variety 
of different techniques; in vitro these have usually been conducted using 
scaffolds (Angele et al., 1999, Fensky et al., 2014). However, these in vitro 
techniques are often limited due to the requirement of two separate medium 
sources and/or complex scaffold design. Therefore, generating a cell-only 
osteochondral model using an osteogenic MSC spheroid combined with a 
chondrogenic MSC spheroid could be beneficial. Osteogenic MSC spheroids and 
chondrogenic MSC spheroids were combined together after 24 hours in culture; 
within 8 hours the two separate spheroids formed an integrated osteochondral 
boundary. Within 3 days the two separate spheroids merged together to form a 
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single spheroid. A similar study was successfully performed using bone-like and 
cartilage-like cells derived from MSCs in a micropellet or microspheroid 
formation;, 24,000 of these individual micropellets were then layered together to 
create a biphasic structure. The micropellets amalgamated to form a continuous 
structure with bone-like and cartilage-like regions  (Babur et al., 2015). This proof 
of concept study showed that bone-like and cartilage-like MSCs could be cultured 
together, however, the method used to produce the cellular structure was highly 
complex and labour intensive. 
Spheroid section analysis of osteo+chondro spheroids showed a distinct 
separation between the two spheroids after 24 hours in culture together, after 3 
days the osteochondral boundary was still well defined. Through quantification of 
CellTracker™ green and red within the osteogenic and chondrogenic regions this 
distinction between the two regions was significantly different for all time points. 
With single and multi-cellular aggregates limited cellular migration has been 
reported (Thompson et al., 2012, Bauer et al., 2012). This limitation migration is 
attributed towards a dense cellular network and strong cell-cell contacts. Within 
the context of an osteochondral boundary this limited cell migration is desired, 
within the native environment bone and cartilage tissue are clearly separated, 
however, the diffusion of oxygen, nutrients and waste products is essential for 
both tissues homeostasis (Smith and Mansour, 2000).  
To determine the long-term bone and cartilage formation within various 
osteochondral spheroid combinations, immunofluorescent labelling was 
performed on day 21 spheroid sections. Spheroid sections were stained for the 
bone markers collagen type I and osteonectin, cartilage markers collagen type II 
and Sox 9 and CD31 for ECs. Positive collagen type I staining was observed in 
OC, OCE and O+C spheroid sections, limited collagen type II staining was 
observed within the same sections. Within OC and O+C sections collagen type I 
and II staining appeared more laterally separated, whilst within OCE section 
collagen type I appeared more predominantly at the spheroid surface and 
collagen type II appeared more predominantly at the spheroid core. This 
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organisation confirms the organisation patterns seen within CellTracker™ 
labelled spheroids. No positive Sox 9 staining was observed within any spheroid 
section, however, Sox 9 is a transient marker of chondrogenic differentiation and 
is frequently described as an early marker (Antunes et al., 2015, Hardingham et 
al., 2006). Therefore, Sox 9 expression could have been missed. Positive CD31 
staining was only observed within OCE spheroids, this result was expected as 
these were the only spheroids that contained ECs. The CD31 staining appeared 
to be evenly distributed throughout the spheroid, confirming the results previous 
observed through CellTracker™ analysis. Positive osteonectin staining appeared 
evenly distributed within OC, OCE and O+C spheroid sections. Osteonectin is a 
traditional bone marker, however, it has been observed within both senescent 
MSCs and cartilage tissue (Juhasova et al., 2011, Vidal et al., 2012, 
Chandrasekhar et al., 1994). Within OCE sections this osteonectin staining was 
particularly strong; this might have been attributed towards chondrogenic MSCs 
in the presence of both osteogenic MSCs and ECs undergoing a transition into 
bone tissue. Within the native bone following injury cartilage tissue initially forms 
before being replaced with vascularised bone tissue, a similar process also 
occurs in endochondral ossification (Tannous et al., 2013, Sisask et al., 2013, 
Chan et al., 2009). A similar transition might have occurred in OC and O+C; 
however, due to a lack of ECs osteonectin staining was not as strong. Indeed, 
ECs have been shown to enhance the osteogenic differentiation potential of 
MSCs (Saleh et al., 2011a, Gershovich et al., 2013). Overall the 
immunohistochemical staining was poor, these results were mainly attributed 
towards problems with the primary antibodies. Positive controls such as HeLa 
were stained and negative results were observed for many of the primary 
antibodies. A positive control of human bone sections was also trialled, however, 
human bone is highly auto-fluorescent preventing confirmation of the primary 
antibody. 
To determine possible signalling mechanisms responsible for the organisation 
pattern observed within osteochondral spheroids, PDGFRi, FGFRi and DBZ were 
added to OC cell suspensions prior to spheroid formation. 3D whole spheroid 
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images were taken and analysed to assess spheroid diameter and percentage of 
green labelled MSCs at the spheroid surface. PDGFRi treatment resulted in a 
significantly greater spheroid diameter at all time points compared to untreated 
control OC spheroids. This result is consistent with the effects of PDGFRi 
treatment on co-cultured MSC-EC spheroids (Section 4.4.5). PDGF signalling 
has been shown to affect the shape of MSCs in 2D culture, the addition of a 
similar small molecular inhibitor of PDGFR resulted in MSCs having a more 
rounded shape (Ball et al., 2012). More specifically PDGF signalling has been 
linked to controlling cell size within Drosophila, therefore, inhibition of this cell 
signalling pathway could result in larger cells and subsequently larger spheroids 
(Sims et al., 2009). To observe internal organisation, the OC spheroids treated 
with the various inhibitors were sectioned and no differences in spheroid 
organisation were observed with inhibitor treatments. All spheroid sections 
appeared to demonstrate a lateral separation of osteogenic and chondrogenic 
MSCs. Increased PDGF expression has been observed within the osteochondral 
region of patients with osteoarthritis, however, this occurred in conjunction with 
increased VEGF expression. Therefore, PDGF expression could be a 
consequence of VEGF (Walsh et al., 2010). FGF treatment has been 
successfully used to improve osteochondral defects within rabbits (Maehara et 
al., 2010). However, FGF treatment is known to increase cell proliferation and 
improve wound healing (Budiraharjo et al., 2013). Notch signalling modulation 
has been shown to effect osteochondral fracture healing, however, Notch is 
believed to regulate osteogenic differentiation (Matthews et al., 2014). The 
regulatory role of a signalling pathway in osteochondral cell organisation is 
currently unknown. 
Overall the results within this chapter demonstrate that MSCs are a useful cell 
source for in vitro modelling of osteochondral tissues. Specifically MSCs require 
only 7 days of pre-differentiation in either osteogenic or chondrogenic conditions 
to generate distinctive and separate osteogenic MSCs or chondrogenic MSCs. 
These cells could then be used in a variety of combinations with the addition of 
ECs to create an osteochondral spheroid. Using these cells it was possible to 
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recreate in vitro an osteochondral boundary and by specifically combining all 
three cell types produced a unique self-organised endochondral ossification-like 
model. Where chondrogenic MSCs were at the core of the spheroid, osteogenic 
MSCs were at the periphery of the spheroid and ECs were evenly distributed 
throughout. The organisation and function of these regions was confirmed using 
immunofluorescent labelling; OCE spheroids expressed the known bone markers 
collagen type I and osteonectin and the cartilage marker collagen type II. 
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Chapter 6 : Discussion 
The work within this thesis has primarily focused on using MSCs and ECs in a 
novel 3D co-culture to generate in vitro models. MSCs were chosen due to them 
being a stem cell with great potential for tissue engineering and regenerative 
medicine. MSCs have been successfully used within a wide variety of studies 
such as; bone repair, immunity disorders and ischemia (Lu et al., 2014, Introna et 
al., 2014, Bhang et al., 2012b). ECs were specifically chosen due to MSCs 
principally residing within vascularised tissues; indeed this relationship with the 
vasculature is so important it has been hypothesised that MSCs reside within a 
perivascular niche (Crisan et al., 2008, Shi and Gronthos, 2003). Therefore, 
direct co-culture of MSCs and ECs in 3D would more closely represent the native 
environment. Direct co-culture of MSCs and ECs in 3D was found to enhance the 
osteogenic potential of MSCs using qualitative staining and quantitatively using 
the novel calcium depletion from culture medium method (Chapter 3). Using 
fluorescent labelling in combination with 3D co-culture it was possible to track 
and identify cell types within the spheroids using non-destructive 3D confocal 
imaging and destructive spheroid sectioning. These techniques were then utilised 
to understand the possible mechanisms responsible for the unique lattice-like 
self-organisation pattern observed in 3D spheroid co-culture of MSCs and ECs 
specifically (Chapter 4). This fluorescent labelling was then used in conjunction 
with osteogenic and chondrogenic differentiation of MSCs and ECs to create a 
variety of osteochondral models (Chapter 5). 
6.1 ECs enhance the osteogenic differentiation potential of 
MSCs in 3D 
Studies have previously observed that direct and in-direct culture of ECs 
enhanced the osteogenic differentiation potential of MSCs; this effect is attributed 
towards a paracrine factor secreted by ECs (Saleh et al., 2011a, Saleh et al., 
2011b, Gershovich et al., 2013). However, these studies relied upon qualitative 
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staining in 3D studies; consequently statistical analysis was not performed. 
Therefore, a novel method to quantitatively assess MSC osteogenic 
differentiation specifically in 3D and also 2D was developed. Calcium deposition 
is an important factor in the osteogenic differentiation of MSCs, bone ECM is 
primarily composed of calcium based compounds and Alizarin Red S a common 
bone stain specifically binds to calcium (Wen et al., 2012, Paul et al., 1983). 
Therefore, it was hypothesised that during osteogenic differentiation of MSCs, 
soluble calcium within the culture medium would be converted into insoluble 
calcium salt deposits. Therefore, calcium ion depletion from culture medium was 
quantified and found to quantitatively assess osteogenic differentiation of MSCs 
in both 2D and 3D culture.  
Using this method in conjunction with traditional staining it was observed that 
ECs were able to significantly improve the osteogenic differentiation potential of 
MSCs in 3D co-culture (Figure 3.4.11and Figure 3.4.12). Calcium depletion offers 
a non-destructive, sensitive and real-time technique to assess osteogenic 
differentiation. Indeed alternative methods such as Alizarin Red S staining and 
quantification were found to produce false positive results in unique 
circumstances. Specifically it was found that Donor 3 (K107) was an osteogenic 
inert donor, however, Alizarin Red S staining and quantification found significant 
differences between basal and osteogenic medium at day 21. However, using 
calcium depletion no statistically significant differences were observed, further 
verifying this method to quantitatively assess osteogenic differentiation in both 2D 
and 3D. 
6.2 Fluorescent labelled of MSCs and ECs for spheroid 
organisation assessment 
Previous work within the laboratory found that when MSCs and ECs were co-
cultured together in 3D, a unique self-organisation pattern of ECs developed. 
This pattern was described as a capillary-like structure and comparable 
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observations have been made in other studies involving the co-cultures of MSCs 
and ECs (Saleh et al., 2011b, Takebe et al., 2013, Rivron et al., 2012). However, 
the underlying mechanisms and if MSCs are directing ECs remained unclear. In 
this study fluorescent labelling using CellTracker™ green, red and blue were 
used in conjunction with 3D and 4D imaging techniques to track multiple cell 
types within a spheroid. Using these techniques, it was possible to non-
destructively quantify the spheroid diameter, volume and surface. These 
measurements in conjunction with spheroid sections to observe internal 
organisation and subsequent quantification of the EC network resulted in a 
tractable model. Untreated control MSC-EC spheroid formation was assessed 
and found to initially be controlled by the differential adhesion hypothesis, 
resulting in ECs migrating towards the periphery of the spheroid during formation. 
However, after this ECs began to migrate into the spheroid producing a lattice-
like network (Figure 4.4.5). From direct comparison of untreated control MSC-EC 
and HDF-EC spheroids it was determined that MSCs were able to direct ECs into 
forming a lattice-like network, within HDF-EC spheroids no EC network was 
detected. Therefore, the EC network observed within MSC-EC spheroids was not 
caused by an innate ability.  
Subsequently the in vitro model was used to determine the possible underlying 
cell signalling mechanism responsible. Five different small molecule inhibitors 
were trialled; FGFRi, PDGFRi, EGFRi, ILKi and DBZ, these were chosen due to 
their association with MSC migration, EC migration or angiogenesis (Dos Santos 
et al., 2014, Wyler von Ballmoos et al., 2010, Liao et al., 2014, Lu et al., 2013). 
These were found to have a various effects; FGFRi appeared to most 
predominantly affect EC migration, PDGFRi strongly affected EC network 
organisation and spheroid size, EGFRi had no effect, ILKi principally affected 
MSC migration and DBZ mainly affected EC migration. However, this model 
could not be used to directly confirm effects specific to these signalling pathways, 
to do this inhibition or significant decrease of specific downstream signalling 
molecules would be required. This model was then developed further to 
incorporate osteogenic MSCs, chondrogenic MSCs and ECs to create various 
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osteochondral models. Different cell combinations were trialled and three strong 
candidates were established; OC, osteo+chondro and OCE. All three of these 
combinations produced unique organisation patterns of distinct functional 
regions. OC spheroids self-organised into separated regions of osteogenic MSCs 
and chondrogenic MSCs (Figure 5.4.6). Osteo+chondro spheroids were formed 
from the combination of two individual spheroids to produce a distinct 
osteochondral boundary (Figure 5.4.10). OCE spheroids self-organised into an 
outer and core region, further analysis found the outer region containing mainly 
osteogenic MSCs, the core region predominantly contained chondrogenic MSCs 
and ECs were evenly distributed throughout (Figure 5.4.7).  
6.3  Future Directions 
There are two main areas of further research that have been highlighted in this 
work. Firstly, the use of 3D spheroid co-cultures of MSCs and ECs as a high 
throughput screening technique. The self-organisation observed within these 
spheroids was highly similar to those observed in 2D culture of ECs on matrigel, 
the culture of ECs on matrigel is commonly used as an angiogenesis model 
(Mezentsev et al., 2005). Additional experiments would be required to confirm the 
effects of inhibiting specific signalling pathways, specifically known downstream 
signalling molecules would need to be inhibited or significantly reduced. 
Enhancement of the specific signalling pathways could also be used to further 
clarify these effects. However, overall the 3D spheroid co-culture of MSCs and 
ECs could be utilised as a possible 3D in vitro angiogenesis model. Further 
analysis of this model could be performed using genome editing technologies 
such as clustered regularly interspaced short palindromic repeats (CRIPSR) or 
transcription activator-like effector nucleases (TALENs) to knockout specific 
signalling molecules in only MSCs or ECs (Park and Telugu, 2013).  
The second area of interest is in the further development of osteogenic MSCs 
and chondrogenic MSCs for osteochondral and endochondral ossification 
applications. Functional observations into known markers such as collagen type 
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X, osteocalcin and osteonectin could be used to verify the functionality and ratify 
these cells within an osteochondral and/or endochondral ossification model 
(Scotti et al., 2013). These results could be further confirmed through the use of 
the inhibitor molecules such as; FGFRi or PDGFRi to hinder osteogenic and 
chondrogenic differentiation of MSCs during long term culture. 
6.4 Conclusions 
The work present here demonstrates how MSCs are a highly versatile stem cell 
source. MSCs combined with ECs in the 3D spheroid culture system were able to 
enhance the osteogenic potential of MSCs; this was quantified and confirmed 
using the novel calcium depletion from culture medium method. The culture 
system was then developed to incorporate fluorescent labelling to identify and 
track a specific cell type within the 3D spheroid for up to 7 days. Using these 
techniques it was possible to identify that MSCs direct ECs to self-assembling 
into a lattice-like network with organisational similarities to angiogenesis. The 
underlying mechanisms responsible for this were found to be strongly linked to 
FGF, PDGF and Notch signalling. Finally MSC pre-differentiation to either an 
osteogenic or chondrogenic lineage was found to create osteochondral tissue 
with a defined boundary. Combination of these MSCs with ECs was found to 
result in a unique self-organisation pattern with structural and functional 
similarities to adult bone repair and endochondral ossification.  
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List of Abbreviations 
ALP – Alkaline Phosphatise  
BMP – Bone morphogenetic protein 
BSA – Bovine Serum Albumin  
CPC - Cetylpyridinium chloride 
CRISPR - Clustered regularly interspaced short palindromic repeats 
DAPI - 4’, 6- diamidino-2-phenylindole 
DBZ – Dibenzazepine (Notch inhibitor) 
DFM - Deferoxamine mesylate 
DMEM – Dulbecco’s modified Eagle medium 
ECM – Extra cellular matrix 
ECs – Endothelial cells 
EGF – Epidermal growth factor 
EGFR – Epidermal growth factor receptor 
EGFRi – Epidermal growth factor receptor inhibitor 
ESCs – Embryonic stem cells 
FBS – Foetal bovine serum 
FGF – Fibroblast growth factor 
FGFR – Fibroblast growth factor receptor 
FGFRi – Fibroblast growth factor receptor inhibitor 
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HDFs – Human Dermal Fibroblasts  
HIF-1α - Hypoxia inducible factor one alpha 
HSCs – Haematopoietic stem cells 
HUVECs – Human umbilical vein endothelial cells 
IGF – Insulin-like growth factor 
ILK – Integrin-linked kinase 
ILKi – Integrin-linked kinase inhibitor 
ICD – Intracellular domain  
iPS – Induced pluripotent stem cells  
JAK - Janus Kinase 
LIF – Leukaemia inhibitor factor 
MAPK – Mitogen activated protein kinase 
MHC – Major histocompatible complex 
MSCs – Mesenchymal stromal cells or Mesenchymal stem cells 
OC – Osteochondral 
OCE – Osteochondral endothelial 
OCT – Optimised cutting tissue  
ON - Osteonectin 
PBS – Phosphate buffer saline 
PDGF – Platelet-derived growth factor 
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PDGFR – Platelet-derived growth factor receptor 
PDGFRi – Platelet-derived growth factor receptor inhibitor 
PECAM-1 - Platelet endothelial cell adhesion molecule 
PFA – Paraformaldehyde 
PI3K - Phosphoinositide 3-kinase 
PLC-γ - Phosphoinositide phospholipase C-γ 
P/S – Penicillin-streptomycin  
SHG – Second harmonic generation 
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